1. Coronavirus diagnosed at mink farms in North Brabant. NOS 2020. https://nos.nl/artikel/2331784- coronavirus-vastgesteld-bij-nertsenfokkerijen-in-noord-brabant.html
2. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2022926
3. First case of SARS-CoV-2 in mink confirmed in Oregon. Oregon Department of Agriculture: 2020. https://odanews.wpengine.com/first-case-of-sars-cov-2-in-mink-confirmed-in-oregon/
4. In Response: Yan et al. Preprint Examinations of the Origin of SARS-CoV-2; Johns Hopkins Bloomberg School of Public Health, Center for Health Security: 2020. https://www.centerforhealthsecurity.org/our- work/pubs_archive/pubs-pdfs/2020/200921-in-response-yan.pdf
5. India's new paper Covid-19 test could be a ‘game changer’. BBC 2020. https://www.bbc.com/news/world-asia-india-54338864
6. Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings. Annals of Internal Medicine 0 (0), null. https://www.acpjournals.org/doi/abs/10.7326/M20-3213
7. Research Shows Virus Undetectable on Five Highly Circulated Library Materials After Three Days. Institute for Library and Museum Services: 2020. https://www.imls.gov/news/research-shows-virus- undetectable-five-highly-circulated-library-materials-after-three-days
8. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020. . MMWR 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e2.htm?s_cid=mm6912e2_w#suggestedcitation 
9. Update Alert: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings. Annals of Internal Medicine 0 (0), null. https://www.acpjournals.org/doi/abs/10.7326/L20-0948
10. 3M, Decontamination of 3M Filtering Facepiece Respirators, such as N95 Respirators, in the United States - Considerations; 3M: 2020. https://multimedia.3m.com/mws/media/1824869O/decontamination-methods-for-3m-filtering- facepiece-respirators-technical-bulletin.pdf
11. AAAS, You may be able to spread coronavirus just by breathing, new report finds. Science 2 April, 2020. https://www.sciencemag.org/news/2020/04/you-may-be-able-spread-coronavirus-just-breathing- new-report-finds
12. Abbott, S.; Hellewell, J.; Thompson, R.; Sherratt, K.; Gibbs, H.; Bosse, N.; Munday, J.; Meakin, S.; Doughty, E.; Chun, J.; Chan, Y.; Finger, F.; Campbell, P.; Endo, A.; Pearson, C.; Gimma, A.; Russell, T.; null, n.; Flasche, S.; Kucharski, A.; Eggo, R.; Funk, S., Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts [version 1; peer review: awaiting peer review]. Wellcome Open Research 2020, 5 (112). https://wellcomeopenresearch.org/articles/5-112/v1
13. Abella, B. S.; Jolkovsky, E. L.; Biney, B. T.; Uspal, J. E.; Hyman, M. C.; Frank, I.; Hensley, S. E.; Gill, S.; Vogl, D. T.; Maillard, I.; Babushok, D. V.; Huang, A. C.; Nasta, S. D.; Walsh, J. C.; Wiletyo, E. P.; Gimotty, P. A.; Milone, M. C.; Amaravadi, R. K., Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre- exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial. JAMA Intern Med 2020.
14. Ackermann, M.; Verleden, S. E.; Kuehnel, M.; Haverich, A.; Welte, T.; Laenger, F.; Vanstapel, A.; Werlein, C.; Stark, H.; Tzankov, A.; Li, W. W.; Li, V. W.; Mentzer, S. J.; Jonigk, D., Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2015432
15. Adam, D.; Wu, P.; Wong, J.; Lau, E.; Tsang, T.; Cauchemez, S.; Leung, G.; Cowling, B., Clustering and superspreading potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in Hong Kong. 2020.
16. Adam, D. C.; Wu, P.; Wong, J. Y.; Lau, E. H. Y.; Tsang, T. K.; Cauchemez, S.; Leung, G. M.; Cowling, B. J., Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nature Medicine 2020. https://doi.org/10.1038/s41591-020-1092-0
17. Adams, M.; Katz, D.; Grandpre, J., Updated Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States. Emerging Infectious Disease journal 2020, 26 (9). https://wwwnc.cdc.gov/eid/article/26/9/20-2117_article
18. Afshar, Y.; Gaw, S. L.; Flaherman, V. J.; Chambers, B. D.; Krakow, D.; Berghella, V.; Shamshirsaz, A. A.; Boatin, A. A.; Aldrovandi, G.; Greiner, A.; Riley, L.; Boscardin, W. J.; Jamieson, D. J.; Jacoby, V. L., Clinical Presentation of Coronavirus Disease 2019 (COVID-19) in Pregnant and Recently Pregnant People. Obstetrics & Gynecology 9900, Latest Articles, 10.1097/AOG.0000000000004178. https://journals.lww.com/greenjournal/Fulltext/9900/Clinical_Presentation_of_Coronavirus_Disease_2 019.2.aspx
19. Agrawal, A. S.; Garron, T.; Tao, X.; Peng, B. H.; Wakamiya, M.; Chan, T. S.; Couch, R. B.; Tseng, C. T., Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol 2015, 89 (7), 3659-70. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403411/pdf/zjv3659.pdf
20. Ahmed, S.; Karim, M. M.; Ross, A. G.; Hossain, M. S.; Clemens, J. D.; Sumiya, M. K.; Phru, C. S.; Rahman, M.; Zaman, K.; Somani, J.; Yasmin, R.; Hasnat, M. A.; Kabir, A.; Aziz, A. B.; Khan, W. A., A five day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis 2020.
21. Ahmed, W.; Bertsch, P. M.; Bibby, K.; Haramoto, E.; Hewitt, J.; Huygens, F.; Gyawali, P.; Korajkic, A.; Riddell, S.; Sherchan, S. P.; Simpson, S. L.; Sirikanchana, K.; Symonds, E. M.; Verhagen, R.; Vasan, S. S.; Kitajima, M.; Bivins, A., Decay of SARS-CoV-2 and surrogate murine hepatitis virus RNA in untreated wastewater to inform application in wastewater-based epidemiology. Environmental Research 2020, 110092. http://www.sciencedirect.com/science/article/pii/S0013935120309890
22. Airora, The development, testing and verification of Airora's patented biocidal technology. https://www.airora.com/verification.html (accessed 19 Oct 2020).
23. Aleta, A.; Martin-Corral, D.; Pastore y Piontti, A.; Ajelli, M.; Litivinova, M.; Chinazzi, M.; Dean, N.; Halloran, M. E.; Longini, I.; Merler, S.; Pentland, A.; Vespignani, A.; Moro, E.; Moreno, Y., Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic. Preprint 2020. https://www.mobs- lab.org/uploads/6/7/8/7/6787877/tracing_main_may4.pdf
24. Ali, S. T.; Wang, L.; Lau, E. H. Y.; Xu, X.-K.; Du, Z.; Wu, Y.; Leung, G. M.; Cowling, B. J., Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions. Science 2020, eabc9004. https://science.sciencemag.org/content/sci/early/2020/07/20/science.abc9004.full.pdf
25. Allen, D., Graphene Face Masks Set to Boost Coronavirus Protection. http://emag.medicalexpo.com/graphene-face-masks-set-to-boost-coronavirus-protection/ (accessed 16 Nov 2020).
26. Allotey, J.; Stallings, E.; Bonet, M.; Yap, M.; Chatterjee, S.; Kew, T.; Debenham, L.; Llavall, A. C.; Dixit, A.; Zhou, D.; Balaji, R.; Lee, S. I.; Qiu, X.; Yuan, M.; Coomar, D.; van Wely, M.; van Leeuwen, E.; Kostova, E.; Kunst, H.; Khalil, A.; Tiberi, S.; Brizuela, V.; Broutet, N.; Kara, E.; Kim, C. R.; Thorson, A.; Oladapo, O. T.; Mofenson, L.; Zamora, J.; Thangaratinam, S., Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta- analysis. BMJ 2020, 370, m3320. https://www.bmj.com/content/bmj/370/bmj.m3320.full.pdf
27. Alsharidah, S.; Ayed, M.; Ameen, R. M.; Alhuraish, F.; Rouheldeen, N. A.; Alshammari, F. R.; Embaireeg, A.; Almelahi, M.; Adel, M.; Dawoud, M. E.; Aljasmi, M. A.; Alshammari, N.; Alsaeedi, A.; Al- Adsani, W.; Arian, H.; Awad, H.; Alenezi, H. A.; Alzafiri, A.; Gouda, E. F.; Almehanna, M.; Alqahtani, S.; Alshammari, A.; Askar, M. Z., COVID-19 Convalescent Plasma Treatment of Moderate and Severe Cases of SARS-CoV-2 Infection: A Multicenter Interventional Study. Int J Infect Dis 2020.
28. Althouse, B. M.; Wenger, E. A.; Miller, J. C.; Scarpino, S. V.; Allard, A.; Hébert-Dufresne, L.; Hu, H., Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control. PLOS Biology 2020, 18 (11), e3000897. https://doi.org/10.1371/journal.pbio.3000897
29. Altmann, D. M.; Douek, D. C.; Boyton, R. J., What policy makers need to know about COVID-19 protective immunity. The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30985-5
30. Alves, A. M.; Yvamoto, E. Y.; Marzinotto, M. A. N.; Teixeira, A. C. d. S.; Carrilho, F. J., SARS-CoV-2 leading to acute pancreatitis: an unusual presentation. The Brazilian Journal of Infectious Diseases 2020. http://www.sciencedirect.com/science/article/pii/S1413867020301392
31. Amoroso, A.; Magistroni, P.; Vespasiano, F.; Bella, A.; Bellino, S.; Puoti, F.; Alizzi, S.; Vaisitti, T.; Boros, S.; Grossi, P. A.; Trapani, S.; Lombardini, L.; Pezzotti, P.; Deaglio, S.; Brusaferro, S.; Cardillo, M., HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity. Transplantation 2020. 
32. An, J.; Wei, R.; Zhou, H.; Luong, T. Q.; Gould, M. K.; Mefford, M. T.; Harrison, T. N.; Creekmur, B.; Lee, M. S.; Sim, J. J.; Brettler, J. W.; Martin, J. P.; Ong-Su, A. L.; Reynolds, K., Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824,650 Patients with Hypertension from a US integrated Healthcare System. J Am Heart Assoc 2020, e017773.
33. Anand, S.; Montez-Rath, M.; Han, J.; Bozeman, J.; Kerschmann, R.; Beyer, P.; Parsonnet, J.; Chertow, G. M., Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)32009-2
34. Anastassopoulou, C.; Gkizarioti, Z.; Patrinos, G. P.; Tsakris, A., Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Hum Genomics 2020, 14 (1), 40. 
35. Andersen, K. G.; Rambaut, A.; Lipkin, W. I.; Holmes, E. C.; Garry, R. F., The proximal origin of SARS- CoV-2. Nature Medicine 2020. https://doi.org/10.1038/s41591-020-0820-9
36. Anderson, E. L.; Turnham, P.; Griffin, J. R.; Clarke, C. C., Consideration of the Aerosol Transmission for COVID-19 and Public Health. Risk Analysis 2020, 40 (5), 902-907. https://onlinelibrary.wiley.com/doi/abs/10.1111/risa.13500
37. Anderson, K., Estimates of the clock and TMRCA for 2019-nCoV based on 27 genomes. http://virological.org/t/clock-and-tmrca-based-on-27-genomes/347 (accessed 01/26/2020).
38. Angus, D. C.; Derde, L.; Al-Beidh, F.; Annane, D.; Arabi, Y.; Beane, A.; van Bentum-Puijk, W.; Berry, L.; Bhimani, Z.; Bonten, M.; Bradbury, C.; Brunkhorst, F.; Buxton, M.; Buzgau, A.; Cheng, A. C.; de Jong, M.; Detry, M.; Estcourt, L.; Fitzgerald, M.; Goossens, H.; Green, C.; Haniffa, R.; Higgins, A. M.; Horvat, C.; Hullegie, S. J.; Kruger, P.; Lamontagne, F.; Lawler, P. R.; Linstrum, K.; Litton, E.; Lorenzi, E.; Marshall, J.; McAuley, D.; McGlothin, A.; McGuinness, S.; McVerry, B.; Montgomery, S.; Mouncey, P.; Murthy, S.; Nichol, A.; Parke, R.; Parker, J.; Rowan, K.; Sanil, A.; Santos, M.; Saunders, C.; Seymour, C.; Turner, A.; van de Veerdonk, F.; Venkatesh, B.; Zarychanski, R.; Berry, S.; Lewis, R. J.; McArthur, C.; Webb, S. A.; Gordon, A. C., Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. Jama 2020. https://jamanetwork.com/journals/jama/fullarticle/2770278
39. Arentz, M.; Yim, E.; Klaff, L.; Lokhandwala, S.; Riedo, F. X.; Chong, M.; Lee, M., Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020. https://doi.org/10.1001/jama.2020.4326
40. Argenziano, M. G.; Bruce, S. L.; Slater, C. L.; Tiao, J. R.; Baldwin, M. R.; Barr, R. G.; Chang, B. P.; Chau, K. H.; Choi, J. J.; Gavin, N.; Goyal, P.; Mills, A. M.; Patel, A. A.; Romney, M.-L. S.; Safford, M. M.; Schluger, N. W.; Sengupta, S.; Sobieszczyk, M. E.; Zucker, J. E.; Asadourian, P. A.; Bell, F. M.; Boyd, R.; Cohen, M. F.; Colquhoun, M. I.; Colville, L. A.; de Jonge, J. H.; Dershowitz, L. B.; Dey, S. A.; Eiseman, K. A.; Girvin, Z. P.; Goni, D. T.; Harb, A. A.; Herzik, N.; Householder, S.; Karaaslan, L. E.; Lee, H.; Lieberman, E.; Ling, A.; Lu, R.; Shou, A. Y.; Sisti, A. C.; Snow, Z. E.; Sperring, C. P.; Xiong, Y.; Zhou, H. W.; Natarajan, K.; Hripcsak, G.; Chen, R., Characterization and Clinical Course of 1000 Patients with COVID-19 in New York: retrospective case series. medRxiv 2020, 2020.04.20.20072116. https://www.medrxiv.org/content/medrxiv/early/2020/04/22/2020.04.20.20072116.full.pdf
41. Arons, M. M.; Hatfield, K. M.; Reddy, S. C.; Kimball, A.; James, A.; Jacobs, J. R.; Taylor, J.; Spicer, K.; Bardossy, A. C.; Oakley, L. P.; Tanwar, S.; Dyal, J. W.; Harney, J.; Chisty, Z.; Bell, J. M.; Methner, M.; Paul, P.; Carlson, C. M.; McLaughlin, H. P.; Thornburg, N.; Tong, S.; Tamin, A.; Tao, Y.; Uehara, A.; Harcourt, J.; Clark, S.; Brostrom-Smith, C.; Page, L. C.; Kay, M.; Lewis, J.; Montgomery, P.; Stone, N. D.; Clark, T. A.; Honein, M. A.; Duchin, J. S.; Jernigan, J. A., Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2008457
42. Asadi, S.; Cappa, C. D.; Barreda, S.; Wexler, A. S.; Bouvier, N. M.; Ristenpart, W. D., Efficacy of masks and face coverings in controlling outward aerosol particle emission from expiratory activities. Scientific Reports 2020, 10 (1), 15665. https://doi.org/10.1038/s41598-020-72798-7
43. Assis, M. S.; Araújo, R.; Lopes, A. M. M., Safety alert for hospital environments and health professional: chlorhexidine is ineffective for coronavirus. Rev Assoc Med Bras (1992) 2020, 66Suppl 2 (Suppl 2), 124-129.
44. AstraZeneca, AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19. https://www.astrazeneca.com/media-centre/press-releases/2020/azd1222hlr.html.
45. Auger, K. A.; Shah, S. S.; Richardson, T.; Hartley, D.; Hall, M.; Warniment, A.; Timmons, K.; Bosse, D.; Ferris, S. A.; Brady, P. W.; Schondelmeyer, A. C.; Thomson, J. E., Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US. JAMA 2020. https://doi.org/10.1001/jama.2020.14348
46. Avanzato, V. A.; Matson, M. J.; Seifert, S. N.; Pryce, R.; Williamson, B. N.; Anzick, S. L.; Barbian, K.; Judson, S. D.; Fischer, E. R.; Martens, C.; Bowden, T. A.; de Wit, E.; Riedo, F. X.; Munster, V. J., Case Study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient. Cell 2020. https://doi.org/10.1016/j.cell.2020.10.049
47. Aziz, M.; Fatima, R.; Assaly, R., Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis. J Med Virol 2020.
48. Badr, H. S.; Du, H.; Marshall, M.; Dong, E.; Squire, M. M.; Gardner, L. M., Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study. The Lancet Infectious Diseases 2020. https://doi.org/10.1016/S1473-3099(20)30553-3
49. Bae, S. H.; Shin, H.; Koo, H.-Y.; Lee, S. W.; Yang, J. M.; Yon, D. K., Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight. Emerging Infectious Disease journal 2020, 26 (11). https://wwwnc.cdc.gov/eid/article/26/11/20-3353_article
50. Bai, Y.; Yao, L.; Wei, T.; Tian, F.; Jin, D.-Y.; Chen, L.; Wang, M., Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA.
51. Baig, A. M., Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers. Journal of Medical Virology 2020, n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26624
52. Bailey, L. C.; Razzaghi, H.; Burrows, E. K.; Bunnell, H. T.; Camacho, P. E. F.; Christakis, D. A.; Eckrich, D.; Kitzmiller, M.; Lin, S. M.; Magnusen, B. C.; Newland, J.; Pajor, N. M.; Ranade, D.; Rao, S.; Sofela, O.; Zahner, J.; Bruno, C.; Forrest, C. B., Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. JAMA Pediatrics 2020. https://doi.org/10.1001/jamapediatrics.2020.5052
53. Baldassarri, M.; Picchiotti, N.; Fava, F.; Fallerini, C.; Benetti, E.; Daga, S.; Valentino, F.; Doddato, G.; Furini, S.; Giliberti, A.; Tita, R.; Amitrano, S.; Bruttini, M.; Croci, S.; Meloni, I.; Pinto, A. M.; Gabbi, C.; Sciarra, F.; Venneri, M. A.; Gori, M.; Sanarico, M.; Crawley, F. P.; Pagotto, U.; Fanelli, F.; Mezzullo, M.; Dominguez-Garrido, E.; Planas-Serra, L.; Schluter, A.; Colobran, R.; Soler-Palacin, P.; Lapunzina, P.; Tenorio, J.; Pujol, A.; Castagna, M. G.; Marcelli, M.; Isidori, A. M.; Renieri, A.; Frullanti, E.; Mari, F., Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in males. medRxiv 2020, 2020.11.04.20225680. http://medrxiv.org/content/early/2020/11/05/2020.11.04.20225680.abstract
54. Bao, L.; Gao, H.; Deng, W.; Lv, Q.; Yu, H.; Liu, M.; Yu, P.; Liu, J.; Qu, Y.; Gong, S.; Lin, K.; Qi, F.; Xu, Y.; Li, F.; Xiao, C.; Xue, J.; Song, Z.; Xiang, Z.; Wang, G.; Wang, S.; Liu, X.; Zhao, W.; Han, Y.; Wei, Q.; Qin, C., Transmission of SARS-CoV-2 via close contact and respiratory droplets among hACE2 mice. The Journal of Infectious Diseases 2020. https://doi.org/10.1093/infdis/jiaa281
55. Barakat, T.; Muylkens, B.; Su, B.-L., Is Particulate Matter of Air Pollution a Vector of Covid-19 Pandemic? Matter 2020, 3 (4), 977-980. http://www.sciencedirect.com/science/article/pii/S2590238520305129
56. Barnkob, M. B.; Pottegård, A.; Støvring, H.; Haunstrup, T. M.; Homburg, K.; Larsen, R.; Hansen, M. B.; Titlestad, K.; Aagaard, B.; Møller, B. K.; Barington, T., Reduced prevalence of SARS-CoV-2 infection in ABO blood group O. Blood Advances 2020, 4 (20), 4990-4993. https://doi.org/10.1182/bloodadvances.2020002657
57. Barrington, L.; Cornwell, A., China's Sinopharm begins late stage trial of COVID-19 vaccine in UAE. https://www.reuters.com/article/us-health-coronavirus-emirates-vaccine/chinas-sinopharm-begins- late-stage-trial-of-covid-19-vaccine-in-abu-dhabi-idUSKCN24H14T.
58. Bartlett, S. L.; Diel, D. G.; Wang, L.; Zec, S.; Laverack, M.; Martins, M.; Caserta, L. C.; Killian, M. L.; Terio, K.; Olmstead, C.; Delaney, M. A.; Stokol, T.; Ivančić, M.; Jenkins-Moore, M.; Ingerman, K.; Teegan, T.; McCann, C.; Thomas, P.; McAloose, D.; Sykes, J. M.; Calle, P. P., SARS-CoV-2 Infection And Longitudinal Fecal Screening In Malayan Tigers (<em>Panthera tigris jacksoni</em>), Amur Tigers (<em>Panthera tigris altaica</em>), And African Lions (<em>Panthera leo krugeri</em>) At The Bronx Zoo, New York, USA. bioRxiv 2020, 2020.08.14.250928. https://www.biorxiv.org/content/biorxiv/early/2020/08/14/2020.08.14.250928.full.pdf
59. Bazant, M. Z.; Bush, J. W. M., Beyond Six Feet: A Guideline to Limit Indoor Airborne Transmission of COVID-19. medRxiv 2020, 2020.08.26.20182824. https://www.medrxiv.org/content/medrxiv/early/2020/11/03/2020.08.26.20182824.full.pdf
60. Bedford, T.; Neher, R., Genomic epidemiology of novel coronavirus (nCoV) using data from GISAID. https://nextstrain.org/ncov.
61. Bedrosian, N.; Mitchell, E.; Rohm, E.; Rothe, M.; Kelly, C.; String, G.; Lantagne, D., A Systematic Review of Surface Contamination, Stability, and Disinfection Data on SARS-CoV-2 (Through July 10, 2020). Environ Sci Technol 2020.
62. Behzadinasab, S.; Chin, A.; Hosseini, M.; Poon, L. L. M.; Ducker, W. A., A Surface Coating that Rapidly Inactivates SARS-CoV-2. ACS Applied Materials & Interfaces 2020. https://doi.org/10.1021/acsami.0c11425
63. Beigel, J. H.; Tomashek, K. M.; Dodd, L. E.; Mehta, A. K.; Zingman, B. S.; Kalil, A. C.; Hohmann, E.; Chu, H. Y.; Luetkemeyer, A.; Kline, S.; Lopez de Castilla, D.; Finberg, R. W.; Dierberg, K.; Tapson, V.; Hsieh, L.; Patterson, T. F.; Paredes, R.; Sweeney, D. A.; Short, W. R.; Touloumi, G.; Lye, D. C.; Ohmagari, N.; Oh, M.- d.; Ruiz-Palacios, G. M.; Benfield, T.; Fätkenheuer, G.; Kortepeter, M. G.; Atmar, R. L.; Creech, C. B.; Lundgren, J.; Babiker, A. G.; Pett, S.; Neaton, J. D.; Burgess, T. H.; Bonnett, T.; Green, M.; Makowski, M.; Osinusi, A.; Nayak, S.; Lane, H. C., Remdesivir for the Treatment of Covid-19 — Final Report. New England Journal of Medicine 2020. https://doi.org/10.1056/NEJMoa2007764
64. Bellos, I.; Pandita, A.; Panza, R., Maternal and perinatal outcomes in pregnant women infected by SARS-CoV-2: A meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology 2021, 256, 194-204. http://www.sciencedirect.com/science/article/pii/S0301211520307491
65. Bi, Q.; Lessler, J.; Eckerle, I.; Lauer, S. A.; Kaiser, L.; Vuilleumier, N.; Cummings, D. A.; Flahault, A.; Petrovic, D.; Guessous, I.; Stringhini, S.; Azman, A. S., Household Transmission of SARS-COV-2: Insights from a Population-based Serological Survey. medRxiv 2020, 2020.11.04.20225573. https://www.medrxiv.org/content/medrxiv/early/2020/11/04/2020.11.04.20225573.full.pdf
66. Bidra, A. S.; Pelletier, J. S.; Westover, J. B.; Frank, S.; Brown, S. M.; Tessema, B., Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse. Journal of Prosthodontics 2020, n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/jopr.13209
67. Biggerstaff, M.; Cowling, B.; Cucunubá, Z.; Dinh, L.; Ferguson, N.; Gao, H.; Hill, V.; Imai, N.; Johansson, M.; Kada, S.; Morgan, O.; Pastore y Piontti, A.; Polonsky, J.; Prasad, P. V.; Quandelacy, T.; Rambaut, A.; Tappero, J.; Vandemaele, K.; Vespignani, A.; Warmbrod, K. L.; Wong, J., Early Insights from Statistical and Mathematical Modeling of Key Epidemiologic Parameters of COVID-19. Emerging Infectious Disease journal 2020, 26 (11). https://wwwnc.cdc.gov/eid/article/26/11/20-1074_article
68. Biryukov, J.; Boydston, J. A.; Dunning, R. A.; Yeager, J. J.; Wood, S.; Reese, A. L.; Ferris, A.; Miller, D.; Weaver, W.; Zeitouni, N. E.; Phillips, A.; Freeburger, D.; Hooper, I.; Ratnesar-Shumate, S.; Yolitz, J.; Krause, M.; Williams, G.; Dawson, D. G.; Herzog, A.; Dabisch, P.; Wahl, V.; Hevey, M. C.; Altamura, L. A., Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces. mSphere 2020, 5 (4), e00441-20. https://msphere.asm.org/content/msph/5/4/e00441-20.full.pdf
69. Bixler, D.; Miller, A. D.; Mattison, C. P.; al., e., SARS-CoV-2–Associated Deaths Among Persons Aged <21 Years — United States, February 12–July 31, 2020. Morbidity and Mortality Weekly Report 2020, 2020 (69), 1324-1329. https://www.cdc.gov/mmwr/volumes/69/wr/mm6937e4.htm
70. Blackburn, J.; Yiannoutsos, C. T.; Carroll, A. E.; Halverson, P. K.; Menachemi, N., Infection Fatality Ratios for COVID-19 Among Noninstitutionalized Persons 12 and Older: Results of a Random-Sample Prevalence Study. Annals of Internal Medicine 2020, 0 (0), null. https://www.acpjournals.org/doi/abs/10.7326/M20-5352
71. Blair, R. V.; Vaccari, M.; Doyle-Meyers, L. A.; Roy, C. J.; Russell-Lodrigue, K.; Fahlberg, M.; Monjure, C. J.; Beddingfield, B.; Plante, K. S.; Plante, J. A.; Weaver, S. C.; Qin, X.; Midkiff, C. C.; Lehmicke, G.; Golden, N.; Threeton, B.; Penney, T.; Allers, C.; Barnes, M. B.; Pattison, M.; Datta, P. K.; Maness, N. J.; Birnbaum, A.; Bohm, R. P.; Rappaport, J., ARDS and Cytokine Storm in SARS-CoV-2 Infected Caribbean Vervets. bioRxiv 2020, 2020.06.18.157933. http://biorxiv.org/content/early/2020/06/19/2020.06.18.157933.abstract
72. Böhmer, M. M.; Buchholz, U.; Corman, V. M.; Hoch, M.; Katz, K.; Marosevic, D. V.; Böhm, S.; Woudenberg, T.; Ackermann, N.; Konrad, R.; Eberle, U.; Treis, B.; Dangel, A.; Bengs, K.; Fingerle, V.; Berger, A.; Hörmansdorfer, S.; Ippisch, S.; Wicklein, B.; Grahl, A.; Pörtner, K.; Muller, N.; Zeitlmann, N.; Boender, T. S.; Cai, W.; Reich, A.; An der Heiden, M.; Rexroth, U.; Hamouda, O.; Schneider, J.; Veith, T.; Mühlemann, B.; Wölfel, R.; Antwerpen, M.; Walter, M.; Protzer, U.; Liebl, B.; Haas, W.; Sing, A.; Drosten, C.; Zapf, A., Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series. The Lancet. Infectious diseases 2020, S1473-3099(20)30314-5. https://pubmed.ncbi.nlm.nih.gov/32422201 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228725/
73. Boni, M. F.; Lemey, P.; Jiang, X.; Lam, T. T.-Y.; Perry, B. W.; Castoe, T. A.; Rambaut, A.; Robertson, D. L., Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nature Microbiology 2020. https://doi.org/10.1038/s41564-020-0771-4
74. Bosco-Lauth, A. M.; Hartwig, A. E.; Porter, S. M.; Gordy, P. W.; Nehring, M.; Byas, A. D.; VandeWoude, S.; Ragan, I. K.; Maison, R. M.; Bowen, R. A., Pathogenesis, transmission and response to re-exposure of SARS-CoV-2 in domestic cats. bioRxiv 2020, 2020.05.28.120998. http://biorxiv.org/content/early/2020/05/29/2020.05.28.120998.abstract
75. Boukli, N.; Le Mene, M.; Schnuriger, A.; Cuervo, N. S.; Laroche, C.; Morand-Joubert, L.; Gozlan, J., High incidence of false positive results in patients with other acute infections, using the LIAISON® SARS- CoV-2 commercial chemiluminescent micro-particle immunoassay for detection of IgG anti SARS-CoV-2 antibodies. Journal of Clinical Microbiology 2020, JCM.01352-20. https://jcm.asm.org/content/jcm/early/2020/08/25/JCM.01352-20.full.pdf
76. Boulware, D. R.; Pullen, M. F.; Bangdiwala, A. S.; Pastick, K. A.; Lofgren, S. M.; Okafor, E. C.; Skipper, C. P.; Nascene, A. A.; Nicol, M. R.; Abassi, M.; Engen, N. W.; Cheng, M. P.; LaBar, D.; Lother, S. A.; MacKenzie, L. J.; Drobot, G.; Marten, N.; Zarychanski, R.; Kelly, L. E.; Schwartz, I. S.; McDonald, E. G.; Rajasingham, R.; Lee, T. C.; Hullsiek, K. H., A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2016638
77. Bozzi, G.; Mangioni, D.; Minoia, F.; Aliberti, S.; Grasselli, G.; Barbetta, L.; Castelli, V.; Palomba, E.; Alagna, L.; Lombardi, A.; Ungaro, R.; Agostoni, C.; Baldini, M.; Blasi, F.; Cesari, M.; Costantino, G.; Fracanzani, A. L.; Montano, N.; Monzani, V.; Pesenti, A.; Peyvandi, F.; Sottocorno, M.; Muscatello, A.; Filocamo, G.; Gori, A.; Bandera, A., Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study. J Allergy Clin Immunol 2020.
78. Bradburne, A. F.; Bynoe, M. L.; Tyrrell, D. A., Effects of a "new" human respiratory virus in volunteers. British medical journal 1967, 3 (5568), 767-769. https://pubmed.ncbi.nlm.nih.gov/6043624 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1843247/
79. Brady, T., Irish company develops groundbreaking Covid spray that will provide near complete protection. https://www.independent.ie/irish-news/health/irish-company-develops-groundbreaking- covid-spray-that-will-provide-near-complete-protection-39717080.html (accessed 09 Nov 2020).
80. Bramante, C. T.; Ingraham, N. E.; Murray, T. A.; Marmor, S.; Hovertsen, S.; Gronski, J.; McNeil, C.; Feng, R.; Guzman, G.; Abdelwahab, N.; King, S.; Tamariz, L.; Meehan, T.; Pendleton, K. M.; Benson, B.; Vojta, D.; Tignanelli, C. J., Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. The Lancet Healthy Longevity. https://doi.org/10.1016/S2666- 7568(20)30033-7
81. Braun, J.; Loyal, L.; Frentsch, M.; Wendisch, D.; Georg, P.; Kurth, F.; Hippenstiel, S.; Dingeldey, M.; Kruse, B.; Fauchere, F.; Baysal, E.; Mangold, M.; Henze, L.; Lauster, R.; Mall, M.; Beyer, K.; Roehmel, J.; Schmitz, J.; Miltenyi, S.; Mueller, M. A.; Witzenrath, M.; Suttorp, N.; Kern, F.; Reimer, U.; Wenschuh, H.; Drosten, C.; Corman, V. M.; Giesecke-Thiel, C.; Sander, L.-E.; Thiel, A., Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors. medRxiv 2020, 2020.04.17.20061440. https://www.medrxiv.org/content/medrxiv/early/2020/04/22/2020.04.17.20061440.full.pdf
82. Brennan, Z., FDA issues 2nd EUA for decontamination system for N95 masks. Regulatory Focus 2020. https://www.raps.org/news-and-articles/news-articles/2020/4/fda-issues-2nd-eua-for- decontamination-system-for
83. Brosseau, L. M., COMMENTARY: COVID-19 transmission messages should hinge on science. http://www.cidrap.umn.edu/news-perspective/2020/03/commentary-covid-19-transmission-messages- should-hinge-science.
84. Brosseau, L. M.; Jones, R., Commentary: Protecting health workers from airborne MERS-CoV - learning from SARS. http://www.cidrap.umn.edu/news-perspective/2014/05/commentary-protecting- health-workers-airborne-mers-cov-learning-sars.
85. Brotons, P.; Launes, C.; Buetas, E.; Fumado, V.; Henares, D.; de Sevilla, M. F.; Redin, A.; Fuente-Soro, L.; Cuadras, D.; Mele, M.; Jou, C.; Millat, P.; Jordan, I.; Garcia-Garcia, J. J.; Bassat, Q.; Muñoz-Almagro, C.; Group, o. b. o. K. C. S., Susceptibility to Sars-COV-2 Infection Among Children And Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa1721
86. Bryner, J., First US infant death linked to COVID-19 reported in Illinois. LiveScience 2020. https://www.livescience.com/us-infant-dies-coronavirus.html
87. Buitrago-Garcia, D.; Egli-Gany, D.; Counotte, M. J.; Hossmann, S.; Imeri, H.; Ipekci, A. M.; Salanti, G.; Low, N., Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis. PLOS Medicine 2020, 17 (9), e1003346. https://doi.org/10.1371/journal.pmed.1003346
88. Bulfone, T. C.; Malekinejad, M.; Rutherford, G. W.; Razani, N., Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review. The Journal of Infectious Diseases 2020. https://doi.org/10.1093/infdis/jiaa742
89. Bundgaard, H.; Bundgaard, J. S.; Raaschou-Pedersen, D. E. T.; al., e., Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers. Annals of Internal Medicine 2020, 0 (0), null. https://www.acpjournals.org/doi/abs/10.7326/M20-6817
90. Burbelo, P. D.; Riedo, F. X.; Morishima, C.; Rawlings, S.; Smith, D.; Das, S.; Strich, J. R.; Chertow, D. S.; Davey, R. T.; Cohen, J. I., Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients. J Infect Dis 2020.
91. Bussani, R.; Schneider, E.; Zentilin, L.; Collesi, C.; Ali, H.; Braga, L.; Volpe, M. C.; Colliva, A.; Zanconati, F.; Berlot, G.; Silvestri, F.; Zacchigna, S.; Giacca, M., Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine 2020. https://doi.org/10.1016/j.ebiom.2020.103104
92. Bustin, S.; Coward, A.; Sadler, G.; Teare, L.; Nolan, T., CoV2-ID, a MIQE-compliant sub-20-min 5-plex RT-PCR assay targeting SARS-CoV-2 for the diagnosis of COVID-19. Scientific Reports 2020, 10 (1), 22214. https://doi.org/10.1038/s41598-020-79233-x
93. Byambasuren, O.; Cardona, M.; Bell, K.; Clark, J.; McLaws, M.-L.; Glasziou, P., Estimating the extent of true asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. Available at SSRN 3586675 2020.
94. Callaway, E., Russia announces positive COVID-vaccine results from controversial trial. https://www.nature.com/articles/d41586-020-03209-0.
95. Callow, K.; Parry, H.; Sergeant, M.; Tyrrell, D., The time course of the immune response to experimental coronavirus infection of man. Epidemiology & Infection 1990, 105 (2), 435-446.
96. Callow, K. A.; Parry, H. F.; Sergeant, M.; Tyrrell, D. A., The time course of the immune response to experimental coronavirus infection of man. Epidemiology and infection 1990, 105 (2), 435-446. https://pubmed.ncbi.nlm.nih.gov/2170159 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2271881/
97. Cao, B.; Wang, Y.; Wen, D.; Liu, W.; Wang, J.; Fan, G.; Ruan, L.; Song, B.; Cai, Y.; Wei, M.; Li, X.; Xia, J.; Chen, N.; Xiang, J.; Yu, T.; Bai, T.; Xie, X.; Zhang, L.; Li, C.; Yuan, Y.; Chen, H.; Li, H.; Huang, H.; Tu, S.; Gong, F.; Liu, Y.; Wei, Y.; Dong, C.; Zhou, F.; Gu, X.; Xu, J.; Liu, Z.; Zhang, Y.; Li, H.; Shang, L.; Wang, K.; Li, K.; Zhou, X.; Dong, X.; Qu, Z.; Lu, S.; Hu, X.; Ruan, S.; Luo, S.; Wu, J.; Peng, L.; Cheng, F.; Pan, L.; Zou, J.; Jia, C.; Wang, J.; Liu, X.; Wang, S.; Wu, X.; Ge, Q.; He, J.; Zhan, H.; Qiu, F.; Guo, L.; Huang, C.; Jaki, T.; Hayden, F. G.; Horby, P. W.; Zhang, D.; Wang, C., A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2001282
98. Carfì, A.; Bernabei, R.; Landi, F.; Group, f. t. G. A. C.-P.-A. C. S., Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020. https://doi.org/10.1001/jama.2020.12603
99. Caronna, E.; Ballvé, A.; Llauradó, A.; Gallardo, V. J.; María Ariton, D.; Lallana, S.; Maza, S. L.; Gadea, M. O.; Quibus, L.; Restrepo, J. L.; Rodrigo-Gisbert, M.; Vilaseca, A.; Gonzalez, M. H.; Gallo, M. M.; Alpuente, A.; Torres-Ferrus, M.; Borrell, R. P.; Alvarez-Sabin, J.; Pozo-Rosich, P., Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia 2020, 40 (13), 1410-1421. https://doi.org/10.1177/0333102420965157
100. Casey, M.; Griffin, J.; McAloon, C. G.; Byrne, A. W.; Madden, J. M.; McEvoy, D.; Collins, A. B.; Hunt, K.; Barber, A.; Butler, F.; Lane, E. A.; O Brien, K.; Wall, P.; Walsh, K. A.; More, S. J., Estimating pre- symptomatic transmission of COVID-19: a secondary analysis using published data. medRxiv 2020, 2020.05.08.20094870. https://www.medrxiv.org/content/medrxiv/early/2020/05/11/2020.05.08.20094870.full.pdf
101. Cauchois, R.; Koubi, M.; Delarbre, D.; Manet, C.; Carvelli, J.; Blasco, V. B.; Jean, R.; Fouche, L.; Bornet, C.; Pauly, V.; Mazodier, K.; Pestre, V.; Jarrot, P.-A.; Dinarello, C. A.; Kaplanski, G., Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19. Proceedings of the National Academy of Sciences 2020, 202009017. http://www.pnas.org/content/early/2020/07/21/2009017117.abstract
102. Cavalcanti, A. B.; Zampieri, F. G.; Rosa, R. G.; Azevedo, L. C. P.; Veiga, V. C.; Avezum, A.; Damiani, L. P.; Marcadenti, A.; Kawano-Dourado, L.; Lisboa, T.; Junqueira, D. L. M.; de Barros e Silva, P. G. M.; Tramujas, L.; Abreu-Silva, E. O.; Laranjeira, L. N.; Soares, A. T.; Echenique, L. S.; Pereira, A. J.; Freitas, F. G. R.; Gebara, O. C. E.; Dantas, V. C. S.; Furtado, R. H. M.; Milan, E. P.; Golin, N. A.; Cardoso, F. F.; Maia, I. S.; Hoffmann Filho, C. R.; Kormann, A. P. M.; Amazonas, R. B.; Bocchi de Oliveira, M. F.; Serpa-Neto, A.; Falavigna, M.; Lopes, R. D.; Machado, F. R.; Berwanger, O., Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2019014
103. CDC, About Masks. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/about-face- coverings.html.
104. CDC, ACIP Evidence to Recommendations for Use of Pfizer-BioNTech COVID-19 Vaccine under an Emergency Use Authorization. https://www.cdc.gov/vaccines/acip/recs/grade/covid-19-pfizer-biontech- etr.html#:~:text=Pfizer%2DBioNTech%20COVID%2D19%20vaccine%20is%20recommended%20for%20pr evention%20of,under%20an%20Emergency%20Use%20Authorization.
105. CDC, Confirmation of COVID-19 in Two Pet Cats in New York. Centers for Disease Control and Prevention: 2020. https://www.cdc.gov/media/releases/2020/s0422-covid-19-cats-NYC.html
106. CDC, COVID-19 Forecasts. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/forecasting- us.html.
107. CDC, Interim healthcare infection prevention and control recommendations for patients under investigation for 2019 novel coronavirus. https://www.cdc.gov/coronavirus/2019-ncov/infection- control.html.
108. CDC, Recommendation Regarding the Use of Cloth Face Coverings, Especially in Areas of Significant Community-Based Transmission. 2020. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting- sick/cloth-face-cover.html
109. CDC, Scientific Brief: Community Use of Cloth Masks to Control the Spread of SARS-CoV-2. https://www.cdc.gov/coronavirus/2019-ncov/more/masking-science-sars-cov2.html.
110. CDC, Scientific Brief: SARS-CoV-2 and Potential Airborne Transmission. https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html.
111. CDC, Situation summary. https://www.cdc.gov/coronavirus/2019-nCoV/summary.html.
112. CDC, Symptoms of Coronavirus. https://www.cdc.gov/coronavirus/2019-ncov/symptoms- testing/symptoms.html.
113. CDC, C., China's CDC detects a large number of new coronaviruses in the South China seafood market in Wuhan http://www.chinacdc.cn/yw_9324/202001/t20200127_211469.html (accessed 01/27/2020).
114. CEID, Nowcasts for the US, states, and territories. http://2019-coronavirus- tracker.com/nowcast.html.
115. Centers for Disease Control and Prevention (CDC), Coronaivurs Disease 2019 (COVID-19) 2020 Interim Case Definition, Approved August 5 2020. https://wwwn.cdc.gov/nndss/conditions/coronavirus- disease-2019-covid-19/case-definition/2020/08/05/ (accessed 21 Sept 2020).
116. Centers for Disease Control and Prevention (CDC), Overview of Testing for SARS-CoV-2 (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html (accessed 22 September 2020). 
117. Cevik, M.; Marcus, J.; Buckee, C.; Smith, T., SARS-CoV-2 transmission dynamics should inform policy. Available at SSRN 3692807 2020.
118. Cevik, M.; Tate, M.; Lloyd, O.; Maraolo, A. E.; Schafers, J.; Ho, A., SARS-CoV-2, SARS-CoV, and MERS- CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta- analysis. The Lancet Microbe 2020. https://doi.org/10.1016/S2666-5247(20)30172-5
119. Chan, J. F.-W.; Yuan, S.; Kok, K.-H.; To, K. K.-W.; Chu, H.; Yang, J.; Xing, F.; Liu, J.; Yip, C. C.-Y.; Poon, R. W.-S.; Tsoi, H.-W.; Lo, S. K.-F.; Chan, K.-H.; Poon, V. K.-M.; Chan, W.-M.; Ip, J. D.; Cai, J.-P.; Cheng, V. C.-C.; Chen, H.; Hui, C. K.-M.; Yuen, K.-Y., A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet 2020. https://www.sciencedirect.com/science/article/pii/S0140673620301549
120. Chan, J. F.; Zhang, A. J.; Yuan, S.; Poon, V. K.; Chan, C. C.; Lee, A. C.; Chan, W. M.; Fan, Z.; Tsoi, H. W.; Wen, L.; Liang, R.; Cao, J.; Chen, Y.; Tang, K.; Luo, C.; Cai, J. P.; Kok, K. H.; Chu, H.; Chan, K. H.; Sridhar, S.; Chen, Z.; Chen, H.; To, K. K.; Yuen, K. Y., Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis 2020. https://www.ncbi.nlm.nih.gov/pubmed/32215622
121. Chande, A. T.; Gussler, W.; Harris, M.; Lee, S.; Rishishwar, L.; Jordan, I. K.; Andris, C. M.; Weitz, J. S., Interactive COVID-19 Event Risk Assessment Planning Tool. http://covid19risk.biosci.gatech.edu/.
122. Chandrashekar, A.; Liu, J.; Martinot, A. J.; McMahan, K.; Mercado, N. B.; Peter, L.; Tostanoski, L. H.; Yu, J.; Maliga, Z.; Nekorchuk, M.; Busman-Sahay, K.; Terry, M.; Wrijil, L. M.; Ducat, S.; Martinez, D. R.; Atyeo, C.; Fischinger, S.; Burke, J. S.; Slein, M. D.; Pessaint, L.; Van Ry, A.; Greenhouse, J.; Taylor, T.; Blade, K.; Cook, A.; Finneyfrock, B.; Brown, R.; Teow, E.; Velasco, J.; Zahn, R.; Wegmann, F.; Abbink, P.; Bondzie, E. A.; Dagotto, G.; Gebre, M. S.; He, X.; Jacob-Dolan, C.; Kordana, N.; Li, Z.; Lifton, M. A.; Mahrokhian, S. H.; Maxfield, L. F.; Nityanandam, R.; Nkolola, J. P.; Schmidt, A. G.; Miller, A. D.; Baric, R. S.; Alter, G.; Sorger, P. K.; Estes, J. D.; Andersen, H.; Lewis, M. G.; Barouch, D. H., SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science 2020, eabc4776. https://science.sciencemag.org/content/sci/early/2020/05/19/science.abc4776.full.pdf
123. Chang, S.; Pierson, E.; Koh, P. W.; Gerardin, J.; Redbird, B.; Grusky, D.; Leskovec, J., Mobility network models of COVID-19 explain inequities and inform reopening. Nature 2020. https://doi.org/10.1038/s41586-020-2923-3
124. Changzheng, L. J. L., Experts in the medical treatment team: Wuhan's unexplained viral pneumonia patients can be controlled more. https://www.cn-healthcare.com/article/20200110/content- 528579.html.
125. Chen, C.; Cao, M.; Peng, L.; Guo, X.; Yang, F.; Wu, W.; Chen, L.; Yang, Y.; Liu, Y.; Wang, F., Coronavirus Disease-19 Among Children Outside Wuhan, China. SSRN 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3546071
126. Chen, Q.; Song, Y.; Wang, L.; Zhang, Y.; Han, L.; Liu, J.; Yang, M.; Ma, J.; Wang, T., Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study. Expert Rev Respir Med 2020.
127. Cheng, H.-Y.; Jian, S.-W.; Liu, D.-P.; Ng, T.-C.; Huang, W.-T.; Lin, H.-H.; Team, f. t. T. C.-O. I., Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Internal Medicine 2020. https://doi.org/10.1001/jamainternmed.2020.2020
128. Chhatwal, J.; Ayer, T.; Linas, B. P. D., O. O.; Mueller, P.; Adee, M.; Ladd, M. A.; Xiao, J. Y. X., COVID- 19. https://www.covid19sim.org/.
129. Chin, A.; Chu, J.; Perera, M.; Hui, K.; Yen, H.-L.; Chan, M.; Peiris, M.; Poon, L., Stability of SARS-CoV-2 in different environmental conditions. medRxiv 2020, 2020.03.15.20036673. https://www.medrxiv.org/content/medrxiv/early/2020/03/27/2020.03.15.20036673.full.pdf
130. Chin, A. W. H.; Chu, J. T. S.; Perera, M. R. A.; Hui, K. P. Y.; Yen, H.-L.; Chan, M. C. W.; Peiris, M.; Poon, L. L. M., Stability of SARS-CoV-2 in different environmental conditions. The Lancet Microbe 2020, 1 (1), e10. https://doi.org/10.1016/S2666-5247(20)30003-3
131. Chin, A. W. H.; Chu, J. T. S.; Perera, M. R. A.; Hui, K. P. Y.; Yen, H.-L.; Chan, M. C. W.; Peiris, M.; Poon, L. L. M., Stability of SARS-CoV-2 in different environmental conditions. The Lancet Microbe. https://doi.org/10.1016/S2666-5247(20)30003-3
132. Choe, P. G.; Kang, C. K.; Suh, H. J.; Jung, J.; Kang, E.; Lee, S. Y.; Song, K.-H.; Kim, H. B.; Kim, N. J.; Park, W. B.; Kim, E. S.; Oh, M.-d., Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients. Emerging Infectious Disease journal 2020, 26 (10), 2484. https://wwwnc.cdc.gov/eid/article/26/10/20-2211_article
133. Choi, E.; Chu, D. K. W.; Cheng, P. K. C.; Tsang, D. N. C.; Peiris, M.; Bausch, D.; Poon, L. L. M.; Watson- Jones, D., In-Flight Transmission of Severe Acute Respiratory Syndrome Coronavirus 2. Emerging Infectious Disease journal 2020, 26 (11). https://wwwnc.cdc.gov/eid/article/26/11/20-3254_article
134. Christensen, B.; Favaloro, E. J.; Lippi, G.; Van Cott, E. M., Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19). Semin Thromb Hemost 2020, (EFirst).
135. Chu, D. K.; Akl, E. A.; Duda, S.; Solo, K.; Yaacoub, S.; Schünemann, H. J.; Chu, D. K.; Akl, E. A.; El- harakeh, A.; Bognanni, A.; Lotfi, T.; Loeb, M.; Hajizadeh, A.; Bak, A.; Izcovich, A.; Cuello-Garcia, C. A.; Chen, C.; Harris, D. J.; Borowiack, E.; Chamseddine, F.; Schünemann, F.; Morgano, G. P.; Muti Schünemann, G. E. U.; Chen, G.; Zhao, H.; Neumann, I.; Chan, J.; Khabsa, J.; Hneiny, L.; Harrison, L.; Smith, M.; Rizk, N.; Giorgi Rossi, P.; AbiHanna, P.; El-khoury, R.; Stalteri, R.; Baldeh, T.; Piggott, T.; Zhang, Y.; Saad, Z.; Khamis, A.; Reinap, M.; Duda, S.; Solo, K.; Yaacoub, S.; Schünemann, H. J., Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. The Lancet 2020. https://doi.org/10.1016/S0140- 6736(20)31142-9
136. Clapp, P. W.; Sickbert-Bennett, E. E.; Samet, J. M.; Berntsen, J.; Zeman, K. L.; Anderson, D. J.; Weber, D. J.; Bennett, W. D.; Control, U. C. f. D.; Program, P. E., Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic. JAMA Internal Medicine 2020. https://doi.org/10.1001/jamainternmed.2020.8168
137. Clark, K. E. N.; Collas, O.; Lachmann, H.; Singh, A.; Buckley, J.; Bhagani, S., Safety of intravenous Anakinra in COVID-19 with evidence of hyperinflammation, a case series. Rheumatology Advances in Practice 2020. https://doi.org/10.1093/rap/rkaa040
138. Clean Flow, Clean Flow Healthcare Mini. https://cleanworkscorp.com/wp- content/uploads/2020/04/Clean_Works_Heathcare_Mini.pdf (accessed 09 Nov 2020).
139. Clift, A. K.; Coupland, C. A. C.; Keogh, R. H.; Hemingway, H., COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults. Annals of Internal Medicine 2020, 0 (0), null. https://www.acpjournals.org/doi/abs/10.7326/M20-4986
140. Clover, A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19 (SCB-2019). https://clinicaltrials.gov/ct2/show/NCT04672395.
141. Cockrell, A. S.; Yount, B. L.; Scobey, T.; Jensen, K.; Douglas, M.; Beall, A.; Tang, X.-C.; Marasco, W. A.; Heise, M. T.; Baric, R. S., A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nature microbiology 2016, 2 (2), 1-11.
142. Cohen, J., Mining coronavirus genomes for clues to the outbreak’s origins. Science 2020. https://www.sciencemag.org/news/2020/01/mining-coronavirus-genomes-clues-outbreak-s-origins
143. Cohen, J., Wuhan seafood market may not be source of novel virus spreading globally. https://www.sciencemag.org/news/2020/01/wuhan-seafood-market-may-not-be-source-novel-virus- spreading-globally (accessed 01/27/2020).
144. Control, E. C. f. D. P. a., Rapid Risk Assessment: Detection of new SARS-CoV-2 variants related to mink. European Centre for Disease Prevention and Control 2020. https://www.ecdc.europa.eu/en/publications-data/detection-new-sars-cov-2-variants- mink?ftag=MSF0951a18
145. Costa, V. d. O.; de Almeida, G. B. C.; Nicolini, E. M.; Rodrigues, G. d. A.; da Costa, B. M. A.; Carvalho, G. H.; dos Reis, Á. L. S.; Colen, D. P., Acute arterial occlusion of the lower limb as the main clinical manifestation in a patient with Covid-19 – Case Report. International Journal of Surgery Case Reports 2020, 77, 454-458. http://www.sciencedirect.com/science/article/pii/S2210261220310695
146. Courtemanche, C.; Garuccio, J.; Le, A.; Pinkston, J.; Yelowitz, A., Strong Social Distancing Measures In The United States Reduced The COVID-19 Growth Rate. Health Affairs 2020, 10.1377/hlthaff.2020.00608. https://doi.org/10.1377/hlthaff.2020.00608
147. Coutard, B.; Valle, C.; de Lamballerie, X.; Canard, B.; Seidah, N.; Decroly, E., The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral research 2020, 176, 104742.
148. CureVac, A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults. https://clinicaltrials.gov/ct2/show/NCT04652102.
149. Cutts, T.; Kasloff, S.; Safronetz, D.; Krishnan, J., Decontamination of Common Healthcare Facility Surfaces Contaminated with SARS-CoV-2 using Peracetic Acid Dry Fogging. bioRxiv 2020, 2020.12.04.412585. https://www.biorxiv.org/content/biorxiv/early/2020/12/07/2020.12.04.412585.full.pdf
150. da Rosa Mesquita, R.; Francelino Silva Junior, L. C.; Santos Santana, F. M.; Farias de Oliveira, T.; Campos Alcântara, R.; Monteiro Arnozo, G.; Rodrigues da Silva Filho, E.; Galdino dos Santos, A. G.; Oliveira da Cunha, E. J.; Salgueiro de Aquino, S. H.; Freire de Souza, C. D., Clinical manifestations of COVID-19 in the general population: systematic review. Wiener klinische Wochenschrift 2020. https://doi.org/10.1007/s00508-020-01760-4
151. Damas, J.; Hughes, G. M.; Keough, K. C.; Painter, C. A.; Persky, N. S.; Corbo, M.; Hiller, M.; Koepfli, K.-P.; Pfenning, A. R.; Zhao, H.; Genereux, D. P.; Swofford, R.; Pollard, K. S.; Ryder, O. A.; Nweeia, M. T.; Lindblad-Toh, K.; Teeling, E. C.; Karlsson, E. K.; Lewin, H. A., Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proceedings of the National Academy of Sciences 2020, 202010146. https://www.pnas.org/content/pnas/early/2020/08/20/2010146117.full.pdf 
152. Dasgupta, S.; Bowen, V. B. L., A.; al., e., Association Between Social Vulnerability and a County’s Risk for Becoming a COVID-19 Hotspot — United States, June 1–July 25, 2020. Morbidity and Mortality Weekly Report 2020, 2020 (69), 1535-1541. https://www.cdc.gov/mmwr/volumes/69/wr/mm6942a3.htm
153. Dattner, I.; Goldberg, Y.; Katriel, G.; Yaari, R.; Gal, N.; Miron, Y.; Ziv, A.; Sheffer, R.; Hamo, Y.; Huppert, A., The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children. medRxiv 2020, 2020.06.03.20121145. https://www.medrxiv.org/content/medrxiv/early/2020/10/11/2020.06.03.20121145.full.pdf
154. Davies, A.; Thompson, K. A.; Giri, K.; Kafatos, G.; Walker, J.; Bennett, A., Testing the efficacy of homemade masks: would they protect in an influenza pandemic? Disaster Med Public Health Prep 2013, 7 (4), 413-8. https://www.ncbi.nlm.nih.gov/pubmed/24229526
155. De Albuquerque, N.; Baig, E.; Ma, X.; Zhang, J.; He, W.; Rowe, A.; Habal, M.; Liu, M.; Shalev, I.; Downey, G. P.; Gorczynski, R.; Butany, J.; Leibowitz, J.; Weiss, S. R.; McGilvray, I. D.; Phillips, M. J.; Fish, E.N.; Levy, G. A., Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol 2006, 80 (21), 10382-94. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1641767/pdf/0747-06.pdf
156. de Haan, C. A. M.; Haijema, B. J.; Schellen, P.; Schreur, P. W.; te Lintelo, E.; Vennema, H.; Rottier, P. J. M., Cleavage of Group 1 Coronavirus Spike Proteins: How Furin Cleavage Is Traded Off against Heparan Sulfate Binding upon Cell Culture Adaptation. Journal of Virology 2008, 82 (12), 6078-6083. https://jvi.asm.org/content/jvi/82/12/6078.full.pdf
157. de Vries, R. D.; Schmitz, K. S.; Bovier, F. T.; Noack, D.; Haagmans, B. L.; Biswas, S.; Rockx, B.; Gellman, S. H.; Alabi, C. A.; de Swart, R. L.; Moscona, A.; Porotto, M., Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets. bioRxiv 2020, 2020.11.04.361154. https://www.biorxiv.org/content/biorxiv/early/2020/11/05/2020.11.04.361154.full.pdf
158. Dediego, M. L.; Pewe, L.; Alvarez, E.; Rejas, M. T.; Perlman, S.; Enjuanes, L., Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice. Virology 2008, 376 (2), 379- 389. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810402/
159. Degesys, N. F.; Wang, R. C.; Kwan, E.; Fahimi, J.; Noble, J. A.; Raven, M. C., Correlation Between N95 Extended Use and Reuse and Fit Failure in an Emergency Department. JAMA 2020. https://doi.org/10.1001/jama.2020.9843
160. Delahoy, M. J.; Whitaker, M.; O'Halloran, A.; al., e., Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020. Morbidity and Mortality Weekly Report 2020, ePub: 16 September 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6938e1.htm?s_cid=mm6938e1_w
161. Demichev, V.; Tober-Lau, P.; Nazarenko, T.; Thibeault, C.; Whitwell, H.; Lemke, O.; Röhl, A.; Freiwald, A.; Szyrwiel, L.; Ludwig, D.; Correia-Melo, C.; Helbig, E. T.; Stubbemann, P.; Grüning, N.-M.; Blyuss, O.; Vernardis, S.; White, M.; Messner, C. B.; Joannidis, M.; Sonnweber, T.; Klein, S. J.; Pizzini, A.; Wohlfarter, Y.; Sahanic, S.; Hilbe, R.; Schaefer, B.; Wagner, S.; Mittermaier, M.; Machleidt, F.; Garcia, C.; Ruwwe-Glösenkamp, C.; Lingscheid, T.; de Jarcy, L. B.; Stegemann, M. S.; Pfeiffer, M.; Jürgens, L.; Denker, S.; Zickler, D.; Enghard, P.; Zelezniak, A.; Campbell, A.; Hayward, C.; Porteous, D. J.; Marioni, R. E.; Uhrig, A.; Müller-Redetzky, H.; Zoller, H.; Löffler-Ragg, J.; Keller, M. A.; Tancevski, I.; Timms, J. F.; Zaikin, A.; Hippenstiel, S.; Ramharter, M.; Witzenrath, M.; Suttorp, N.; Lilley, K.; Mülleder, M.; Sander, L. E.; Ralser, M.; Kurth, F., A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome. medRxiv 2020, 2020.11.09.20228015. https://www.medrxiv.org/content/medrxiv/early/2020/11/12/2020.11.09.20228015.full.pdf
162. Denas, G.; Gennaro, N.; Ferroni, E.; Fedeli, U.; Lorenzoni, G.; Gregori, D.; Iliceto, S.; Pengo, V., Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population- based propensity score matched study. Int J Cardiol 2020. https://www.sciencedirect.com/science/article/pii/S0167527320342728?via%3Dihub
163. Deng, W.; Bao, L.; Gao, H.; Xiang, Z.; Qu, Y.; Song, Z.; Gong, S.; Liu, J.; Liu, J.; Yu, P.; Qi, F.; Xu, Y.; Li, F.; Xiao, C.; Lv, Q.; Xue, J.; Wei, Q.; Liu, M.; Wang, G.; Wang, S.; Yu, H.; Chen, T.; Liu, X.; Zhao, W.; Han, Y.; Qin, C., Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nature Communications 2020, 11 (1), 4400. https://doi.org/10.1038/s41467-020-18149-6
164. Deng, W.; Bao, L.; Gao, H.; Xiang, Z.; Qu, Y.; Song, Z.; Gong, S.; Liu, J.; Liu, J.; Yu, P.; Qi, F.; Xu, Y.; Li, F.; Xiao, C.; Lv, Q.; Xue, J.; Wei, Q.; Liu, M.; Wang, G.; Wang, S.; Yu, H.; Liu, X.; Zhao, W.; Han, Y.; Qin, C., Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in Rhesus macaques. bioRxiv 2020.
165. Deng, W.; Bao, L.; Liu, J.; Xiao, C.; Liu, J.; Xue, J.; Lv, Q.; Qi, F.; Gao, H.; Yu, P.; Xu, Y.; Qu, Y.; Li, F.; Xiang, Z.; Yu, H.; Gong, S.; Liu, M.; Wang, G.; Wang, S.; Song, Z.; Liu, Y.; Zhao, W.; Han, Y.; Zhao, L.; Liu, X.; Wei, Q.; Qin, C., Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science 2020, eabc5343. https://science.sciencemag.org/content/sci/early/2020/07/01/science.abc5343.full.pdf
166. Dentali, F.; Sironi, A. P.; Ageno, W.; Turato, S.; Bonfanti, C.; Frattini, F.; Crestani, S.; Franchini, M., In Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature, Seminars in thrombosis and hemostasis, Thieme Medical Publishers: 2012; pp 535-548.
167. Dequin, P. F.; Heming, N.; Meziani, F.; Plantefève, G.; Voiriot, G.; Badié, J.; François, B.; Aubron, C.; Ricard, J. D.; Ehrmann, S.; Jouan, Y.; Guillon, A.; Leclerc, M.; Coffre, C.; Bourgoin, H.; Lengellé, C.; Caille- Fénérol, C.; Tavernier, E.; Zohar, S.; Giraudeau, B.; Annane, D.; Le Gouge, A., Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial. Jama 2020. https://jamanetwork.com/journals/jama/fullarticle/2770276
168. DHS, Estimated Airborne Decay of SARS-CoV-2. https://www.dhs.gov/science-and-technology/sars- airborne-calculator.
169. DHS, Estimated Natural Decay of SARS-CoV-2 (virus that causes COVID-19) on surfaces under a range of temperatures and relative humidity. https://www.dhs.gov/science-and-technology/sars-calculator.
170. DHS, Low-Cost Decontamination of N95 Respirators; Department of Homeland Security Science &Technology Directorate: 2020. https://www.dhs.gov/sites/default/files/publications/multicooker_n95_decontamination_factsheet_v9 _2020_06_15.pdf
171. Ding, X.; Yin, K.; Li, Z.; Lalla, R. V.; Ballesteros, E.; Sfeir, M. M.; Liu, C., Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nature Communications 2020, 11 (1), 4711. https://doi.org/10.1038/s41467-020-18575-6
172. Doi, Y.; Hibino, M.; Hase, R.; Yamamoto, M.; Kasamatsu, Y.; Hirose, M.; Mutoh, Y.; Homma, Y.; Terada, M.; Ogawa, T.; Kashizaki, F.; Yokoyama, T.; Koba, H.; Kasahara, H.; Yokota, K.; Kato, H.; Yoshida, J.; Kita, T.; Kato, Y.; Kamio, T.; Kodama, N.; Uchida, Y.; Ikeda, N.; Shinoda, M.; Nakagawa, A.; Nakatsumi, H.; Horiguchi, T.; Iwata, M.; Matsuyama, A.; Banno, S.; Koseki, T.; Teramachi, M.; Miyata, M.; Tajima, S.; Maeki, T.; Nakayama, E.; Taniguchi, S.; Lim, C. K.; Saijo, M.; Imai, T.; Yoshida, H.; Kabata, D.; Shintani, A.; Yuzawa, Y.; Kondo, M., A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19. Antimicrob Agents Chemother 2020.
173. Dollard, P.; Griffin, I.; Berro, A.; al., e., Risk Assessment and Management of COVID-19 Among Travelers Arriving at Designated U.S. Airports, January 17–September 13, 2020. Morbidity and Mortality Weekly Report 2020, 2020 (69), 1681-1685. https://www.cdc.gov/mmwr/volumes/69/wr/mm6945a4.htm
174. Dong, Y.; Mo, X.; Hu, Y.; Qi, X.; Jiang, F.; Jiang, Z.; Tong, S., Epidemiological Characteristics of 2143 Pediatric Patients With 2019 Coronavirus Disease in China. Pediatrics 2020, e20200702. https://pediatrics.aappublications.org/content/pediatrics/early/2020/03/16/peds.2020-0702.full.pdf 
175. Dooling, K., Phased Allocation of COVID-19 Vaccines. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2020-12/slides-12-20/02-COVID- Dooling.pdf.
176. Doung-Ngern, P.; Suphanchaimat, R.; Panjangampatthana, A.; Janekrongtham, C.; Ruampoom, D.; Daochaeng, N.; Eungkanit, N.; Pisitpayat, N.; Srisong, N.; Yasopa, O.; Plernprom, P.; Promduangsi, P.; Kumphon, P.; Suangtho, P.; Watakulsin, P.; Chaiya, S.; Kripattanapong, S.; Chantian, T.; Bloss, E.; Namwat, C.; Limmathurotsakul, D., Case-Control Study of Use of Personal Protective Measures and Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Thailand. Emerg Infect Dis 2020, 26 (11).
177. Du, Z.; Xu, X.; Wang, L.; Fox, S. J.; Cowling, B. J.; Galvani, A. P.; Meyers, L. A., Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China. Emerg Infect Dis 2020, 26 (9).
178. Du, Z.; Xu, x.; Wu, Y.; Wang, L.; Cowling, B. J.; Meyers, L. A., COVID-19 serial interval estimates based on confirmed cases in public reports from 86 Chinese cities. medRxiv 2020, 2020.04.23.20075796. https://www.medrxiv.org/content/medrxiv/early/2020/04/27/2020.04.23.20075796.full.pdf
179. Du, Z.; Xu, X.; Wu, Y.; Wang, L.; Cowling, B. J.; Meyers, L. A., The serial interval of COVID-19 from publicly reported confirmed cases. medRxiv 2020, 2020.02.19.20025452. https://www.medrxiv.org/content/medrxiv/early/2020/03/13/2020.02.19.20025452.full.pdf
180. Dufort, E. M.; Koumans, E. H.; Chow, E. J.; Rosenthal, E. M.; Muse, A.; Rowlands, J.; Barranco, M. A.; Maxted, A. M.; Rosenberg, E. S.; Easton, D.; Udo, T.; Kumar, J.; Pulver, W.; Smith, L.; Hutton, B.; Blog, D.; Zucker, H., Multisystem Inflammatory Syndrome in Children in New York State. New England Journal of Medicine 2020, 383 (4), 347-358. https://www.nejm.org/doi/full/10.1056/NEJMoa2021756
181. Dunker, S.; Hornick, T.; Szczepankiewicz, G.; Maier, M.; Bastl, M.; Bumberger, J.; Treudler, R.; Liebert, U. G.; Simon, J.-C., No SARS-CoV-2 detected in air samples (pollen and particulate matter) in Leipzig during the first spread. Science of The Total Environment 2020, 142881. http://www.sciencedirect.com/science/article/pii/S0048969720364111
182. Dzien, C.; Halder, W.; Winner, H.; Lechleitner, M., Covid-19 screening: are forehead temperature measurements during cold outdoor temperatures really helpful? Wiener Klinische Wochenschrift 2020, 1-5. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582437/
183. ECDC, Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom European Centre for Disease Prevention and Control: 20 December 2020, 2020. https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-variant-multiple-spike-protein- mutations-United-Kingdom.pdf
184. Edridge, A. W. D.; Kaczorowska, J.; Hoste, A. C. R.; Bakker, M.; Klein, M.; Jebbink, M. F.; Matser, A.; Kinsella, C. M.; Rueda, P.; Prins, M.; Sastre, P.; Deijs, M.; Hoek, L. v. d., Coronavirus protective immunity is short-lasting Pre-print 2020. https://www.medrxiv.org/content/10.1101/2020.05.11.20086439v2.full.pdf
185. Eikenberry, S. E.; Mancuso, M.; Iboi, E.; Phan, T.; Eikenberry, K.; Kuang, Y.; Kostelich, E.; Gumel, A. B., To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infectious Disease Modelling 2020.
186. Ellume Health, FDA Authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At- Home Diagnostic Test. https://www.globenewswire.com/news- release/2020/12/15/2145612/0/en/FDA-Authorizes-Ellume-COVID-19-Home-Test-as-First-Over-the- Counter-Fully-At-Home-Diagnostic-Test.html (accessed 16 Dec 2020).
187. Endeman, H.; van der Zee, P.; van Genderen, M. E.; van den Akker, J. P. C.; Gommers, D., Progressive respiratory failure in COVID-19: a hypothesis. The Lancet Infectious Diseases 2020. https://doi.org/10.1016/S1473-3099(20)30366-2
188. Endo, A.; Abbott, S.; Kucharski, A.; Funk, S., Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China [version 1; peer review: 1 approved, 1 approved with reservations]. Wellcome Open Research 2020, 5 (67). https://wellcomeopenresearch.org/articles/5-67/v1
189. Environmental Protection Agency (EPA), List N: Disinfectants for Use Against SARS-CoV-2 (COVID- 19). https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2-covid-19 (accessed 21 Sept 2020).
190. Environmental Protection Agency (EPA), Section 18 Emergency Exemption Requests and Coronavirus (COVID-19). https://www.epa.gov/pesticide-registration/section-18-emergency-exemption- requests-and-coronavirus-covid-19 (accessed 31 August 2020).
191. Eythorsson, E.; Helgason, D.; Ingvarsson, R. F.; Bjornsson, H. K.; Olafsdottir, L. B.; Bjarnadottir, V.; Runolfsdottir, H. L.; Bjarnadottir, S.; Agustsson, A. S.; Oskarsdottir, K.; Thorvaldsson, H. H.; Kristjansdottir, G.; Armannsdottir, B.; Bjarnason, A.; Johannsson, B.; Gudlaugsson, O.; Gottfredsson, M.; Sigurdsson, M. I.; Indridason, O. S.; Palsson, R., Clinical spectrum of coronavirus disease 2019 in Iceland: population based cohort study. BMJ 2020, 371, m4529. https://www.bmj.com/content/bmj/371/bmj.m4529.full.pdf
192. Fabre Estremera, M.; Ruiz-Martinez, S.; Monserrat, M. E.; Cortizo Garrido, S.; Beunza Fabra, Z.; PerÃ¡n, M.; Benito, R.; Mateo, P.; Paules, C.; OrÃ3s, D., EXPRESS: SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: a false friend? Annals of Clinical Biochemistry 2020, 0004563220980495. https://doi.org/10.1177/0004563220980495
193. Facchetti, F.; Bugatti, M.; Drera, E.; Tripodo, C.; Sartori, E.; Cancila, V.; Papaccio, M.; Castellani, R.; Casola, S.; Boniotti, M. B.; Cavadini, P.; Lavazza, A., SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta. EBioMedicine 2020, 59. https://doi.org/10.1016/j.ebiom.2020.102951
194. Fagre, A.; Lewis, J.; Eckley, M.; Zhan, S.; Rocha, S. M.; Sexton, N. R.; Burke, B.; Geiss, B. J.; Peersen, O.; Kading, R.; Rovnak, J.; Ebel, G. D.; Tjalkens, R. B.; Aboellail, T.; Schountz, T., SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for reverse zoonosis to New World rodents. bioRxiv 2020, 2020.08.07.241810. http://biorxiv.org/content/early/2020/08/07/2020.08.07.241810.abstract
195. FDA, Coronavirus (COVID-19) Update: FDA Authorizes First Test that Detects Neutralizing Antibodies from Recent or Prior SARS-CoV-2 Infection. Food and Drug Administration: 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes- first-test-detects-neutralizing-antibodies-recent-or
196. FDA, Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine. U.S. Food and Drug Administration: 2020. https://www.fda.gov/news- events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization- chloroquine-and
197. FDA, COVID-19 Update: FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19. Food and Drug Administration: 2020. https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-broadens-emergency- use-authorization-veklury-remdesivir-include-all-hospitalized
198. FDA, Emergency Use Authorization; Food and Drug Administration: 2020. https://www.fda.gov/media/136529/download
199. FDA, FAQs on Shortages of Surgical Masks and Gowns. https://www.fda.gov/medical- devices/personal-protective-equipment-infection-control/faqs-shortages-surgical-masks-and- gowns#kn95.
200. FDA, FAQs on Testing for SARS-CoV-2. https://www.fda.gov/medical-devices/emergency-situations- medical-devices/faqs-testing-sars-cov-2#nolonger.
201. FDA, FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine. https://www.fda.gov/news-events/press- announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use- authorization-second-covid.
202. FDA, FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine. https://www.fda.gov/news-events/press-announcements/fda-takes-key-action- fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19.
203. FDA, Protective Barrier Enclosures Without Negative Pressure Used During the COVID-19 Pandemic May Increase Risk to Patients and Health Care Providers - Letter to Health Care Providers. Food and Drug Administration: 2020. https://www.fda.gov/medical-devices/letters-health-care-providers/protective- barrier-enclosures-without-negative-pressure-used-during-covid-19-pandemic-may-increase
204. FDA, Quest Diagnostics RC COVID-19 +Flu RT-PCR. https://www.fda.gov/media/144180/download. 
205. FDA, Respirator Models Removed from Appendix A. https://www.fda.gov/media/137928/download (accessed 05/15/2020).
206. FDA, U. S., FDA Approves First Treatment for COVID-19. 2020. https://www.fda.gov/news- events/press-announcements/fda-approves-first-treatment-covid-19
207. FDA, U. S., FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic. 2020. https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization- convalescent-plasma-potential-promising-covid-19-treatment
208. Fears, A.; Klimstra, W.; Duprex, P.; Hartman, A.; Weaver, S.; Plante, K.; Mirchandani, D.; Plante, J. A.; Aguilar, P.; Fernández, D.; Nalca, A.; Totura, A.; Dyer, D.; Kearney, B.; Lackemeyer, M.; Bohannon, J. K.; Johnson, R.; Garry, R.; Reed, D.; Roy, C., Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions. Emerging Infectious Disease journal 2020, 26 (9). https://wwwnc.cdc.gov/eid/article/26/9/20-1806_article
209. Feldman, O.; Meir, M.; Shavit, D.; Idelman, R.; Shavit, I., Exposure to a Surrogate Measure of Contamination From Simulated Patients by Emergency Department Personnel Wearing Personal Protective Equipment. JAMA 2020. https://doi.org/10.1001/jama.2020.6633
210. Ferguson, N.; Laydon, D.; Nedjati-Gilani, G.; Imai, N.; Ainslie, K.; Baguelin, M.; Bhatia, S.; Boonyasiri, A.; Cucunuba, Z.; Cuomo-Dannenburg, G.; Dighe, A.; Dorigatti, I.; Fu, H.; Gaythorpe, K.; Green, W.; Hamlet, A.; Hinsley, W.; Okell, L.; van Elsland, S.; Thompson, H.; Verity, R.; Volz, E.; Wang, H.; Wang, Y.; Walker, P.; Walters, C.; Winskill, P.; Whittaker, C.; Donnelly, C.; Riley, S.; Ghani, A., Impact of non- pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand; 2020. https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial- College-COVID19-NPI-modelling-16-03-2020.pdf
211. Figueiredo-Campos, P.; Blankenhaus, B.; Mota, C.; Gomes, A.; Serrano, M.; Ariotti, S.; Costa, C.; Nunes-Cabaço, H.; Mendes, A. M.; Gaspar, P.; Pereira-Santos, M. C.; Rodrigues, F.; Condeço, J.; Escoval, M. A.; Santos, M.; Ramirez, M.; Melo-Cristino, J.; Simas, J. P.; Vasconcelos, E.; Afonso, Â.; Veldhoen, M., Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to six months post disease onset. European Journal of Immunology n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1002/eji.202048970
212. Fiolet, T.; Guihur, A.; Rebeaud, M.; Mulot, M.; Peiffer-Smadja, N.; Mahamat-Saleh, Y., Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis. Clinical Microbiology and Infection 2020. http://www.sciencedirect.com/science/article/pii/S1198743X2030505X
213. Firth, J. A.; Hellewell, J.; Klepac, P.; Kissler, S. M.; Group, C. C.-W.; Kucharski, A. J.; Spurgin, L. G., Combining fine-scale social contact data with epidemic modelling reveals interactions between contact tracing, quarantine, testing and physical distancing for controlling COVID-19. Preprint 2020. https://cmmid.github.io/topics/covid19/reports/2020_05_25_firth_et_al_manuscript.pdf
214. Fischer, E. P.; Fischer, M. C.; Grass, D.; Henrion, I.; Warren, W. S.; Westman, E., Low-cost measurement of facemask efficacy for filtering expelled droplets during speech. Science Advances 2020, 07 August 2020.
215. Fischer, K. A.; Olson, S. M.; Tenforde, M. W.; al., e., Telework Before Illness Onset Among Symptomatic Adults Aged ≥18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities — United States, July 2020. Morbidity and Mortality Weekly Report 2020, 2020 (69), 1648-1653. https://www.cdc.gov/mmwr/volumes/69/wr/mm6944a4.htm?s_cid=mm6944a4_w
216. Fischer, R.; Morris, D.; van Doremalen, N.; Sarchette, S.; Matson, M. J.; Bushmaker, T.; Yinda, C. K.; Seifert, S.; Gamble, A.; Williamson, B.; Judson, S.; de Wit, E.; Lloyd-Smith, J.; Munster, V., Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus. Emerging Infectious Disease journal 2020, 26 (9), 2253. https://wwwnc.cdc.gov/eid/article/26/9/20-1524_article
217. Fischer, R.; Morris, D. H.; van Doremalen, N.; Sarchette, S.; Matson, J.; Bushmaker, T.; Yinda, C. K.; Seifert, S.; Gamble, A.; Williamson, B.; Judson, S.; de Wit, E.; Lloyd-Smith, J.; Munster, V., Assessment of N95 respirator decontamination and re-use for SARS-CoV-2. medRxiv 2020, 2020.04.11.20062018. https://www.medrxiv.org/content/medrxiv/early/2020/04/24/2020.04.11.20062018.full.pdf
218. Fisher, D.; Reilly, A.; Zheng, A. K. E.; Cook, A. R.; Anderson, D. E., Seeding of outbreaks of COVID-19 by contaminated fresh and frozen food. bioRxiv 2020, 2020.08.17.255166. https://www.biorxiv.org/content/biorxiv/early/2020/08/18/2020.08.17.255166.full.pdf
219. Fisher, K. A., Factors associated with cloth face covering use among adults during the COVID-19 pandemic—United States, April and May 2020. MMWR. Morbidity and Mortality Weekly Report 2020, 69.
220. Fisher, K. A.; Tenforde, M. W.; Feldstein, L. R.; al., e., Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities — United States, July 2020. Morbidity and Mortality Weekly Report 2020, 2020 (69), 1258-1264. https://www.cdc.gov/mmwr/volumes/69/wr/mm6936a5.htm
221. Fisman, D. N.; Greer, A. L.; Tuite, A. R., Bidirectional impact of imperfect mask use on reproduction number of COVID-19: A next generation matrix approach. Infectious Disease Modelling 2020, 5, 405-408. http://www.sciencedirect.com/science/article/pii/S2468042720300191
222. Fitzpatrick, J.; DeSalvo, K., Helping public health officials combat COVID-19. Google: 2020. https://www.blog.google/technology/health/covid-19-community-mobility-reports?hl=en
223. Flahault, A.; Manetti, E.; Simonson, T.; Lee, G.; Choirat, C., COVID-19 Forecasting. https://renkulab.shinyapps.io/COVID-19-Epidemic-Forecasting/_w_e0463e1e/#shiny-tab-about.
224. Flannery, D. D.; Gouma, S.; Dhudasia, M. B.; Mukhopadhyay, S.; Pfeifer, M. R.; Woodford, E. C.; Gerber, J. S.; Arevalo, C. P.; Bolton, M. J.; Weirick, M. E.; Goodwin, E. C.; Anderson, E. M.; Greenplate, A. R.; Kim, J.; Han, N.; Pattekar, A.; Dougherty, J.; Kuthuru, O.; Mathew, D.; Baxter, A. E.; Vella, L. A.; Weaver, J.; Verma, A.; Leite, R.; Morris, J. S.; Rader, D. J.; Elovitz, M. A.; Wherry, E. J.; Puopolo, K. M.; Hensley, S. E., SARS-CoV-2 seroprevalence among parturient women in Philadelphia. Science Immunology 2020, 5 (49), eabd5709. https://immunology.sciencemag.org/content/immunology/5/49/eabd5709.full.pdf
225. Flores-Alanis, A.; Sandner-Miranda, L.; Delgado, G.; Cravioto, A.; Morales-Espinosa, R., The receptor binding domain of SARS-CoV-2 spike protein is the result of an ancestral recombination between the bat-CoV RaTG13 and the pangolin-CoV MP789. BMC Research Notes 2020, 13 (1), 398. https://doi.org/10.1186/s13104-020-05242-8
226. Food and Drug Administration (FDA), Coronavirus (COVID-19) Update: December 16, 2020. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-december-16- 2020 (accessed 17 Dec 2020).
227. Food and Drug Administration (FDA), Coronavirus (COVID-19) Update: FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19. https://www.fda.gov/news- events/press-announcements/coronavirus-covid-19-update-fda-authorizes-antigen-test-first-over- counter-fully-home-diagnostic (accessed 17 Dec 2020).
228. Food and Drug Administration (FDA), Coronavirus (COVID-19) Update: FDA Authorizes First COVID- 19 Test for Self-Testing at Home. https://www.fda.gov/news-events/press-announcements/coronavirus- covid-19-update-fda-authorizes-first-covid-19-test-self-testing-home (accessed 30 Nov 2020).
229. Food and Drug Administration (FDA), Coronavirus (COVID-19) Update: FDA Issues New Authorization for the BinaxNOW COVID-19 Ag Card Home Test. https://www.fda.gov/news- events/press-announcements/coronavirus-covid-19-update-fda-issues-new-authorization-binaxnow- covid-19-ag-card-home-test (accessed 17 Dec 2020).
230. Food and Drug Administration (FDA), SARS-CoV-2 Reference Panel Comparative Data. https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference- panel-comparative-data (accessed 28 Sept 2020).
231. Frank, S.; Brown, S. M.; Capriotti, J. A.; Westover, J. B.; Pelletier, J. S.; Tessema, B., In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2. JAMA Otolaryngology–Head & Neck Surgery 2020. https://doi.org/10.1001/jamaoto.2020.3053
232. Fraser, D. D.; Slessarev, M.; Martin, C. M.; Daley, M.; Patel, M. A.; Miller, M. R.; Patterson, E. K.; O’Gorman, D. B.; Gill, S. E.; Wishart, D. S.; Mandal, R.; Cepinskas, G.; Team, O. b. o. t. L. C. S., Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers. Critical Care Explorations 2020, 2 (10), e0272. https://journals.lww.com/ccejournal/Fulltext/2020/10000/Metabolomics_Profiling_of_Critically_Ill.44.a spx
233. Freuling, C. M.; Breithaupt, A.; Müller, T.; Sehl, J.; Balkema-Buschmann, A.; Rissmann, M.; Klein, A.; Wylezich, C.; Höper, D.; Wernike, K.; Aebischer, A.; Hoffmann, D.; Friedrichs, V.; Dorhoi, A.; Groschup, M. H.; Beer, M.; Mettenleiter, T. C., Susceptibility of raccoon dogs for experimental SARS-CoV-2 infection. bioRxiv 2020, 2020.08.19.256800. http://biorxiv.org/content/early/2020/08/20/2020.08.19.256800.abstract
234. FUJIFILM Toyama Chemical Co., L., Anti-influenza drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients. Fujifilm, 2020. https://www.fujifilm.com/news/n200923.html
235. Gaebler, C.; Wang, Z.; Lorenzi, J. C. C.; Muecksch, F.; Finkin, S.; Tokuyama, M.; Ladinsky, M.; Cho, A.; Jankovic, M.; Schaefer-Babajew, D.; Oliveira, T. Y.; Cipolla, M.; Viant, C.; Barnes, C. O.; Hurley, A.; Turroja, M.; Gordon, K.; Millard, K. G.; Ramos, V.; Schmidt, F.; Weisblum, Y.; Jha, D.; Tankelevich, M.; Yee, J.; Shimeliovich, I.; Robbiani, D. F.; Zhao, Z.; Gazumyan, A.; Hatziioannou, T.; Bjorkman, P. J.; Mehandru, S.; Bieniasz, P. D.; Caskey, M.; Nussenzweig, M. C., Evolution of Antibody Immunity to SARS-CoV-2. bioRxiv 2020, 2020.11.03.367391. https://www.biorxiv.org/content/biorxiv/early/2020/11/05/2020.11.03.367391.full.pdf
236. Gallaway, M. S.; Rigler, J.; Robinson, S.; al., e., Trends in COVID-19 Incidence After Implementation of Mitigation Measures — Arizona, January 22–August 7, 2020. Morbidity and Mortality Weekly Report 2020, 2020 (69), 1460-1463.
237. Gamaleya, SECOND INTERIM ANALYSIS OF CLINICAL TRIAL DATA SHOWED A 91.4% EFFICACY FOR THE SPUTNIK V VACCINE ON DAY 28 AFTER THE FIRST DOSE; VACCINE EFFICACY IS OVER 95% 42 DAYS AFTER THE FIRST DOSE. https://sputnikvaccine.com/newsroom/pressreleases/second-interim-analysis- of-clinical-trial-data-showed-a-91-4-efficacy-for-the-sputnik-v-vaccine-on-d/.
238. Gao, G.; Wang, A.; Wang, S.; Qian, F.; Chen, M.; Yu, F.; Zhang, J.; Wang, X.; Ma, X.; Zhao, T.; Zhang, F.; Chen, Z., A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients. J Acquir Immune Defic Syndr 2020.
239. Garg, M.; Sharma, A. L.; Singh, S., Advancement in biosensors for inflammatory biomarkers of SARS- CoV-2 during 2019–2020. Biosensors and Bioelectronics 2021, 171, 112703. http://www.sciencedirect.com/science/article/pii/S0956566320306928
240. Garg, S., Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory- Confirmed Coronavirus Disease 2019—COVID-NET, 14 States, March 1–30, 2020. MMWR. Morbidity and Mortality Weekly Report 2020, 69.
241. Garvin, M. R.; Alvarez, C.; Miller, J. I.; Prates, E. T.; Walker, A. M.; Amos, B. K.; Mast, A. E.; Justice, A.; Aronow, B.; Jacobson, D., A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. eLife 2020, 9, e59177. https://doi.org/10.7554/eLife.59177
242. Gasser, R.; Cloutier, M.; Prévost, J.; Fink, C.; Ducas, É.; Ding, S.; Dussault, N.; Landry, P.; Tremblay, T.; Laforce-Lavoie, A.; Lewin, A.; Beaudoin-Bussières, G.; Laumaea, A.; Medjahed, H.; Larochelle, C.; Richard, J.; Dekaban, G. A.; Dikeakos, J. D.; Bazin, R.; Finzi, A., Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2. bioRxiv 2020, 2020.10.09.333278. https://www.biorxiv.org/content/biorxiv/early/2020/10/09/2020.10.09.333278.full.pdf
243. Gatto, M.; Bertuzzo, E.; Mari, L.; Miccoli, S.; Carraro, L.; Casagrandi, R.; Rinaldo, A., Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures. Proceedings of the National Academy of Sciences 2020, 202004978. https://www.pnas.org/content/pnas/early/2020/04/22/2004978117.full.pdf
244. Gendelman, O.; Amital, H.; Bragazzi, N. L.; Watad, A.; Chodick, G., Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis. Autoimmunity Reviews 2020, 102566. http://www.sciencedirect.com/science/article/pii/S1568997220301282
245. Giacomet, V.; Stracuzzi, M.; Paradiso, L.; Di Cosimo, M. E.; Rubinacci, V.; Zuccotti, G., Defining the clinical phenotype of COVID-19 in children. Pediatric Allergy and Immunology 2020, 31 (S26), 82-84. https://onlinelibrary.wiley.com/doi/abs/10.1111/pai.13355
246. GlobenNewswire, Delta 9 Develops Proprietary Decontamination Technology to Help Fight COVID- 19 Pandemic. https://www.globenewswire.com/news-release/2020/11/25/2134134/0/en/Delta-9- Develops-Proprietary-Decontamination-Technology-to-Help-Fight-COVID-19-Pandemic.html (accessed 30 Nov 2020).
247. Godfred-Cato, S.; Bryant, B.; Leung, J.; Oster, M. E.; Conklin, L.; Abrams, J.; Roguski, K.; Wallace, B.; Prezzato, E.; Koumans, E. H.; Lee, E. H.; Geevarughese, A.; Lash, M. K.; Reilly, K. H.; Pulver, W. P.; Thomas, D.; Feder, K. A.; Hsu, K. K.; Plipat, N.; Richardson, G.; Reid, H.; Lim, S.; Schmitz, A.; Pierce, T.; Hrapcak, S.; Datta, D.; Morris, S. B.; Clarke, K.; Belay, E.; Team, C. M.-C. R., COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6932e2.htm?s_cid=mm6932e2_w.
248. Godoy, M., Mystery Inflammatory Syndrome In Kids And Teens Likely Linked To COVID-19. NPR 2020. https://www.npr.org/sections/health-shots/2020/05/07/851725443/mystery-inflammatory- syndrome-in-kids-and-teens-likely-linked-to-covid-19
249. Gold, J. A.; Rossen, L. M.; Ahmad, F. B.; al., e., Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 — United States, May–August 2020. Morbidity and Mortality Weekly Report 2020, ePub: 16 October 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6942e1.htm
250. Goldbaum, C., Is the Subway Risky? It May Be Safer Than You Think. The New York Times 2020. https://www.nytimes.com/2020/08/02/nyregion/nyc-subway-coronavirus-safety.html
251. Goldstein, E.; Lipsitch, M.; Cevik, M., On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community. The Journal of Infectious Diseases 2020. https://doi.org/10.1093/infdis/jiaa691
252. Golinelli, D.; Boetto, E.; Maietti, E.; Fantini, M. P., The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis. PLOS ONE 2020, 15 (9), e0239508. https://doi.org/10.1371/journal.pone.0239508
253. Google, U.S. COVID-19 Public Forecasts. https://datastudio.google.com/reporting/52f6e744-66c6- 47aa-83db-f74201a7c4df/page/EfwUB?s=ou-b6M0HXag.
254. Goren, A.; Vaño-Galván, S.; Wambier, C. G.; McCoy, J.; Gomez-Zubiaur, A.; Moreno-Arrones, O. M.; Shapiro, J.; Sinclair, R. D.; Gold, M. H.; Kovacevic, M.; Mesinkovska, N. A.; Goldust, M.; Washenik, K., A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain – A potential clue to the role of androgens in COVID-19 severity. Journal of Cosmetic Dermatology n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/jocd.13443
255. Goren, A.; Wambier, C. G.; Herrera, S.; McCoy, J.; Vaño-Galván, S.; Gioia, F.; Comeche, B.; Ron, R.; Serrano-Villar, S.; Ramos, P. M.; Cadegiani, F. A.; Kovacevic, M.; Tosti, A.; Shapiro, J.; Sinclair, R., Anti- androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. J Eur Acad Dermatol Venereol 2020.
256. Götzinger, F.; Santiago-García, B.; Noguera-Julián, A.; al., e., COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child & Adolescent Health 2020. https://doi.org/10.1016/S2352-4642(20)30177-2
257. Goyal, M. K.; Simpson, J. N.; Boyle, M. D.; Badolato, G. M.; Delaney, M.; McCarter, R.; Cora- Bramble, D., Racial/Ethnic and Socioeconomic Disparities of SARS-CoV-2 Infection Among Children. Pediatrics 2020, e2020009951. https://pediatrics.aappublications.org/content/pediatrics/early/2020/08/03/peds.2020-009951.full.pdf 
258. Griffin, B. D.; Chan, M.; Tailor, N.; Mendoza, E. J.; Leung, A.; Warner, B. M.; Duggan, A. T.; Moffat, E.; He, S.; Garnett, L.; Tran, K. N.; Banadyga, L.; Albietz, A.; Tierney, K.; Audet, J.; Bello, A.; Vendramelli, R.; Boese, A. S.; Fernando, L.; Lindsay, L. R.; Jardine, C. M.; Wood, H.; Poliquin, G.; Strong, J. E.; Drebot, M.; Safronetz, D.; Embury-Hyatt, C.; Kobasa, D., North American deer mice are susceptible to SARS-CoV- 2. bioRxiv 2020, 2020.07.25.221291. http://biorxiv.org/content/early/2020/07/26/2020.07.25.221291.abstract
259. Griffin, J.; Casey, M.; Collins, Á.; Hunt, K.; McEvoy, D.; Byrne, A.; McAloon, C.; Barber, A.; Lane, E. A.; More, S., Rapid review of available evidence on the serial interval and generation time of COVID-19. BMJ Open 2020, 10 (11), e040263. https://bmjopen.bmj.com/content/bmjopen/10/11/e040263.full.pdf
260. Griffin, S., Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds. BMJ 2020, 370, m2650. http://www.bmj.com/content/370/bmj.m2650.abstract
261. Grifoni, A.; Weiskopf, D.; Ramirez, S. I.; Mateus, J.; Dan, J. M.; Moderbacher, C. R.; Rawlings, S. A.; Sutherland, A.; Premkumar, L.; Jadi, R. S., Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 2020.
262. Grijalva, C. G.; Rolfes, M. A.; Zhu, Y.; al., e., Transmission of SARS-COV-2 Infections in Households — Tennessee and Wisconsin, April–September 2020. Morbidity and Mortality Weekly Report 2020, ePub (30 October 2020). https://www.cdc.gov/mmwr/volumes/69/wr/mm6944e1.htm?s_cid=mm6944e1_w 
263. Group, C. s. T. a. F., Update on Children, Schools and Transmission; Scientific Advisory Group for Emergencies (SAGE): 4 November 2020, 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/93 5125/tfc-covid-19-children-transmission-s0860-041120.pdf
264. GSK, Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate. https://www.gsk.com/en-gb/media/press-releases/medicago-and-gsk-announce-start-of- phase-23-clinical-trials-of-adjuvanted-covid-19-vaccine-candidate/.
265. Gu, Y., COVID-19 Projections Using Machine Learning. https://covid19-projections.com/#view- projections.
266. Guan, L.; Zhou, L.; Zhang, J.; Peng, W.; Chen, R., More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China. European Respiratory Journal 2020, 55 (3), 2000352. https://erj.ersjournals.com/content/erj/55/3/2000352.full.pdf
267. Guan, W.-j.; Ni, Z.-y.; Hu, Y.; Liang, W.-h.; Ou, C.-q.; He, J.-x.; Liu, L.; Shan, H.; Lei, C.-l.; Hui, D. S. C.; Du, B.; Li, L.-j.; Zeng, G.; Yuen, K.-Y.; Chen, R.-c.; Tang, C.-l.; Wang, T.; Chen, P.-y.; Xiang, J.; Li, S.-y.; Wang, J.-l.; Liang, Z.-j.; Peng, Y.-x.; Wei, L.; Liu, Y.; Hu, Y.-h.; Peng, P.; Wang, J.-m.; Liu, J.-y.; Chen, Z.; Li, G.; Zheng, Z.-j.; Qiu, S.-q.; Luo, J.; Ye, C.-j.; Zhu, S.-y.; Zhong, N.-s., Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine 2020, 382, 1708-1720. https://www.nejm.org/doi/full/10.1056/NEJMoa2002032?query=recirc_artType_railA_article
268. Guardian, Covid patients have lung damage 'weeks after leaving hospital'. The Guardian 2020. https://www.theguardian.com/world/2020/sep/06/covid-patients-have-lung-damage-weeks-after- leaving-hospital
269. Gudbjartsson, D. F.; Norddahl, G. L.; Melsted, P.; Gunnarsdottir, K.; Holm, H.; Eythorsson, E.; Arnthorsson, A. O.; Helgason, D.; Bjarnadottir, K.; Ingvarsson, R. F.; Thorsteinsdottir, B.; Kristjansdottir, S.; Birgisdottir, K.; Kristinsdottir, A. M.; Sigurdsson, M. I.; Arnadottir, G. A.; Ivarsdottir, E. V.; Andresdottir, M.; Jonsson, F.; Agustsdottir, A. B.; Berglund, J.; Eiriksdottir, B.; Fridriksdottir, R.; Gardarsdottir, E. E.; Gottfredsson, M.; Gretarsdottir, O. S.; Gudmundsdottir, S.; Gudmundsson, K. R.; Gunnarsdottir, T. R.; Gylfason, A.; Helgason, A.; Jensson, B. O.; Jonasdottir, A.; Jonsson, H.; Kristjansson, T.; Kristinsson, K. G.; Magnusdottir, D. N.; Magnusson, O. T.; Olafsdottir, L. B.; Rognvaldsson, S.; le Roux, L.; Sigmundsdottir, G.; Sigurdsson, A.; Sveinbjornsson, G.; Sveinsdottir, K. E.; Sveinsdottir, M.; Thorarensen, E. A.; Thorbjornsson, B.; Thordardottir, M.; Saemundsdottir, J.; Kristjansson, S. H.; Josefsdottir, K. S.; Masson, G.; Georgsson, G.; Kristjansson, M.; Moller, A.; Palsson, R.; Gudnason, T.; Thorsteinsdottir, U.; Jonsdottir, I.; Sulem, P.; Stefansson, K., Humoral Immune Response to SARS-CoV-2 in Iceland. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2026116
270. Gudmundsdottir, Á.; Scheving, R.; Lindberg, F.; Stefansson, B., Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against common cold. Journal of Medical Virology n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26554
271. Guilamo-Ramos, V.; Benzekri, A.; Thimm-Kaiser, M.; Hidalgo, A.; Perlman, D. C., Reconsidering assumptions of adolescent and young adult SARS-CoV-2 transmission dynamics. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa1348
272. Gussow, A. B.; Auslander, N.; Faure, G.; Wolf, Y. I.; Zhang, F.; Koonin, E. V., Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses. Proceedings of the National Academy of Sciences 2020, 202008176. https://www.pnas.org/content/pnas/early/2020/06/09/2008176117.full.pdf 
273. Halfmann, P. J.; Hatta, M.; Chiba, S.; Maemura, T.; Fan, S.; Takeda, M.; Kinoshita, N.; Hattori, S. I.; Sakai-Tagawa, Y.; Iwatsuki-Horimoto, K.; Imai, M.; Kawaoka, Y., Transmission of SARS-CoV-2 in Domestic Cats. N Engl J Med 2020.
274. Hall, J. S.; Knowles, S.; Nashold, S. W.; Ip, H. S.; Leon, A. E.; Rocke, T.; Keller, S.; Carossino, M.; Balasuriya, U.; Hofmeister, E., Experimental challenge of a North American bat species, big brown bat (Eptesicus fuscus), with SARS-CoV-2. Transboundary and Emerging Diseases 2020, n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/tbed.13949
275. Han, J.; Zhang, X.; He, S.; Jia, P., Can the coronavirus disease be transmitted from food? A review of evidence, risks, policies and knowledge gaps. Environmental Chemistry Letters 2020. https://doi.org/10.1007/s10311-020-01101-x
276. Hao, X.; Cheng, S.; Wu, D.; Wu, T.; Lin, X.; Wang, C., Reconstruction of the full transmission dynamics of COVID-19 in Wuhan. Nature 2020. https://doi.org/10.1038/s41586-020-2554-8
277. Harbourt, D.; Haddow, A.; Piper, A.; Bloomfield, H.; Kearney, B.; Gibson, K.; Minogue, T., Modeling the Stability of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on Skin, Currency, and Clothing. medRxiv 2020, 2020.07.01.20144253. https://www.medrxiv.org/content/medrxiv/early/2020/07/03/2020.07.01.20144253.full.pdf
278. Harris, J. E., Data from the COVID-19 epidemic in Florida suggest that younger cohorts have been transmitting their infections to less socially mobile older adults. Review of Economics of the Household 2020. https://doi.org/10.1007/s11150-020-09496-w
279. Hart, B.; Tu, Y. P.; Jennings, R.; Verma, P.; Padgett, L. R.; Rains, D.; Vojta, D.; Berke, E. M., A comparison of health care worker-collected foam and polyester nasal swabs in convalescent COVID-19 patients. PLoS One 2020, 15 (10), e0241100.
280. Hartman, A. L.; Nambulli, S.; McMillen, C. M.; White, A. G.; Tilston-Lunel, N.; Albe, J. R.; Cottle, E. L.; Dunn, M. D.; Frye, L. J.; Gilliland, T. H.; Olsen, E. L.; Malley, K. J.; Schwarz, M. M.; Tomko, J. A.; Walker, R. C.; Xia, M.; Hartman, M. S.; Klein, E.; Scanga, C.; Flynn, J. L.; Klimstra, W. B.; McElroy, A. K.; Reed, D. S.; Duprex, W. P., SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and prolonged shedding of infectious virus from both respiratory and gastrointestinal tracts. bioRxiv 2020, 2020.06.20.137687. http://biorxiv.org/content/early/2020/06/21/2020.06.20.137687.abstract
281. Harvey, A. P.; Fuhrmeister, E. R.; Cantrell, M.; Pitol, A. K.; Swarthout, J. M.; Powers, J. E.; Nadimpalli, M. L.; Julian, T. R.; Pickering, A. J., Longitudinal monitoring of SARS-CoV-2 RNA on high-touch surfaces in a community setting. medRxiv 2020, 2020.10.27.20220905. https://www.medrxiv.org/content/medrxiv/early/2020/11/01/2020.10.27.20220905.full.pdf
282. He, R.; Lu, Z.; Zhang, L.; Fan, T.; Xiong, R.; Shen, X.; Feng, H.; Meng, H.; Lin, W.; Jiang, W.; Geng, Q., The clinical course and its correlated immune status in COVID-19 pneumonia. Journal of Clinical Virology 2020, 127, 104361. http://www.sciencedirect.com/science/article/pii/S1386653220301037
283. He, X.; Lau, E. H. Y.; Wu, P.; Deng, X.; Wang, J.; Hao, X.; Lau, Y. C.; Wong, J. Y.; Guan, Y.; Tan, X.; Mo, X.; Chen, Y.; Liao, B.; Chen, W.; Hu, F.; Zhang, Q.; Zhong, M.; Wu, Y.; Zhao, L.; Zhang, F.; Cowling, B. J.; Li, F.; Leung, G. M., Temporal dynamics in viral shedding and transmissibility of COVID-19. Nature Medicine 2020. https://doi.org/10.1038/s41591-020-0869-5
284. Hermine, O.; Mariette, X.; Tharaux, P.-L.; Resche-Rigon, M.; Porcher, R.; Ravaud, P.; Group, C.-C., Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial. JAMA Internal Medicine 2020. https://doi.org/10.1001/jamainternmed.2020.6820
285. Hernández-Mora, M. G.; Cabello Úbeda, A.; Pérez, L. P.; Álvarez, F. V.; Álvarez, B.; Rodríguez Nieto, M. J.; Acosta, I. C.; Ormaechea, I. F.; Al-Hayani, A. W. M.; Carballosa, P.; Martínez, S. C.; Ezzine, F.; González, M. C.; Naya, A.; de Las Heras, M. L.; Rodríguez Guzmán, M. J.; Guijarro, A. C.; Lavado, A. B.; Valcayo, A. M.; García, M. M.; Martínez, J. B.; Roblas, R. F.; Piris Pinilla, M.; Alen, J. F.; Pernaute, O. S.; Bueno, F. R.; Frades, S. H.; Romero, G. P. B., Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. Int J Infect Dis 2020.
286. Hippich, M.; Holthaus, L.; Assfalg, R.; Zapardiel-Gonzalo, J.; Kapfelsperger, H.; Heigermoser, M.; Haupt, F.; Ewald, D. A.; Welzhofer, T. C.; Marcus, B. A.; Heck, S.; Koelln, A.; Stock, J.; Voss, F.; Secchi, M.; Piemonti, L.; de la Rosa, K.; Protzer, U.; Boehmer, M.; Achenbach, P.; Lampasona, V.; Bonifacio, E.; Ziegler, A.-G., A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children. Med 2020. https://doi.org/10.1016/j.medj.2020.10.003
287. Hobbs, C. V.; Martin, L. M.; Kim, S. S.; al., e., Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years — Mississippi, September–November 2020. Morbidity and Mortality Weekly Report 2020, 2020 (69), 1925-1929. https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e3.htm
288. Hoehl, S.; Karaca, O.; Kohmer, N.; Westhaus, S.; Graf, J.; Goetsch, U.; Ciesek, S., Assessment of SARS-CoV-2 Transmission on an International Flight and Among a Tourist Group. JAMA Network Open 2020, 3 (8), e2018044-e2018044. https://doi.org/10.1001/jamanetworkopen.2020.18044
289. Hoiland, R. L.; Fergusson, N. A.; Mitra, A. R.; Griesdale, D. E. G.; Devine, D. V.; Stukas, S.; Cooper, J.; Thiara, S.; Foster, D.; Chen, L. Y. C.; Lee, A. Y. Y.; Conway, E. M.; Wellington, C. L.; Sekhon, M. S., The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Advances 2020, 4 (20), 4981-4989. https://doi.org/10.1182/bloodadvances.2020002623
290. Holmes, L.; Enwere, M.; Williams, J.; Ogundele, B.; Chavan, P.; Piccoli, T.; Chinacherem, C.; Comeaux, C.; Pelaez, L.; Okundaye, O.; Stalnaker, L.; Kalle, F.; Deepika, K.; Philipcien, G.; Poleon, M.; Ogungbade, G.; Elmi, H.; John, V.; Dabney, K. W., Black–White Risk Differentials in COVID-19 (SARS- COV2) Transmission, Mortality and Case Fatality in the United States: Translational Epidemiologic Perspective and Challenges. International Journal of Environmental Research and Public Health 2020, 17 (12), 4322. https://www.mdpi.com/1660-4601/17/12/4322
291. Honein, M. A.; Christie, A.; Rose, D. A.; al., e., Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020. Morbidity and Mortality Weekly Report 2020, ePub: 4 December 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6949e2.htm
292. HongyingLi; YewLeong, F.; GeorgeXu; ZhengweiGe; WeiKang, C.; HuiLim, K., Dispersion of evaporating cough droplets in tropical outdoor environment. Physics of Fluids 2020, 32 (11), 113301. https://aip.scitation.org/doi/abs/10.1063/5.0026360
293. Horby, P.; Lim, W. S.; Emberson, J.; Mafham, M.; Bell, J.; Linsell, L.; Staplin, N.; Brightling, C.; Ustianowski, A.; Elmahi, E.; Prudon, B.; Green, C.; Felton, T.; Chadwick, D.; Rege, K.; Fegan, C.; Chappell, L. C.; Faust, S. N.; Jaki, T.; Jeffery, K.; Montgomery, A.; Rowan, K.; Juszczak, E.; Baillie, J. K.; Haynes, R.; Landray, M. J., Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. medRxiv 2020, 2020.06.22.20137273. https://www.medrxiv.org/content/medrxiv/early/2020/06/22/2020.06.22.20137273.full.pdf
294. Horby, P.; Openshaw, P. J. M.; Hayward, A. H.; Lim, W. S.; Edmunds, J.; Ferguson, N.; Dingwall, R.; Cevik, M.; Barclay, W.; Rubin, J.; Connell, D.; McMenamin, J.; Semple, C.; Evans, C., NERVTAG meeting on SARS-CoV-2 variant under investigation VUI-202012/01; New and Emerging Respiratory Virus Threats Advisory Group: 2020. https://khub.net/documents/135939561/338928724/SARS-CoV- 2+variant+under+investigation%2C+meeting+minutes.pdf/962e866b-161f-2fd5-1030- 32b6ab467896?t=1608470511452
295. Hou, Y. J.; Chiba, S.; Halfmann, P.; Ehre, C.; Kuroda, M.; Dinnon, K. H.; Leist, S. R.; Schäfer, A.; Nakajima, N.; Takahashi, K.; Lee, R. E.; Mascenik, T. M.; Graham, R.; Edwards, C. E.; Tse, L. V.; Okuda, K.; Markmann, A. J.; Bartelt, L.; de Silva, A.; Margolis, D. M.; Boucher, R. C.; Randell, S. H.; Suzuki, T.; Gralinski, L. E.; Kawaoka, Y.; Baric, R. S., SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science 2020, eabe8499. https://science.sciencemag.org/content/sci/early/2020/11/11/science.abe8499.full.pdf
296. Hu, M.; Lin, H.; Wang, J.; Xu, C.; Tatem, A. J.; Meng, B.; Zhang, X.; Liu, Y.; Wang, P.; Wu, G.; Xie, H.; Lai, S., The risk of COVID-19 transmission in train passengers: an epidemiological and modelling study. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa1057
297. Hu, Z.; Song, C.; Xu, C.; Jin, G.; Chen, Y.; Xu, X.; Ma, H.; Chen, W.; Lin, Y.; Zheng, Y.; Wang, J.; Hu, Z.; Yi, Y.; Shen, H., Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China Life Sciences 2020. https://doi.org/10.1007/s11427-020- 1661-4
298. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; Cheng, Z.; Yu, T.; Xia, J.; Wei, Y.; Wu, W.; Xie, X.; Yin, W.; Li, H.; Liu, M.; Xiao, Y.; Gao, H.; Guo, L.; Xie, J.; Wang, G.; Jiang, R.; Gao, Z.; Jin, Q.; Wang, J.; Cao, B., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020. https://www.thelancet.com/journals/lancet/article/PIIS0140- 6736(20)30183-5/fulltext
299. Huang, L.; Xu, S.; Wang, Z.; Xue, K.; Su, J.; Song, Y.; Chen, S.; Zhu, C.; Tang, B. Z.; Ye, R., Self- Reporting and Photothermally Enhanced Rapid Bacterial Killing on a Laser-Induced Graphene Mask. ACS Nano 2020, 14 (9), 12045-12053. https://doi.org/10.1021/acsnano.0c05330
300. Huang, R.; Xia, J.; Chen, Y.; Shan, C.; Wu, C., A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China. The Lancet Infectious Diseases 2020, 20 (5), 534-535. https://doi.org/10.1016/S1473-3099(20)30147-X
301. Huang, Y.; Lyu, X.; Li, D.; Wang, Y.; Wang, L.; Zou, W.; Wei, Y.; Wu, X., A cohort study of 223 patients explores the clinical risk factors for the severity diagnosis of COVID-19. medRxiv 2020, 2020.04.18.20070656. https://www.medrxiv.org/content/medrxiv/early/2020/04/24/2020.04.18.20070656.full.pdf
302. Huang, Z.; Tian, D.; Liu, Y.; Lin, Z.; Lyon, C. J.; Lai, W.; Fusco, D.; Drouin, A.; Yin, X.; Hu, T.; Ning, B., Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis. Biosensors and Bioelectronics 2020, 164, 112316. http://www.sciencedirect.com/science/article/pii/S0956566320303110
303. Hutchins, H. J.; Wolff, B.; Leeb, R.; al., e., COVID-19 Mitigation Behaviors by Age Group — United States, April–June 2020. Morbidity and Mortality Weekly Report 2020, 2020 (69), 1584-1590. https://www.cdc.gov/mmwr/volumes/69/wr/mm6943e4.htm?s_cid=mm6943e4_w
304. Hyde, Z., COVID-19, children and schools: overlooked and at risk. Medical Journal of Australia 2020, 213 (10), 444-446.e1. https://onlinelibrary.wiley.com/doi/abs/10.5694/mja2.50823
305. Ibrahim, D.; Dulipsingh, L.; Zapatka, L.; Eadie, R.; Crowell, R.; Williams, K.; Wakefield, D. B.; Cook, L.; Puff, J.; Hussain, S. A., Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial. Infect Dis Ther 2020, 1-14.
306. IHME, COVID-19 Projections. https://covid19.healthdata.org/united-states-of-america.
307. IHME, First COVID-19 Global Forecast: IHME Projects Three-Quarters of a Million Lives Could be Saved by January 1. Institute for Health Metrics and Evaluation: 2020. https://www.prnewswire.com/il/news-releases/first-covid-19-global-forecast-ihme-projects-three- quarters-of-a-million-lives-could-be-saved-by-january-1-807013447.html
308. Institute of Museum and Library Services; OCLC; Battelle, REopening Archives, Libraries, and Museums (REALM) Test 5: Natural attenuation as a decontamination approach for SARS-CoV-2 on textile materials. https://www.webjunction.org/content/dam/WebJunction/Documents/webJunction/realm/test5- report.pdf (accessed 26 Oct 2020).
309. Institute, S. S., Public Health Authority, State Serum Institute, Report of Findings. 2020. https://coronasmitte.dk/-/media/mediefiler/corona/mink/risikovurdering-af-human-sundhed-ved- fortsat-minkavl_03112020.pdf?la=da&hash=721871D898F1D9F1F9D99E3A002C35F9537F5CEA
310. International Commission on Microbiological Specifications for Foods (ICMSF), ICMSF opinion on SARS-CoV-2 and its relationship to food safety. https://www.icmsf.org/wp- content/uploads/2020/09/ICMSF2020-Letterhead-COVID-19-opinion-final-03-Sept-2020.BF_.pdf (accessed 08 Sept 2020).
311. Ionescu, F.; Jaiyesimi, I.; Petrescu, I.; Lawler, P. R.; Castillo, E.; Munoz-Maldonado, Y.; Imam, Z.; Narasimhan, M.; Abbas, A. E.; Konde, A.; Nair, G. B., Association of Anticoagulation Dose and Survival in Hospitalized COVID-19 Patients: A Retrospective Propensity Score Weighted Analysis. Eur J Haematol 2020.
312. IQ, H., COVID-19 Forecast for United States. https://app.hospiq.com/covid19?region=.
313. Ismail, S. A.; Saliba, V.; Lopez Bernal, J.; Ramsay, M. E.; Ladhani, S. N., SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England. The Lancet Infectious Diseases 2020. https://doi.org/10.1016/S1473- 3099(20)30882-3
314. Iwata, K.; Doi, A.; Miyakoshi, C., Was School Closure Effective in Mitigating Coronavirus Disease 2019 (COVID-19)? Time Series Analysis Using Bayesian Inference. 2020.
315. Janssen, A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants (ENSEMBLE). https://clinicaltrials.gov/ct2/show/NCT04505722.
316. Jarvis, C. I.; Van Zandvoort, K.; Gimma, A.; Prem, K.; Klepac, P.; Rubin, G. J.; Edmunds, W. J., Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Med 2020, 18 (1), 124.
317. Jenco, M., CDC details COVID-19-related inflammatory syndrome in children. AAP News 2020. https://www.aappublications.org/news/2020/05/14/covid19inflammatory051420
318. JHU, Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e 9ecf6.
319. Jiang, N.; Chen, Z.; Yin, X.; Liu, L.; Yang, H.; Tan, X.; Wang, J.; Li, H.; Tian, M.; Lu, Z.; Xiong, N.; Gong, Y., Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study. Diabetes Research and Clinical Practice 2020, 108619. http://www.sciencedirect.com/science/article/pii/S0168822720308767
320. John, A. R.; Raju, S.; Cadnum, J. L.; Lee, K.; McClellan, P.; Akkus, O.; Miller, S. K.; Jennings, W. D.; Buehler, J. A.; Li, D. F.; Redmond, S. N.; Braskie, M.; Hoyen, C. K.; Donskey, C. J., Scalable In-hospital Decontamination of N95 Filtering Facepiece Respirator with a Peracetic Acid Room Disinfection System. Infection Control & Hospital Epidemiology 2020, 1-26. https://www.cambridge.org/core/article/scalable- inhospital-decontamination-of-n95-filtering-facepiece-respirator-with-a-peracetic-acid-room- disinfection-system/4B56043CF6D905CA6E8EF07B19FCF054
321. Johnston, S. C.; Jay, A.; Raymond, J. L.; Rossi, F.; Zeng, X.; Scruggs, J.; Dyer, D.; Frick, O.; Moore, J.; Berrier, K.; Esham, H.; Shamblin, J.; Sifford, W.; Fiallos, J.; Klosterman, L.; Stevens, S.; White, L.; Bowling, P.; Garcia, T.; Jensen, C.; Ghering, J.; Nyakiti, D.; Bellanca, S.; Kearney, B.; Giles, W.; Alli, N.; Paz, F.; Akers, K.; Danner, D.; Barth, J.; Johnson, J. A.; Durant, M.; Kim, R.; Pitt, M. L. M.; Nalca, A., Development of a Coronavirus Disease 2019 Nonhuman Primate Model Using Airborne Exposure. bioRxiv 2020, 2020.06.26.174128. http://biorxiv.org/content/early/2020/06/26/2020.06.26.174128.abstract
322. Jones, R. M., Relative contributions of transmission routes for COVID-19 among healthcare personnel providing patient care. Journal of Occupational and Environmental Hygiene 2020, 1-8. https://doi.org/10.1080/15459624.2020.1784427
323. Jonmarker, S.; Hollenberg, J.; Dahlberg, M.; Stackelberg, O.; Litorell, J.; Everhov Å, H.; Järnbert- Pettersson, H.; Söderberg, M.; Grip, J.; Schandl, A.; Günther, M.; Cronhjort, M., Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients. Crit Care 2020, 24 (1), 653.
324. Joyner, M. J.; Bruno, K. A.; Klassen, S. A.; Kunze, K. L.; Johnson, P. W.; Lesser, E. R.; Wiggins, C. C.; Senefeld, J. W.; Klompas, A. M.; Hodge, D. O.; Shepherd, J. R. A.; Rea, R. F.; Whelan, E. R.; Clayburn, A. J.; Spiegel, M. R.; Baker, S. E.; Larson, K. F.; Ripoll, J. G.; Andersen, K. J.; Buras, M. R.; Vogt, M. N. P.; Herasevich, V.; Dennis, J. J.; Regimbal, R. J.; Bauer, P. R.; Blair, J. E.; Van Buskirk, C. M.; Winters, J. L.; Stubbs, J. R.; van Helmond, N.; Butterfield, B. P.; Sexton, M. A.; Diaz Soto, J. C.; Paneth, N. S.; Verdun, N. C.; Marks, P.; Casadevall, A.; Fairweather, D.; Carter, R. E.; Wright, R. S., Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clinic Proceedings 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368917/
325. Joyner, M. J.; Senefeld, J. W.; Klassen, S. A.; Mills, J. R.; Johnson, P. W.; Theel, E. S.; Wiggins, C. C.; Bruno, K. A.; Klompas, A. M.; Lesser, E. R.; Kunze, K. L.; Sexton, M. A.; Diaz Soto, J. C.; Baker, S. E.; Shepherd, J. R. A.; van Helmond, N.; van Buskirk, C. M.; Winters, J. L.; Stubbs, J. R.; Rea, R. F.; Hodge, D. O.; Herasevich, V.; Whelan, E. R.; Clayburn, A. J.; Larson, K. F.; Ripoll, J. G.; Andersen, K. J.; Buras, M. R.; Vogt, M. N. P.; Dennis, J. J.; Regimbal, R. J.; Bauer, P. R.; Blair, J. E.; Paneth, N. S.; Fairweather, D.; Wright, R. S.; Carter, R. E.; Casadevall, A., Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience. medRxiv 2020, 2020.08.12.20169359. http://medrxiv.org/content/early/2020/08/12/2020.08.12.20169359.abstract
326. Jüni, P.; Rothenbühler, M.; Bobos, P.; Thorpe, K. E.; da Costa, B. R.; Fisman, D. N.; Slutsky, A. S.; Gesink, D., Impact of climate and public health interventions on the COVID-19 pandemic: A prospective cohort study. Canadian Medical Association Journal 2020, cmaj.200920. https://www.cmaj.ca/content/cmaj/early/2020/05/08/cmaj.200920.full.pdf
327. Kalil, A. C.; Patterson, T. F.; Mehta, A. K.; Tomashek, K. M.; Wolfe, C. R.; Ghazaryan, V.; Marconi, V. C.; Ruiz-Palacios, G. M.; Hsieh, L.; Kline, S.; Tapson, V.; Iovine, N. M.; Jain, M. K.; Sweeney, D. A.; El Sahly, H. M.; Branche, A. R.; Regalado Pineda, J.; Lye, D. C.; Sandkovsky, U.; Luetkemeyer, A. F.; Cohen, S. H.; Finberg, R. W.; Jackson, P. E. H.; Taiwo, B.; Paules, C. I.; Arguinchona, H.; Goepfert, P.; Ahuja, N.; Frank, M.; Oh, M.-d.; Kim, E. S.; Tan, S. Y.; Mularski, R. A.; Nielsen, H.; Ponce, P. O.; Taylor, B. S.; Larson, L.; Rouphael, N. G.; Saklawi, Y.; Cantos, V. D.; Ko, E. R.; Engemann, J. J.; Amin, A. N.; Watanabe, M.; Billings, J.; Elie, M.-C.; Davey, R. T.; Burgess, T. H.; Ferreira, J.; Green, M.; Makowski, M.; Cardoso, A.; de Bono, S.; Bonnett, T.; Proschan, M.; Deye, G. A.; Dempsey, W.; Nayak, S. U.; Dodd, L. E.; Beigel, J. H., Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. New England Journal of Medicine 2020. https://doi.org/10.1056/NEJMoa2031994
328. Karnakov, P.; Arampatzis, G.; Kičić, I.; Wermelinger, F.; Wälchli, D.; Papadimitriou, C.; Koumoutsakos, P., Data driven inference of the reproduction number (R0) for COVID-19 before and after interventions for 51 European countries. 2020.
329. Kawasuji, H.; Takegoshi, Y.; Kaneda, M.; Ueno, A.; Miyajima, Y.; Kawago, K.; Fukui, Y.; Yoshida, Y.; Kimura, M.; Yamada, H.; Sakamaki, I.; Tani, H.; Morinaga, Y.; Yamamoto, Y., Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients. PLOS ONE 2020, 15 (12), e0243597. https://doi.org/10.1371/journal.pone.0243597
330. Keller, M. J.; Kitsis, E. A.; Arora, S.; Chen, J. T.; Agarwal, S.; Ross, M. J.; Tomer, Y.; Southern, W., Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19. Journal of Hospital Medicine 2020, Online First, July 22nd, 2020.
331. Kelly, M.; O'Connor, R.; Townsend, L.; Coghlan, M.; Relihan, E.; Moriarty, M.; Carr, B.; Melanophy, G.; Doyle, C.; Bannan, C.; O'Riordan, R.; Merry, C.; Clarke, S.; Bergin, C., Clinical outcomes and adverse events in patients hospitalised with COVID -19, treated with off- label hydroxychloroquine and azithromycin. Br J Clin Pharmacol 2020.
332. Kemp, S. A.; Datir, R. P.; Collier, D. A.; Ferreira, I.; Carabelli, A.; Harvey, W.; Robertson, D. L.; Gupta, R. K., Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/ΔV70. bioRxiv 2020, 2020.12.14.422555. http://biorxiv.org/content/early/2020/12/15/2020.12.14.422555.abstract
333. Kennedy, M.; Helfand, B. K. I.; Gou, R. Y.; Gartaganis, S. L.; Webb, M.; Moccia, J. M.; Bruursema, S. N.; Dokic, B.; McCulloch, B.; Ring, H.; Margolin, J. D.; Zhang, E.; Anderson, R.; Babine, R. L.; Hshieh, T.; Wong, A. H.; Taylor, R. A.; Davenport, K.; Teresi, B.; Fong, T. G.; Inouye, S. K., Delirium in Older Patients With COVID-19 Presenting to the Emergency Department. JAMA Network Open 2020, 3 (11), e2029540- e2029540. https://doi.org/10.1001/jamanetworkopen.2020.29540
334. Kennedy, M.; Lee, S. J.; Epstein, M., Modeling aerosol transmission of SARS-CoV-2 in multi-room facility. Journal of Loss Prevention in the Process Industries 2020, 104336. http://www.sciencedirect.com/science/article/pii/S0950423020306239
335. Kerr, C. C.; Stuart, R. M.; Mistry, D.; Abeysuriya, R. G.; Hart, G.; Rosenfeld, K.; Selvaraj, P.; Nunez, R. C.; Hagedorn, B.; George, L.; Izzo, A.; Palmer, A.; Delport, D.; Bennette, C.; Wagner, B.; Chang, S.; Cohen, J. A.; Panovska-Griffiths, J.; Jastrzebski, M.; Oron, A. P.; Wenger, E.; Famulare, M.; Klein, D. J., Covasim: an agent-based model of COVID-19 dynamics and interventions. medRxiv 2020, 2020.05.10.20097469. https://www.medrxiv.org/content/medrxiv/early/2020/05/15/2020.05.10.20097469.full.pdf
336. Khanh, N. C.; Thai, P. Q.; Quach, H.-L.; Thi, N.-A. H.; Dinh, P. C.; Duong, T. N.; Mai, L. T. Q.; Nghia, N. D.; Tu, T. A.; Quang, L. N.; Quang, T. D.; Nguyen, T.-T.; Vogt, F.; Anh, D. D., Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 During Long Flight. Emerging Infectious Disease journal 2020, 26 (11). https://wwwnc.cdc.gov/eid/article/26/11/20-3299_article
337. Kim, S. E.; Jeong, H. S.; Yu, Y.; Shin, S. U.; Kim, S.; Oh, T. H.; Kim, U. J.; Kang, S. J.; Jang, H. C.; Jung, S. I.; Park, K. H., Viral kinetics of SARS-CoV-2 in asymptomatic carriers and presymptomatic patients. Int J Infect Dis 2020.
338. Kim, U. J.; Lee, S. Y.; Lee, J. Y.; Lee, A.; Kim, S. E.; Choi, O.-J.; Lee, J. S.; Kee, S.-J.; Jang, H.-C., Air and Environmental Contamination Caused by COVID-19 Patients: a Multi-Center Study. J Korean Med Sci 2020, 35 (37). https://doi.org/10.3346/jkms.2020.35.e332
339. Kim, Y.-I.; Kim, S.-G.; Kim, S.-M.; Kim, E.-H.; Park, S.-J.; Yu, K.-M.; Chang, J.-H.; Kim, E. J.; Lee, S.; Casel, M. A. B.; Um, J.; Song, M.-S.; Jeong, H. W.; Lai, V. D.; Kim, Y.; Chin, B. S.; Park, J.-S.; Chung, K.-H.; Foo, S.-S.; Poo, H.; Mo, I.-P.; Lee, O.-J.; Webby, R. J.; Jung, J. U.; Choi, Y. K., Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. Cell Host & Microbe 2020. http://www.sciencedirect.com/science/article/pii/S1931312820301876
340. King, J. A.; Whitten, T. A.; Bakal, J. A.; McAlister, F. A., Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta. Canadian Medical Association Journal 2020, cmaj.202065. https://www.cmaj.ca/content/cmaj/early/2020/11/23/cmaj.202065.full.pdf
341. Knight, S. R.; Ho, A.; Pius, R.; Buchan, I.; Carson, G.; Drake, T. M.; Dunning, J.; Fairfield, C. J.; Gamble, C.; Green, C. A.; Gupta, R.; Halpin, S.; Hardwick, H. E.; Holden, K. A.; Horby, P. W.; Jackson, C.; Mclean, K. A.; Merson, L.; Nguyen-Van-Tam, J. S.; Norman, L.; Noursadeghi, M.; Olliaro, P. L.; Pritchard, M. G.; Russell, C. D.; Shaw, C. A.; Sheikh, A.; Solomon, T.; Sudlow, C.; Swann, O. V.; Turtle, L. C.; Openshaw, P. J.; Baillie, J. K.; Semple, M. G.; Docherty, A. B.; Harrison, E. M., Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ 2020, 370, m3339. https://www.bmj.com/content/bmj/370/bmj.m3339.full.pdf
342. Koh, W. C.; Naing, L.; Chaw, L.; Rosledzana, M. A.; Alikhan, M. F.; Jamaludin, S. A.; Amin, F.; Omar, A.; Shazli, A.; Griffith, M.; Pastore, R.; Wong, J., What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PLOS ONE 2020, 15 (10), e0240205. https://doi.org/10.1371/journal.pone.0240205
343. Konda, A.; Prakash, A.; Moss, G. A.; Schmoldt, M.; Grant, G. D.; Guha, S., Aerosol Filtration Efficiency of Common Fabrics Used in Respiratory Cloth Masks. ACS Nano 2020. https://www.ncbi.nlm.nih.gov/pubmed/32329337
344. Kong, D.; Zheng, Y.; Wu, H.; Pan, H.; Wagner, A. L.; Zheng, Y.; Gong, X.; Zhu, Y.; Jin, B.; Xiao, W.; Mao, S.; Lin, S.; Han, R.; Yu, X.; Cui, P.; Jiang, C.; Fang, Q.; Lu, Y.; Fu, C., Pre-symptomatic transmission of novel coronavirus in community settings. Influenza and Other Respiratory Viruses 2020, n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/irv.12773
345. Kong, T.-k., Longer incubation period of coronavirus disease 2019 (COVID-19) in older adults. AGING MEDICINE 2020, 3 (2), 102-109. https://onlinelibrary.wiley.com/doi/abs/10.1002/agm2.12114 
346. Koo, J. R.; Cook, A. R.; Park, M.; Sun, Y.; Sun, H.; Lim, J. T.; Tam, C.; Dickens, B. L., Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. The Lancet Infectious Diseases 2020, 20 (6), 678-688. https://doi.org/10.1016/S1473-3099(20)30162-6
347. Korber, B.; Fischer, W. M.; Gnanakaran, S.; Yoon, H.; Theiler, J.; Abfalterer, W.; Hengartner, N.; Giorgi, E. E.; Bhattacharya, T.; Foley, B.; Hastie, K. M.; Parker, M. D.; Partridge, D. G.; Evans, C. M.; Freeman, T. M.; de Silva, T. I.; McDanal, C.; Perez, L. G.; Tang, H.; Moon-Walker, A.; Whelan, S. P.; LaBranche, C. C.; Saphire, E. O.; Montefiori, D. C.; Angyal, A.; Brown, R. L.; Carrilero, L.; Green, L. R.; Groves, D. C.; Johnson, K. J.; Keeley, A. J.; Lindsey, B. B.; Parsons, P. J.; Raza, M.; Rowland-Jones, S.; Smith, N.; Tucker, R. M.; Wang, D.; Wyles, M. D., Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 2020. https://doi.org/10.1016/j.cell.2020.06.043 
348. Korevaar, H. M.; Becker, A. D.; Miller, I. F.; Grenfell, B. T.; Metcalf, C. J. E.; Mina, M. J., Quantifying the impact of US state non-pharmaceutical interventions on COVID-19 transmission. medRxiv 2020, 2020.06.30.20142877. https://www.medrxiv.org/content/medrxiv/early/2020/07/01/2020.06.30.20142877.full.pdf
349. Korte, W.; Buljan, M.; Rösslein, M.; Wick, P.; Golubov, V.; Jentsch, J.; Reut, M.; Peier, K.; Nohynek, B.; Fischer, A.; Stolz, R.; Cettuzzi, M.; Nolte, O., SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on. Journal of Infection 2020. https://doi.org/10.1016/j.jinf.2020.08.032
350. Kraemer, M. U. G.; Yang, C.-H.; Gutierrez, B.; Wu, C.-H.; Klein, B.; Pigott, D. M.; du Plessis, L.; Faria, N. R.; Li, R.; Hanage, W. P.; Brownstein, J. S.; Layan, M.; Vespignani, A.; Tian, H.; Dye, C.; Pybus, O. G.; Scarpino, S. V., The effect of human mobility and control measures on the COVID-19 epidemic in China. Science 2020, eabb4218. https://science.sciencemag.org/content/sci/early/2020/03/25/science.abb4218.full.pdf
351. Kratzel, A.; Todt, D.; V'kovski, P.; Steiner, S.; Gultom, M. L.; Thao, T. T. N.; Ebert, N.; Holwerda, M.; Steinmann, J.; Niemeyer, D.; Dijkman, R.; Kampf, G.; Drosten, C.; Steinmann, E.; Thiel, V.; Pfaender, S., Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols. bioRxiv 2020, 2020.03.10.986711. https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711.full.pdf
352. Kucharski, A. J.; Klepac, P.; Conlan, A. J. K.; Kissler, S. M.; Tang, M. L.; Fry, H.; Gog, J. R.; Edmunds, W. J., Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study. Lancet Infect Dis 2020.
353. Kucharski, A. J.; Russell, T. W.; Diamond, C.; Liu, Y.; Edmunds, J.; Funk, S.; Eggo, R. M.; Sun, F.; Jit, M.; Munday, J. D., Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The lancet infectious diseases 2020.
354. Kucirka, L. M.; Lauer, S. A.; Laeyendecker, O.; Boon, D., Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure. Annals of Internal Medicine 2020, 0 (0), null. https://www.acpjournals.org/doi/abs/10.7326/M20-1495
355. Kupferschmidt, K., Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments. Science Magazine 2020, 1. https://www.sciencemag.org/news/2020/10/remdesivir-and-interferon-fall- flat-who-s-megastudy-covid-19-treatments
356. Lai, S.; Ruktanonchai, N. W.; Zhou, L.; Prosper, O.; Luo, W.; Floyd, J. R.; Wesolowski, A.; Santillana, M.; Zhang, C.; Du, X.; Yu, H.; Tatem, A. J., Effect of non-pharmaceutical interventions to contain COVID- 19 in China. Nature 2020. https://doi.org/10.1038/s41586-020-2293-x
357. Lalau, J. D.; Al-Salameh, A.; Hadjadj, S.; Goronflot, T.; Wiernsperger, N.; Pichelin, M.; Allix, I.; Amadou, C.; Bourron, O.; Duriez, T.; Gautier, J. F.; Dutour, A.; Gonfroy, C.; Gouet, D.; Joubert, M.; Julier, I.; Larger, E.; Marchand, L.; Marre, M.; Meyer, L.; Olivier, F.; Prevost, G.; Quiniou, P.; Raffaitin-Cardin, C.; Roussel, R.; Saulnier, P. J.; Seret-Begue, D.; Thivolet, C.; Vatier, C.; Desailloud, R.; Wargny, M.; Gourdy, P.; Cariou, B., Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. Diabetes Metab 2020, 101216.
358. Lam, T. T.-Y.; Shum, M. H.-H.; Zhu, H.-C.; Tong, Y.-G.; Ni, X.-B.; Liao, Y.-S.; Wei, W.; Cheung, W. Y.- M.; Li, W.-J.; Li, L.-F.; Leung, G. M.; Holmes, E. C.; Hu, Y.-L.; Guan, Y., Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins. Nature 2020. https://doi.org/10.1038/s41586-020-2169-0
359. Lan, F.-Y.; Suharlim, C.; Kales, S. N.; Yang, J., Association between SARS-CoV-2 infection, exposure risk and mental health among a cohort of essential retail workers in the USA. Occupational and Environmental Medicine 2020, oemed-2020-106774. https://oem.bmj.com/content/oemed/early/2020/10/11/oemed-2020-106774.full.pdf
360. LANL, COVID-19 Confirmed and Forecasted Case Data. https://covid-19.bsvgateway.org/.
361. Lapin, T., About a dozen US mink farms in quarantine as officials probe COVID-19 outbreaks. New York Post 2020. https://nypost.com/2020/11/10/us-mink-farms-in-quarantine-as-officials-probe-covid- 19-outbreaks/
362. Larosa, E.; Djuric, O.; Cassinadri, M.; Cilloni, S.; Bisaccia, E.; Vicentini, M.; Venturelli, F.; Giorgi Rossi, P.; Pezzotti, P.; Bedeschi, E.; Group, t. R. E. C.-W., Secondary transmission of COVID-19 in preschool and school settings in northern Italy after their reopening in September 2020: a population-based study. Eurosurveillance 2020, 25 (49), 2001911. https://www.eurosurveillance.org/content/10.2807/1560- 7917.ES.2020.25.49.2001911
363. Larsen, J. R.; Martin, M. R.; Martin, J. D.; Kuhn, P.; Hicks, J. B., Modeling the Onset of Symptoms of COVID-19. Frontiers in Public Health 2020, 8 (473). https://www.frontiersin.org/article/10.3389/fpubh.2020.00473
364. Lasry, A.; Kidder, D.; Hast, M.; Poovey, J.; Sunshine, G.; Zviedrite, N.; Ahmed, F.; Ethier, K. A., Timing of community mitigation and changes in reported COVID-19 and community mobility―four US metropolitan areas, February 26–April 1, 2020. morbidity and Mortality Weekly Report 2020, 69, 451- 457. https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e2.htm
365. Lassaunière, R.; Frische, A.; Harboe, Z. B.; Nielsen, A. C.; Fomsgaard, A.; Krogfelt, K. A.; Jørgensen, C. S., Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv 2020, 2020.04.09.20056325. https://www.medrxiv.org/content/medrxiv/early/2020/04/10/2020.04.09.20056325.full.pdf
366. Latinne, A.; Hu, B.; Olival, K. J.; Zhu, G.; Zhang, L.; Li, H.; Chmura, A. A.; Field, H. E.; Zambrana- Torrelio, C.; Epstein, J. H.; Li, B.; Zhang, W.; Wang, L.-F.; Shi, Z.-L.; Daszak, P., Origin and cross-species transmission of bat coronaviruses in China. Nature Communications 2020, 11 (1), 4235. https://doi.org/10.1038/s41467-020-17687-3
367. Latz, C. A.; DeCarlo, C.; Boitano, L.; Png, C. Y. M.; Patell, R.; Conrad, M. F.; Eagleton, M.; Dua, A., Blood type and outcomes in patients with COVID-19. Annals of Hematology 2020. https://doi.org/10.1007/s00277-020-04169-1
368. Lau, M. S. Y.; Grenfell, B.; Thomas, M.; Bryan, M.; Nelson, K.; Lopman, B., Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proceedings of the National Academy of Sciences 2020, 202011802. https://www.pnas.org/content/pnas/early/2020/08/19/2011802117.full.pdf
369. Lauer, S. A.; Grantz, K. H.; Bi, Q.; Jones, F. K.; Zheng, Q.; Meredith, H. R.; Azman, A. S.; Reich, N. G.; Lessler, J., The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of Internal Medicine 2020. https://doi.org/10.7326/M20-0504
370. Lavery, A. M.; Preston, L. E.; Ko, J. Y.; al., e., Characteristics of Hospitalized COVID-19 Patients Discharged and Experiencing Same-Hospital Readmission — United States, March–August 2020. Morbidity and Mortality Weekly Report 2020, ePub: 9 November 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6945e2.htm
371. Lavezzo, E.; Franchin, E.; Ciavarella, C.; Cuomo-Dannenburg, G.; Barzon, L.; Del Vecchio, C.; Rossi, L.; Manganelli, R.; Loregian, A.; Navarin, N.; Abate, D.; Sciro, M.; Merigliano, S.; De Canale, E.; Vanuzzo, M. C.; Besutti, V.; Saluzzo, F.; Onelia, F.; Pacenti, M.; Parisi, S.; Carretta, G.; Donato, D.; Flor, L.; Cocchio, S.; Masi, G.; Sperduti, A.; Cattarino, L.; Salvador, R.; Nicoletti, M.; Caldart, F.; Castelli, G.; Nieddu, E.; Labella, B.; Fava, L.; Drigo, M.; Gaythorpe, K. A. M.; Ainslie, K. E. C.; Baguelin, M.; Bhatt, S.; Boonyasiri, A.; Boyd, O.; Cattarino, L.; Ciavarella, C.; Coupland, H. L.; Cucunubá, Z.; Cuomo-Dannenburg, G.; Djafaara, B. A.; Donnelly, C. A.; Dorigatti, I.; van Elsland, S. L.; FitzJohn, R.; Flaxman, S.; Gaythorpe, K. A. M.; Green, W. D.; Hallett, T.; Hamlet, A.; Haw, D.; Imai, N.; Jeffrey, B.; Knock, E.; Laydon, D. J.; Mellan, T.; Mishra, S.; Nedjati-Gilani, G.; Nouvellet, P.; Okell, L. C.; Parag, K. V.; Riley, S.; Thompson, H. A.; Unwin, H. J. T.; Verity, R.; Vollmer, M. A. C.; Walker, P. G. T.; Walters, C. E.; Wang, H.; Wang, Y.; Watson, O. J.; Whittaker, C.; Whittles, L. K.; Xi, X.; Ferguson, N. M.; Brazzale, A. R.; Toppo, S.; Trevisan, M.; Baldo, V.; Donnelly, C. A.; Ferguson, N. M.; Dorigatti, I.; Crisanti, A.; Imperial College, C.-R. T., Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature 2020. https://doi.org/10.1038/s41586- 020-2488-1
372. Laws, R. L.; Chancey, R. J.; Rabold, E. M.; Chu, V. T.; Lewis, N. M.; Fajans, M.; Reses, H. E.; Duca, L. M.; Dawson, P.; Conners, E. E.; Gharpure, R.; Yin, S.; Buono, S.; Pomeroy, M.; Yousaf, A. R.; Owusu, D.; Wadhwa, A.; Pevzner, E.; Battey, K. A.; Njuguna, H.; Fields, V. L.; Salvatore, P.; O’Hegarty, M.; Vuong, J.; Gregory, C. J.; Banks, M.; Rispens, J.; Dietrich, E.; Marcenac, P.; Matanock, A.; Pray, I.; Westergaard, R.; Dasu, T.; Bhattacharyya, S.; Christiansen, A.; Page, L.; Dunn, A.; Atkinson-Dunn, R.; Christensen, K.; Kiphibane, T.; Willardson, S.; Fox, G.; Ye, D.; Nabity, S. A.; Binder, A.; Freeman, B. D.; Lester, S.; Mills, L.; Thornburg, N.; Hall, A. J.; Fry, A. M.; Tate, J. E.; Tran, C. H.; Kirking, H. L., Symptoms and Transmission of SARS-CoV-2 Among Children — Utah and Wisconsin, March–May 2020. Pediatrics 2020, e2020027268. https://pediatrics.aappublications.org/content/pediatrics/early/2020/12/01/peds.2020-027268.full.pdf
373. Laxminarayan, R.; Wahl, B.; Dudala, S. R.; Gopal, K.; Mohan, C.; Neelima, S.; Jawahar Reddy, K. S.; Radhakrishnan, J.; Lewnard, J. A., Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science 2020, eabd7672. https://science.sciencemag.org/content/sci/early/2020/09/29/science.abd7672.full.pdf
374. Le Bert, N.; Clapham, H. E.; Tan, A. T.; Chia, W. N.; Tham, C. Y.; Lim, J. M.; Kunasegaran, K.; Tan, L.; Dutertre, C.-A.; Shankar, N.; Lim, J. M.; Sun, L. J.; Zahari, M.; Tun, Z. M.; Kumar, V.; Lim, B. L.; Lim, S. H.; Chia, A.; Tan, Y.-J.; Tambyah, P. A.; Kalimuddin, S.; Lye, D. C.; Low, J. G.; Wang, L.-F.; Wan, W. Y.; Hsu, L. Y.; Bertoletti, A.; Tam, C. C., Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. bioRxiv 2020, 2020.11.25.399139. https://www.biorxiv.org/content/biorxiv/early/2020/11/27/2020.11.25.399139.full.pdf
375. Le Bert, N.; Tan, A. T.; Kunasegaran, K.; Tham, C. Y. L.; Hafezi, M.; Chia, A.; Chng, M. H. Y.; Lin, M.; Tan, N.; Linster, M.; Chia, W. N.; Chen, M. I. C.; Wang, L.-F.; Ooi, E. E.; Kalimuddin, S.; Tambyah, P. A.; Low, J. G.-H.; Tan, Y.-J.; Bertoletti, A., SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 2020. https://doi.org/10.1038/s41586-020-2550-z
376. Leclerc, Q.; Fuller, N.; Knight, L.; null, n.; Funk, S.; Knight, G., What settings have been linked to SARS-CoV-2 transmission clusters? [version 2; peer review: 2 approved]. Wellcome Open Research 2020, 5 (83). https://wellcomeopenresearch.org/articles/5-83/v2
377. Lee, C. Y.-P.; Amrun, S. N.; Chee, R. S.-L.; Goh, Y. S.; Mak, T.-M.; Octavia, S.; Yeo, N. K.-W.; Chang, Z. W.; Tay, M. Z.; Torres-Ruesta, A.; Carissimo, G.; Poh, C. M.; Fong, S.-W.; Bei, W.; Lee, S.; Young, B. E.; Tan, S.-Y.; Leo, Y.-S.; Lye, D. C.; Lin, R. T. P.; Maurer-Stroh, S.; Lee, B.; Cheng-I, W.; Renia, L.; Ng, L. F. P., Neutralizing antibodies from early cases of SARS-CoV-2 infection offer cross-protection against the SARS- CoV-2 D614G variant. bioRxiv 2020, 2020.10.08.332544. https://www.biorxiv.org/content/biorxiv/early/2020/10/09/2020.10.08.332544.full.pdf
378. Lee, E. H.; Kepler, K. L.; Geevarughese, A.; Paneth-Pollak, R.; Dorsinville, M. S.; Ngai, S.; Reilly, K. H., Race/Ethnicity Among Children With COVID-19–Associated Multisystem Inflammatory Syndrome. JAMA Network Open 2020, 3 (11), e2030280-e2030280. https://doi.org/10.1001/jamanetworkopen.2020.30280
379. Lee, J.; Hughes, T.; Lee, M.-H.; Field, H.; Rovie-Ryan, J. J.; Sitam, F. T.; Sipangkui, S.; Nathan, S. K. S. S.; Ramirez, D.; Kumar, S. V.; Lasimbang, H.; Epstein, J. H.; Daszak, P., No evidence of coronaviruses or other potentially zoonotic viruses in Sunda pangolins (<em>Manis javanica</em>) entering the wildlife trade via Malaysia. bioRxiv 2020, 2020.06.19.158717. https://www.biorxiv.org/content/biorxiv/early/2020/06/19/2020.06.19.158717.full.pdf
380. Lee, Y.-H.; Hong, C. M.; Kim, D. H.; Lee, T. H.; Lee, J., Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea. Emerging Infectious Disease journal 2020, 26 (10). https://wwwnc.cdc.gov/eid/article/26/10/20- 1620_article
381. Lendvay, T. S.; Chen, J.; Harcourt, B. H.; Scholte, F. E. M.; Kilinc-Balci, F. S.; Lin, Y. L.; Lamb, M. M.; Chu, L. F.; Price, A.; Evans, D.; Lin, Y.-C.; Mores, C. N.; Sahni, J.; Kabra, K. B.; Haubruge, E.; Thiry, E.; Heyne, B.; Laperre, J.; Simmons, S.; Davies, J. M.; Cui, Y.; Wagner, T.; Clark, T.; Smit, S. J.; Parker, R.; Gallagher, T.; Timm, E.; Ludwig-Begall, L. F.; Macia, N.; Mackie, C.; Hope, K.; Page, K.; Reader, S.; Faris, P.; Jolois, O.; Patel, A.; Lemyre, J.-L.; Molloy-Simard, V.; Homdayjanakul, K.; Tritsch, S. R.; Wielick, C.; Mayo, M.; Malott, R.; Willaert, J.-F.; Nauwynck, H.; Dams, L.; De Jaeger, S.; Liao, L.; Zhao, M.; Chu, S.; Conly, J. M.; Chu, M. C., Addressing Personal Protective Equipment (PPE) Decontamination: Methylene Blue and Light Inactivates SARS-CoV-2 on N95 Respirators and Masks with Maintenance of Integrity and Fit. medRxiv 2020, 2020.12.11.20236919. https://www.medrxiv.org/content/medrxiv/early/2020/12/12/2020.12.11.20236919.full.pdf
382. Lenze, E. J.; Mattar, C.; Zorumski, C. F.; Stevens, A.; Schweiger, J.; Nicol, G. E.; Miller, J. P.; Yang, L.; Yingling, M.; Avidan, M. S.; Reiersen, A. M., Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA 2020. https://doi.org/10.1001/jama.2020.22760
383. Letizia, A. G.; Ramos, I.; Obla, A.; Goforth, C.; Weir, D. L.; Ge, Y.; Bamman, M. M.; Dutta, J.; Ellis, E.; Estrella, L.; George, M.-C.; Gonzalez-Reiche, A. S.; Graham, W. D.; van de Guchte, A.; Gutierrez, R.; Jones, F.; Kalomoiri, A.; Lizewski, R.; Lizewski, S.; Marayag, J.; Marjanovic, N.; Millar, E. V.; Nair, V. D.; Nudelman, G.; Nunez, E.; Pike, B. L.; Porter, C.; Regeimbal, J.; Rirak, S.; Santa Ana, E.; Sealfon, R. S. G.; Sebra, R.; Simons, M. P.; Soares-Schanoski, A.; Sugiharto, V.; Termini, M.; Vangeti, S.; Williams, C.; Troyanskaya, O. G.; van Bakel, H.; Sealfon, S. C., SARS-CoV-2 Transmission among Marine Recruits during Quarantine. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2029717
384. Leung, N. H. L.; Chu, D. K. W.; Shiu, E. Y. C.; Chan, K.-H.; McDevitt, J. J.; Hau, B. J. P.; Yen, H.-L.; Li, Y.; Ip, D. K. M.; Peiris, J. S. M.; Seto, W.-H.; Leung, G. M.; Milton, D. K.; Cowling, B. J., Respiratory virus shedding in exhaled breath and efficacy of face masks. Nature Medicine 2020. https://doi.org/10.1038/s41591-020-0843-2
385. Lewis, D., Is the coronavirus airborne? Experts can’t agree. Nature 2020. 10.1038/d41586-020- 00974-w
386. Lewis, N. M.; Chu, V. T.; Ye, D.; al., e., Household Transmission of SARS-CoV-2 in the United States. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa1166
387. Li, D.; Jin, M.; Bao, P.; Zhao, W.; Zhang, S., Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019. JAMA Network Open 2020, 3 (5), e208292-e208292. https://doi.org/10.1001/jamanetworkopen.2020.8292
388. Li, K.; Wohlford-Lenane, C.; Perlman, S.; Zhao, J.; Jewell, A. K.; Reznikov, L. R.; Gibson-Corley, K. N.; Meyerholz, D. K.; McCray, P. B., Jr., Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4. J Infect Dis 2016, 213 (5), 712-22. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747621/pdf/jiv499.pdf
389. Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K. S. M.; Lau, E. H. Y.; Wong, J. Y.; Xing, X.; Xiang, N.; Wu, Y.; Li, C.; Chen, Q.; Li, D.; Liu, T.; Zhao, J.; Liu, M.; Tu, W.; Chen, C.; Jin, L.; Yang, R.; Wang, Q.; Zhou, S.; Wang, R.; Liu, H.; Luo, Y.; Liu, Y.; Shao, G.; Li, H.; Tao, Z.; Yang, Y.; Deng, Z.; Liu, B.; Ma, Z.; Zhang, Y.; Shi, G.; Lam, T. T. Y.; Wu, J. T.; Gao, G. F.; Cowling, B. J.; Yang, B.; Leung, G. M.; Feng, Z., Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMoa2001316 https://www.nejm.org/doi/10.1056/NEJMoa2001316
390. Li, Q.; Li, W.; Jin, Y.; Xu, W.; Huang, C.; Li, L.; Huang, Y.; Fu, Q.; Chen, L., Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study. Infect Dis Ther 2020.
391. Li, R.; Pei, S.; Chen, B.; Song, Y.; Zhang, T.; Yang, W.; Shaman, J., Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science 2020, eabb3221. https://science.sciencemag.org/content/sci/early/2020/03/13/science.abb3221.full.pdf
392. Li, X.; Giorgi, E. E.; Marichannegowda, M. H.; Foley, B.; Xiao, C.; Kong, X.-P.; Chen, Y.; Gnanakaran, S.; Korber, B.; Gao, F., Emergence of SARS-CoV-2 through recombination and strong purifying selection. Science Advances 2020, eabb9153. https://advances.sciencemag.org/content/advances/early/2020/05/28/sciadv.abb9153.full.pdf
393. Li, X.; Xiao, K.; Chen, X.; Liang, X.; Zhang, X.; Zhang, Z.; Zhai, J.; Wang, R.; Zhou, N.; Chen, Z.-J.; Su, R.; Zhou, F.; Holmes, E. C.; Irwin, D. M.; Chen, R.-A.; He, Q.; Wu, Y.-J.; Wang, C.; Du, X.-Q.; Peng, S.-M.; Xie, W.-J.; Shan, F.; Li, W.-P.; Dai, J.-W.; Shen, X.; Feng, Y.; Xiao, L.; Chen, W.; Shen, Y., Pathogenicity, tissue tropism and potential vertical transmission of SARSr-CoV-2 in Malayan pangolins. bioRxiv 2020, 2020.06.22.164442. http://biorxiv.org/content/early/2020/06/22/2020.06.22.164442.abstract
394. Li, X.; Zai, J.; Zhao, Q.; Nie, Q.; Li, Y.; Foley, B. T.; Chaillon, A., Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. Journal of Medical Virology 2020, n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25731
395. Li, Y.; Campbell, H.; Kulkarni, D.; Harpur, A.; Nundy, M.; Wang, X.; Nair, H., The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (<em>R</em>) of SARS-CoV-2: a modelling study across 131 countries. The Lancet Infectious Diseases 2020. https://doi.org/10.1016/S1473-3099(20)30785-4
396. Li, Y.; Qian, H.; Hang, J.; Chen, X.; Hong, L.; Liang, P.; Li, J.; Xiao, S.; Wei, J.; Liu, L.; Kang, M., Evidence for probable aerosol transmission of SARS-CoV-2 in a poorly ventilated restaurant. medRxiv 2020, 2020.04.16.20067728. https://www.medrxiv.org/content/medrxiv/early/2020/04/22/2020.04.16.20067728.full.pdf
397. Li, Y.; Xie, Z.; Lin, W.; Cai, W.; Wen, C.; Guan, Y.; Mo, X.; Wang, J.; Wang, Y.; Peng, P.; Chen, X.; Hong, W.; Xiao, G.; Liu, J.; Zhang, L.; Hu, F.; Li, F.; Zhang, F.; Deng, X.; Li, L., Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial. Med. https://doi.org/10.1016/j.medj.2020.04.001
398. Liao, J.; Fan, S.; Chen, J.; Wu, J.; Xu, S.; Guo, Y.; Li, C.; Zhang, X.; Wu, C.; Mou, H., Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults. The Innovation 2020, 1 (1), 100001.
399. Lieu, A.; Mah, J.; Zanichelli, V.; Exantus, R. C.; Longtin, Y., Impact of Extended Use and Decontamination with Vaporized Hydrogen Peroxide on N95 Respirator Fit. American Journal of Infection Control 2020. https://doi.org/10.1016/j.ajic.2020.08.010
400. Lilly, E., Bamlanivimab for COVID-19. Eli Lilly: 2020. https://www.lilly.com/news/media/media- kits/bamlanivimab-covid19
401. Lilly, E., Lilly Statement Regarding NIH’s ACTIV-3 Clinical Trial. Eli Lilly and Company: 2020. https://www.lilly.com/news/stories/statement-activ3-clinical-trial-nih-covid19
402. Liotta, E. M.; Batra, A.; Clark, J. R.; Shlobin, N. A.; Hoffman, S. C.; Orban, Z. S.; Koralnik, I. J., Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Annals of Clinical and Translational Neurology 2020, n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1002/acn3.51210
403. Liotti, F. M.; Menchinelli, G.; Marchetti, S.; Posteraro, B.; Landi, F.; Sanguinetti, M.; Cattani, P., Assessment of SARS-CoV-2 RNA Test Results Among Patients Who Recovered From COVID-19 With Prior Negative Results. JAMA Internal Medicine 2020. https://doi.org/10.1001/jamainternmed.2020.7570
404. Lisboa Bastos, M.; Tavaziva, G.; Abidi, S. K.; Campbell, J. R.; Haraoui, L.-P.; Johnston, J. C.; Lan, Z.; Law, S.; MacLean, E.; Trajman, A.; Menzies, D.; Benedetti, A.; Ahmad Khan, F., Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ 2020, 370, m2516. https://www.bmj.com/content/bmj/370/bmj.m2516.full.pdf
405. Liu, J.; Zhang, S.; Dong, X.; Li, Z.; Xu, Q.; Feng, H.; Cai, J.; Huang, S.; Guo, J.; Zhang, L.; Chen, Y.; Zhu, W.; Du, H.; Liu, Y.; Wang, T.; Chen, L.; Wen, Z.; Annane, D.; Qu, J.; Chen, D., Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome. J Clin Invest 2020.
406. Liu, M.; Li, Q.; Zhou, J.; Ai, W.; Zheng, X.; Zeng, J.; Liu, Y.; Xiang, X.; Guo, R.; Li, X.; Wu, X.; Xu, H.; Jiang, L.; Zhang, H.; Chen, J.; Tian, L.; Luo, J.; Luo, C., Value of swab types and collection time on SARS- COV-2 detection using RT-PCR assay. Journal of Virological Methods 2020, 286, 113974. http://www.sciencedirect.com/science/article/pii/S0166093420302263
407. Liu, N.; Zhang, T.; Ma, L.; Zhang, H.; Wang, H.; Wei, W.; Pei, H.; Li, H., The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis. Blood Rev 2020, 100785.
408. Liu, P.; Chen, W.; Chen, J.-P., Viral Metagenomics Revealed Sendai Virus and Coronavirus Infection of Malayan Pangolins (Manis javanica). Viruses 2019, 11 (11), 979. https://www.mdpi.com/1999- 4915/11/11/979
409. Liu, P.; Jiang, J.-Z.; Wan, X.-F.; Hua, Y.; Li, L.; Zhou, J.; Wang, X.; Hou, F.; Chen, J.; Zou, J.; Chen, J., Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLOS Pathogens 2020, 16 (5), e1008421. https://doi.org/10.1371/journal.ppat.1008421
410. Liu, P.; Jiang, J.-Z.; Wan, X.-F.; Hua, Y.; Wang, X.; Hou, F.; Chen, J.; Zou, J.; Chen, J., Are pangolins the intermediate host of the 2019 novel coronavirus (2019-nCoV) ? bioRxiv 2020, 2020.02.18.954628. http://biorxiv.org/content/early/2020/02/20/2020.02.18.954628.abstract
411. Liu, S., U of Guelph team tests produce decontamination technology on hospital gowns. https://www.cbc.ca/news/canada/kitchener-waterloo/decontaminate-hospital-gowns-1.5788587 (accessed 09 Nov 2020).
412. Liu, W.; Zhang, Q.; Chen, J.; Xiang, R.; Song, H.; Shu, S.; Chen, L.; Liang, L.; Zhou, J.; You, L.; Wu, P.; Zhang, B.; Lu, Y.; Xia, L.; Huang, L.; Yang, Y.; Liu, F.; Semple, M. G.; Cowling, B. J.; Lan, K.; Sun, Z.; Yu, H.; Liu, Y., Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMc2003717
413. Liu, Y.; Funk, S.; Flasche, S., The Contribution of Pre-symptomatic Transmission to the COVID-19 Outbreak; London School of Hygiene and Tropical Medicine: 2020. https://cmmid.github.io/topics/covid19/control-measures/pre-symptomatic-transmission.html
414. Liu, Y.; Li, T.; Deng, Y.; Liu, S.; Zhang, D.; Li, H.; Wang, X.; Jia, L.; Han, J.; Bei, Z.; Zhou, Y.; Li, L.; Li, J., Stability of SARS-CoV-2 on environmental surfaces and in human excreta. medRxiv 2020, 2020.05.07.20094805. https://www.medrxiv.org/content/medrxiv/early/2020/05/12/2020.05.07.20094805.full.pdf
415. Liu, Z.; Li, J.; Long, W.; Zeng, W.; Gao, R.; Zeng, G.; Chen, D.; Wang, S.; Li, Q.; Hu, D.; Guo, L.; Li, Z.; Wu, X., Bilirubin Levels as Potential Indicators of Disease Severity in Coronavirus Disease Patients: A Retrospective Cohort Study. Frontiers in Medicine 2020, 7 (799). https://www.frontiersin.org/article/10.3389/fmed.2020.598870
416. Long, Q.-X.; Liu, B.-Z.; Deng, H.-J.; Wu, G.-C.; Deng, K.; Chen, Y.-K.; Liao, P.; Qiu, J.-F.; Lin, Y.; Cai, X.- F.; Wang, D.-Q.; Hu, Y.; Ren, J.-H.; Tang, N.; Xu, Y.-Y.; Yu, L.-H.; Mo, Z.; Gong, F.; Zhang, X.-L.; Tian, W.-G.; Hu, L.; Zhang, X.-X.; Xiang, J.-L.; Du, H.-X.; Liu, H.-W.; Lang, C.-H.; Luo, X.-H.; Wu, S.-B.; Cui, X.-P.; Zhou, Z.; Zhu, M.-M.; Wang, J.; Xue, C.-J.; Li, X.-F.; Wang, L.; Li, Z.-J.; Wang, K.; Niu, C.-C.; Yang, Q.-J.; Tang, X.-J.; Zhang, Y.; Liu, X.-M.; Li, J.-J.; Zhang, D.-C.; Zhang, F.; Liu, P.; Yuan, J.; Li, Q.; Hu, J.-L.; Chen, J.; Huang, A.- L., Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Medicine 2020. https://doi.org/10.1038/s41591-020-0897-1
417. Long, Q.-X.; Tang, X.-J.; Shi, Q.-L.; Li, Q.; Deng, H.-J.; Yuan, J.; Hu, J.-L.; Xu, W.; Zhang, Y.; Lv, F.-J.; Su, K.; Zhang, F.; Gong, J.; Wu, B.; Liu, X.-M.; Li, J.-J.; Qiu, J.-F.; Chen, J.; Huang, A.-L., Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine 2020. https://doi.org/10.1038/s41591-020-0965-6
418. Long, S. W.; Olsen, R. J.; Christensen, P. A.; Bernard, D. W.; Davis, J. J.; Shukla, M.; Nguyen, M.; Saavedra, M. O.; Yerramilli, P.; Pruitt, L.; Subedi, S.; Kuo, H.-C.; Hendrickson, H.; Eskandari, G.; Nguyen, H. A. T.; Long, J. H.; Kumaraswami, M.; Goike, J.; Boutz, D.; Gollihar, J.; McLellan, J. S.; Chou, C.-W.; Javanmardi, K.; Finkelstein, I. J.; Musser, J., Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. medRxiv 2020, 2020.09.22.20199125. http://medrxiv.org/content/early/2020/09/25/2020.09.22.20199125.abstract 
419. Lu, J.; Plessis, L. d.; Liu, Z.; Hill, V.; Kang, M.; Lin, H.; Sun, J.; Francois, S.; Kraemer, M. U. G.; Faria, N. R.; McCrone, J. T.; Peng, J.; Xiong, Q.; Yuan, R.; Zeng, L.; Zhou, P.; Liang, C.; Yi, L.; Liu, J.; Xiao, J.; Hu, J.; Liu, T.; Ma, W.; Li, W.; Su, J.; Zheng, H.; Peng, B.; Fang, S.; Su, W.; Li, K.; Sun, R.; Bai, R.; Tang, X.; Liang, M.; Quick, J.; Song, T.; Rambaut, A.; Loman, N.; Raghwani, J.; Pybus, O.; Ke, C., Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China. medRxiv 2020, 2020.04.01.20047076. https://www.medrxiv.org/content/medrxiv/early/2020/04/04/2020.04.01.20047076.full.pdf
420. Lu, R.; Zhao, X.; Li, J.; Niu, P.; Yang, B.; Wu, H.; Wang, W.; Song, H.; Huang, B.; Zhu, N.; Bi, Y.; Ma, X.; Zhan, F.; Wang, L.; Hu, T.; Zhou, H.; Hu, Z.; Zhou, W.; Zhao, L.; Chen, J.; Meng, Y.; Wang, J.; Lin, Y.; Yuan, J.; Xie, Z.; Ma, J.; Liu, W. J.; Wang, D.; Xu, W.; Holmes, E. C.; Gao, G. F.; Wu, G.; Chen, W.; Shi, W.; Tan, W., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30251-8
421. Lu, S.; Zhao, Y.; Yu, W.; Yang, Y.; Gao, J.; Wang, J.; Kuang, D.; Yang, M.; Yang, J.; Ma, C.; Xu, J.; Qian, X.; Li, H.; Zhao, S.; Li, J.; Wang, H.; Long, H.; Zhou, J.; Luo, F.; Ding, K.; Wu, D.; Zhang, Y.; Dong, Y.; Liu, Y.; Zheng, Y.; Lin, X.; Jiao, L.; Zheng, H.; Dai, Q.; Sun, Q.; Hu, Y.; Ke, C.; Liu, H.; Peng, X., Comparison of nonhuman primates identified the suitable model for COVID-19. Signal Transduction and Targeted Therapy 2020, 5 (1), 157. https://doi.org/10.1038/s41392-020-00269-6
422. Lu, S.; Zhao, Y.; Yu, W.; Yang, Y.; Gao, J.; Wang, J.; Kuang, D.; Yang, M.; Yang, J.; Ma, C.; Xu, J.; Qian, X.; Li, H.; Zhao, S.; Li, J.; Wang, H.; Long, H.; Zhou, J.; Luo, F.; Ding, K.; Wu, D.; Zhang, Y.; Dong, Y.; Liu, Y.; Zheng, Y.; Lin, X.; Jiao, L.; Zheng, H.; Dai, Q.; Sun, Q.; Hu, Y.; Ke, C.; Liu, H.; Peng, X., Comparison of SARS- CoV-2 infections among 3 species of non-human primates. bioRxiv 2020, 2020.04.08.031807. https://www.biorxiv.org/content/biorxiv/early/2020/04/12/2020.04.08.031807.full.pdf
423. Lu, X.; Zhang, L.; Du, H.; Zhang, J.; Li, Y. Y.; Qu, J.; Zhang, W.; Wang, Y.; Bao, S.; Li, Y.; Wu, C.; Liu, H.; Liu, D.; Shao, J.; Peng, X.; Yang, Y.; Liu, Z.; Xiang, Y.; Zhang, F.; Silva, R. M.; Pinkerton, K. E.; Shen, K.; Xiao, H.; Xu, S.; Wong, G. W. K., SARS-CoV-2 Infection in Children. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMc2005073
424. Lu, Y.-f.; Pan, L.-y.; Zhang, W.-W.; Cheng, F.; Hu, S.-S.; Zhang, X.; Jiang, H.-y., A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. International Journal of Infectious Diseases 2020. https://doi.org/10.1016/j.ijid.2020.08.023 
425. Lu, Y.; Li, Y.; Deng, W.; Liu, M.; He, Y.; Huang, L.; Lv, M.; Li, J.; Du, H., Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus Disease 2019: A Retrospective Study of 110 Children in Wuhan. Pediatr Infect Dis J 2020.
426. Lumley, S. F.; O’Donnell, D.; Stoesser, N. E.; Matthews, P. C.; Howarth, A.; Hatch, S. B.; Marsden, B. D.; Cox, S.; James, T.; Warren, F.; Peck, L. J.; Ritter, T. G.; de Toledo, Z.; Warren, L.; Axten, D.; Cornall, R. J.; Jones, E. Y.; Stuart, D. I.; Screaton, G.; Ebner, D.; Hoosdally, S.; Chand, M.; Crook, D. W.; O’Donnell, A.- M.; Conlon, C. P.; Pouwels, K. B.; Walker, A. S.; Peto, T. E.; Hopkins, S.; Walker, T. M.; Jeffery, K.; Eyre, D. W., Antibodies to SARS-CoV-2 are associated with protection against reinfection. medRxiv 2020, 2020.11.18.20234369. https://www.medrxiv.org/content/medrxiv/early/2020/11/19/2020.11.18.20234369.full.pdf
427. Luo, K.; Lei, Z.; Hai, Z.; Xiao, S.; Rui, J.; Yang, H.; Jing, X.; Wang, H.; Xie, Z.; Luo, P.; Li, W.; Li, Q.; Tan, H.; Xu, Z.; Yang, Y.; Hu, S.; Chen, T., Transmission of SARS-CoV-2 in Public Transportation Vehicles: A Case Study in Hunan Province, China. Open Forum Infectious Diseases 2020, 7 (10). https://doi.org/10.1093/ofid/ofaa430
428. Luo, Y.; Trevathan, E.; Qian, Z.; Li, Y.; Li, J.; Xiao, W.; Tu, N.; Zeng, Z.; Mo, P.; Xiong, Y.; Ye, G., Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China. Emerging Infectious Disease journal 2020, 26 (8). https://wwwnc.cdc.gov/eid/article/26/8/20- 1016_article
429. Ma, J.; Qi, X.; Chen, H.; Li, X.; Zhang, Z.; Wang, H.; Sun, L.; Zhang, L.; Guo, J.; Morawska, L.; Grinshpun, S. A.; Biswas, P.; Flagan, R. C.; Yao, M., COVID-19 patients in earlier stages exhaled millions of SARS-CoV-2 per hour. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa1283
430. Madewell, Z. J.; Yang, Y.; Longini, I. M., Jr; Halloran, M. E.; Dean, N. E., Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis. JAMA Network Open 2020, 3 (12), e2031756- e2031756. https://doi.org/10.1001/jamanetworkopen.2020.31756
431. Magleby, R.; Westblade, L. F.; Trzebucki, A.; Simon, M. S.; Rajan, M.; Park, J.; Goyal, P.; Safford, M. M.; Satlin, M. J., Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa851
432. Maier, B. F.; Brockmann, D., Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China. Science 2020, 368 (6492), 742-746. https://science.sciencemag.org/content/sci/368/6492/742.full.pdf
433. Majumder, M.; Mandl, K., Early transmissibility assessment of a novel coronavirus in Wuhan, China. SSRN 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3524675
434. Malgie, J.; Schoones, J. W.; Pijls, B. G., Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies. Clin Infect Dis 2020. 
435. Mallapaty, S., Coronavirus can infect cats — dogs, not so much. Nature 2020. https://www.nature.com/articles/d41586-020-00984-8
436. Mallett, S.; Allen, A. J.; Graziadio, S.; Taylor, S. A.; Sakai, N. S.; Green, K.; Suklan, J.; Hyde, C.; Shinkins, B.; Zhelev, Z.; Peters, J.; Turner, P. J.; Roberts, N. W.; di Ruffano, L. F.; Wolff, R.; Whiting, P.; Winter, A.; Bhatnagar, G.; Nicholson, B. D.; Halligan, S., At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data. BMC Med 2020, 18 (1), 346.
437. Mandavilli, A., The Coronavirus Is Mutating. What Does That Mean for Us? New York Times 2020. https://www.nytimes.com/2020/12/20/health/coronavirus-britain- variant.html?action=click&module=Top%20Stories&pgtype=Homepage
438. Maor, Y.; Cohen, D.; Paran, N.; Israely, T.; Ezra, V.; Axelrod, O.; Shinar, E.; Izak, M.; Rahav, G.; Rahimi-Levene, N.; Bazofin, B. M.; Gelman, R.; Dicker, D.; Brosh-Nissimov, T.; Megged, O.; Dahan, D.; Benov, A.; Paz, A.; Edward, K.; Moran, A.; Rogowski, O.; Sorkine, P.; Mayo, A.; Zimhony, O.; Chen, J., Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID- 19 patients and association with IgG antibody levels in donated plasma. EClinicalMedicine 2020, 100525. 
439. Masana, L.; Correig, E.; Rodríguez-Borjabad, C.; Anoro, E.; Arroyo, J. A.; Jericó, C.; Pedragosa, A.; Miret, M.; Näf, S.; Pardo, A.; Perea, V.; Pérez-Bernalte, R.; Plana, N.; Ramírez-Montesinos, R.; Royuela, M.; Soler, C.; Urquizu-Padilla, M.; Zamora, A.; Pedro-Botet, J.; Group, O., EFFECT oF STATIN THERAPY oN SARS-CoV-2 INFECTION-RELATED. Eur Heart J Cardiovasc Pharmacother 2020.
440. Mateus, J.; Grifoni, A.; Tarke, A.; Sidney, J.; Ramirez, S. I.; Dan, J. M.; Burger, Z. C.; Rawlings, S. A.; Smith, D. M.; Phillips, E.; Mallal, S.; Lammers, M.; Rubiro, P.; Quiambao, L.; Sutherland, A.; Yu, E. D.; da Silva Antunes, R.; Greenbaum, J.; Frazier, A.; Markmann, A. J.; Premkumar, L.; de Silva, A.; Peters, B.; Crotty, S.; Sette, A.; Weiskopf, D., Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science 2020, eabd3871. https://science.sciencemag.org/content/sci/early/2020/08/04/science.abd3871.full.pdf
441. Mbaeyi, S., Use of Pfizer-BioNTech COVID-19 Vaccine: Clinical Considerations. https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2020-12/slides-12-12/COVID-03-Mbaeyi.pdf.
442. McCoy, J.; Cadegiani, F. A.; Wambier, C. G.; Herrera, S.; Vaño-Galván, S.; Mesinkovska, N. A.; Ramos, P. M.; Shapiro, J.; Sinclair, R.; Tosti, A.; Goren, A., 5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia. J Eur Acad Dermatol Venereol 2020.
443. McElvaney, O. J.; Hobbs, B. D.; Qiao, D.; McElvaney, O. F.; Moll, M.; McEvoy, N. L.; Clarke, J.; O'Connor, E.; Walsh, S.; Cho, M. H.; Curley, G. F.; McElvaney, N. G., A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. EBioMedicine 2020, 61, 103026. http://www.sciencedirect.com/science/article/pii/S2352396420304023
444. Mehta, N. S.; Mytton, O. T.; Mullins, E. W. S.; Fowler, T. A.; Falconer, C. L.; Murphy, O. B.; Langenberg, C.; Jayatunga, W. J. P.; Eddy, D. H.; Nguyen-Van-Tam, J. S., SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review. Clinical Infectious Diseases 2020, 71 (9), 2469-2479. https://doi.org/10.1093/cid/ciaa556
445. Menachery, V. D.; Dinnon, K. H.; Yount, B. L.; McAnarney, E. T.; Gralinski, L. E.; Hale, A.; Graham, R. L.; Scobey, T.; Anthony, S. J.; Wang, L.; Graham, B.; Randell, S. H.; Lipkin, W. I.; Baric, R. S., Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection. Journal of Virology 2020, 94 (5), e01774-19. https://jvi.asm.org/content/jvi/94/5/e01774-19.full.pdf
446. Merkler, A. E.; Parikh, N. S.; Mir, S.; Gupta, A.; Kamel, H.; Lin, E.; Lantos, J.; Schenck, E. J.; Goyal, P.; Bruce, S. S.; Kahan, J.; Lansdale, K. N.; LeMoss, N. M.; Murthy, S. B.; Stieg, P. E.; Fink, M. E.; Iadecola, C.; Segal, A. Z.; Cusick, M.; Campion, T. R., Jr; Diaz, I.; Zhang, C.; Navi, B. B., Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. JAMA Neurology 2020. https://doi.org/10.1001/jamaneurol.2020.2730
447. Meyerowitz, E. A.; Richterman, A.; Bogoch, I. I.; Low, N.; Cevik, M., Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2. The Lancet Infectious Diseases 2020. http://www.sciencedirect.com/science/article/pii/S1473309920308379
448. Millett, G. A.; Jones, A. T.; Benkeser, D.; Baral, S.; Mercer, L.; Beyrer, C.; Honermann, B.; Lankiewicz, E.; Mena, L.; Crowley, J. S.; Sherwood, J.; Sullivan, P., Assessing Differential Impacts of COVID-19 on Black Communities. Annals of Epidemiology 2020. http://www.sciencedirect.com/science/article/pii/S1047279720301769
449. Mina, M. J.; Parker, R.; Larremore, D. B., Rethinking Covid-19 Test Sensitivity — A Strategy for Containment. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMp2025631
450. MIT, DELPHI Epidemiological Case Predictions. https://www.covidanalytics.io/projections.
451. Mitchell, S. L.; Ventura, S. E., Evaluation and Comparison of the Hologic Aptima SARS-CoV-2 and the CDC 2019 nCoV real-time RT-PCR Diagnostic Panel using a Four-Sample Pooling Approach. Journal of Clinical Microbiology 2020, JCM.02241-20. https://jcm.asm.org/content/jcm/early/2020/09/17/JCM.02241-20.full.pdf
452. Mitja, O.; Ubals, M.; Corbacho, M.; Alemany, A.; Suner, C.; Tebe, C.; Tobias, A.; Penafiel, J.; Ballana, E.; Perez, C. A.; Admella, P.; Riera-Marti, N.; Laporte, P.; Mitja, J.; Clua, M.; Bertran, L.; Gavilan, S.; Ara, J.; Sarquella, M.; Argimon, J. M.; Cuatrecasas, G.; Canadas, P.; Elizalde-Torrent, A.; Fabregat, R.; Farre, M.; Forcada, A.; Flores-Mateo, G.; Lopez, C.; Muntada, E.; Nadal, N.; Narejos, S.; Gil-Ortega, A. N.; Prat, N.; Puig, J.; Quinones, C.; Ramirez-Viaplana, F.; Reyes-Uruena, J.; Riveira-Munoz, E.; Ruiz, L.; Sanz, S.; Sentis, A.; Sierra, A.; Velasco, C.; Vivanco-Hidalgo, R. M.; Zamora, J.; Casabona, J.; Vall-Mayans, M.; G-Beiras, C.; Clotet, B., A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease. medRxiv 2020, 2020.07.20.20157651. http://medrxiv.org/content/early/2020/07/26/2020.07.20.20157651.abstract
453. MITRE, COVID-19 Dashboard and Tools. https://dashboards.c19hcc.org/.
454. Mizumoto, K.; Kagaya, K.; Zarebski, A.; Chowell, G., Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance 2020, 25 (10), 2000180. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.10.2000180
455. Moderna, Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures. https://investors.modernatx.com/news-releases/news-release-details/moderna- announces-longer-shelf-life-its-covid-19-vaccine.
456. Moderna, Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization. https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-primary- efficacy-analysis-phase-3-cove-study.
457. Moghadam, S. A.; Dini, P.; Nassiri, S.; Motavaselian, M.; Hajibaba, M.; Sohrabi, M., Clinical features of pregnant women in Iran who died due to COVID-19. International Journal of Gynecology & Obstetrics 2020, n/a (n/a). https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1002/ijgo.13461
458. Moiseev, S.; Avdeev, S.; Tao, E.; Brovko, M.; Bulanov, N.; Zykova, A.; Akulkina, L.; Smirnova, I.; Fomin, V., Neither earlier nor late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study. Annals of the Rheumatic Diseases 2020, annrheumdis- 2020-219265. http://ard.bmj.com/content/early/2020/10/30/annrheumdis-2020-219265.abstract 
459. Monchatre-Leroy, E.; Lesellier, S.; Wasniewski, M.; Picard-Meyer, E.; Richomme, C.; Boué, F.; Lacôte, S.; Murri, S.; Pulido, C.; Vulin, J.; Salguero, F. J.; Gouilh, M. A.; Servat, A.; Marianneau, P., Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2. bioRxiv 2020, 2020.09.24.311977. http://biorxiv.org/content/early/2020/09/24/2020.09.24.311977.abstract
460. Monk, P. D.; Marsden, R. J.; Tear, V. J.; Brookes, J.; Batten, T. N.; Mankowski, M.; Gabbay, F. J.; Davies, D. E.; Holgate, S. T.; Ho, L. P.; Clark, T.; Djukanovic, R.; Wilkinson, T. M. A., Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med 2020.
461. Monreal, E.; Sainz de la Maza, S.; Natera-Villalba, E.; Beltrán-Corbellini, Á.; Rodríguez-Jorge, F.; Fernández-Velasco, J. I.; Walo-Delgado, P.; Muriel, A.; Zamora, J.; Alonso-Canovas, A.; Fortún, J.; Manzano, L.; Montero-Errasquín, B.; Costa-Frossard, L.; Masjuan, J.; Villar, L. M., High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study. Eur J Clin Microbiol Infect Dis 2020, 1-9.
462. Montopoli, M.; Zumerle, S.; Vettor, R.; Rugge, M.; Zorzi, M.; Catapano, C. V.; Carbone, G.; Cavalli, A.; Pagano, F.; Ragazzi, E., Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n= 4532). Annals of Oncology 2020.
463. Moore, J. T.; Ricaldi, J. N.; Rose, C. E.; al., e., Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During June 5–18, 2020 — 22 States, February–June 2020. Morbidity and Mortality Weekly Report 2020, ePub: 14 August 2020.
464. Morawska, L.; Milton, D. K., It is Time to Address Airborne Transmission of COVID-19. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa939
465. Moriarty, L. F.; Plucinski, M. M.; Marston, B. J. e. a., Public Health Responses fo COVID-19 Outbreaks on Cruise Ships - Worldwide, February - March 2020. MMWR 2020, (ePub: 23 March 2020). https://www.cdc.gov/mmwr/volumes/69/wr/mm6912e3.htm
466. Morley, C. P.; Anderson, K. B.; Shaw, J.; Stewart, T.; Thomas, S. J.; Wang, D., Social Distancing Metrics and Estimates of SARS-CoV-2 Transmission Rates: Associations Between Mobile Telephone Data Tracking and R. Journal of Public Health Management and Practice 9000, Publish Ahead of Print. https://journals.lww.com/jphmp/Fulltext/9000/Social_Distancing_Metrics_and_Estimates_of.99258.asp x
467. Morris, S. B.; Schwartz, N. G.; Patel, P.; al., e., Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020. Morbidity and Mortality Weekly Report 2020, 2 October 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6940e1.htm
468. Mudd, P. A.; Crawford, J. C.; Turner, J. S.; Souquette, A.; Reynolds, D.; Bender, D.; Bosanquet, J. P.; Anand, N. J.; Striker, D. A.; Martin, R. S.; Boon, A. C. M.; House, S. L.; Remy, K. E.; Hotchkiss, R. S.; Presti, R. M.; O’Halloran, J. A.; Powderly, W. G.; Thomas, P. G.; Ellebedy, A. H., Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Science Advances 2020, eabe3024. https://advances.sciencemag.org/content/advances/early/2020/11/13/sciadv.abe3024.full.pdf
469. Munster, V. J.; Feldmann, F.; Williamson, B. N.; van Doremalen, N.; Pérez-Pérez, L.; Schulz, J.; Meade-White, K.; Okumura, A.; Callison, J.; Brumbaugh, B.; Avanzato, V. A.; Rosenke, R.; Hanley, P. W.; Saturday, G.; Scott, D.; Fischer, E. R.; de Wit, E., Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2. bioRxiv 2020, 2020.03.21.001628. https://www.biorxiv.org/content/biorxiv/early/2020/03/21/2020.03.21.001628.full.pdf
470. Murat, S.; Dogruoz Karatekin, B.; Icagasioglu, A.; Ulasoglu, C.; İçten, S.; Incealtin, O., Clinical presentations of pain in patients with COVID-19 infection. Ir J Med Sci 2020.
471. Murphy, N.; Boland, M.; Bambury, N.; Fitzgerald, M.; Comerford, L.; Dever, N.; O’Sullivan, M. B.; Petty-Saphon, N.; Kiernan, R.; Jensen, M.; O’Connor, L., A large national outbreak of COVID-19 linked to air travel, Ireland, summer 2020. Eurosurveillance 2020, 25 (42), 2001624. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.42.2001624
472. Mutambudzi, M.; Niedwiedz, C.; Macdonald, E. B.; Leyland, A.; Mair, F.; Anderson, J.; Celis-Morales, C.; Cleland, J.; Forbes, J.; Gill, J.; Hastie, C.; Ho, F.; Jani, B.; Mackay, D. F.; Nicholl, B.; O'Donnell, C.; Sattar, N.; Welsh, P.; Pell, J. P.; Katikireddi, S. V.; Demou, E., Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occupational and Environmental Medicine 2020, oemed-2020-106731. https://oem.bmj.com/content/oemed/early/2020/12/01/oemed-2020- 106731.full.pdf
473. Mykytyn, A. Z.; Lamers, M. M.; Okba, N. M. A.; Breugem, T. I.; Schipper, D.; van den Doel, P. B.; van Run, P.; van Amerongen, G.; de Waal, L.; Koopmans, M.; Stittelaar, K. J.; van den Brand, J.; Haagmans, B. L., Susceptibility of rabbits to SARS-CoV-2. bioRxiv 2020, 2020.08.27.263988. http://biorxiv.org/content/early/2020/08/27/2020.08.27.263988.abstract
474. NACCHO, U.S. COVID-19 Dashboard. https://naccho.maps.arcgis.com/apps/opsdashboard/index.html#/745860ceff004059aad1b6f82f196fb5 .
475. Naderi-Azad, S.; Vender, R., Lessons From the First Wave of the Pandemic: Skin Features of COVID- 19 can be Divided Into Inflammatory and Vascular Patterns. Journal of Cutaneous Medicine and Surgery 2020, 1203475420972343. https://doi.org/10.1177/1203475420972343
476. Nadkarni, G. N.; Lala, A.; Bagiella, E.; Chang, H. L.; Moreno, P.; Pujadas, E.; Arvind, V.; Bose, S.; Charney, A. W.; Chen, M. D.; Cordon-Cardo, C.; Dunn, A. S.; Farkouh, M. E.; Glicksberg, B.; Kia, A.; Kohli- Seth, R.; Levin, M. A.; Timsina, P.; Zhao, S.; Fayad, Z. A.; Fuster, V., Anticoagulation, Mortality, Bleeding and Pathology Among Patients Hospitalized with COVID-19: A Single Health System Study. Journal of the American College of Cardiology 2020, 27631. https://www.onlinejacc.org/content/accj/early/2020/08/24/j.jacc.2020.08.041.full.pdf
477. Nasa, P.; Singh, A.; Upadhyay, S.; Bagadia, S.; Polumuru, S.; Shrivastava, P. K.; Sankar, R.; Vijayan, L.; Soliman, M. A.; Ali, A.; Patidar, S., Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers. Indian J Crit Care Med 2020, 24 (9), 771-776.
478. NASEM, Airborne transmission of SARS-CoV-2; Proceedings of a Workshop - in Brief; National Academies of Sciences, Engineering, and Medicine: 2020. https://www.nap.edu/read/25958/chapter/1 
479. National Institutes of Health, NIH observational study of coronavirus infection and multisystem inflammatory syndrome in children begins. https://www.nih.gov/news-events/news-releases/nih- observational-study-coronavirus-infection-multisystem-inflammatory-syndrome-children-begins (accessed 16 Dec 2020).
480. Ndieugnou Djangang, N.; Peluso, L.; Talamonti, M.; Izzi, A.; Gevenois, P. A.; Garufi, A.; Goffard, J.-C.; Henrard, S.; Severgnini, P.; Vincent, J.-L.; Creteur, J.; Taccone, F. S., Eosinopenia in COVID-19 Patients: A Retrospective Analysis. Microorganisms 2020, 8 (12), 1929. https://www.mdpi.com/2076- 2607/8/12/1929
481. Ng, K. W.; Faulkner, N.; Cornish, G. H.; Rosa, A.; Harvey, R.; Hussain, S.; Ulferts, R.; Earl, C.; Wrobel, A. G.; Benton, D. J.; Roustan, C.; Bolland, W.; Thompson, R.; Agua-Doce, A.; Hobson, P.; Heaney, J.; Rickman, H.; Paraskevopoulou, S.; Houlihan, C. F.; Thomson, K.; Sanchez, E.; Shin, G. Y.; Spyer, M. J.; Joshi, D.; O’Reilly, N.; Walker, P. A.; Kjaer, S.; Riddell, A.; Moore, C.; Jebson, B. R.; Wilkinson, M.; Marshall, L. R.; Rosser, E. C.; Radziszewska, A.; Peckham, H.; Ciurtin, C.; Wedderburn, L. R.; Beale, R.; Swanton, C.; Gandhi, S.; Stockinger, B.; McCauley, J.; Gamblin, S. J.; McCoy, L. E.; Cherepanov, P.; Nastouli, E.; Kassiotis, G., Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science 2020, eabe1107. https://science.sciencemag.org/content/sci/early/2020/11/05/science.abe1107.full.pdf
482. Ng, O. T.; Marimuthu, K.; Koh, V.; Pang, J.; Linn, K. Z.; Sun, J.; De Wang, L.; Chia, W. N.; Tiu, C.; Chan, M.; Ling, L. M.; Vasoo, S.; Abdad, M. Y.; Chia, P. Y.; Lee, T. H.; Lin, R. J.; Sadarangani, S. P.; Chen, M. I. C.; Said, Z.; Kurupatham, L.; Pung, R.; Wang, L.-F.; Cook, A. R.; Leo, Y.-S.; Lee, V. J. M., SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(20)30833-1
483. Ngonghala, C. N.; Iboi, E.; Eikenberry, S.; Scotch, M.; MacIntyre, C. R.; Bonds, M. H.; Gumel, A. B., Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus. Mathematical Biosciences 2020, 325, 108364. http://www.sciencedirect.com/science/article/pii/S0025556420300560
484. Nguyen-Contant, P.; Embong, A. K.; Kanagaiah, P.; Chaves, F. A.; Yang, H.; Branche, A. R.; Topham, D. J.; Sangster, M. Y., S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit. mBio 2020, 11 (5), e01991-20. https://mbio.asm.org/content/mbio/11/5/e01991-20.full.pdf
485. Nguyen, L. H.; Drew, D. A.; Graham, M. S.; Joshi, A. D.; Guo, C.-G.; Ma, W.; Mehta, R. S.; Warner, E. T.; Sikavi, D. R.; Lo, C.-H.; Kwon, S.; Song, M.; Mucci, L. A.; Stampfer, M. J.; Willett, W. C.; Eliassen, A. H.; Hart, J. E.; Chavarro, J. E.; Rich-Edwards, J. W.; Davies, R.; Capdevila, J.; Lee, K. A.; Lochlainn, M. N.; Varsavsky, T.; Sudre, C. H.; Cardoso, M. J.; Wolf, J.; Spector, T. D.; Ourselin, S.; Steves, C. J.; Chan, A. T., Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health 2020. http://www.thelancet-press.com/embargo/hcwcovid.pdf
486. NIH, Fact Sheet for Patients And Parent/Caregivers - Emergency Use Authorization (EUA) Of Remdesivir For Coronavirus Disease 2019 (COVID-19); National Institutes of Health: 2020. https://www.fda.gov/media/137565/download
487. Nishiura, H.; Kobayashi, T.; Miyama, T.; Suzuki, A.; Jung, S.-m.; Hayashi, K.; Kinoshita, R.; Yang, Y.; Yuan, B.; Akhmetzhanov, A. R.; Linton, N. M., Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). International Journal of Infectious Diseases 2020, 94, 154-155. http://www.sciencedirect.com/science/article/pii/S1201971220301399
488. Niu, A.; Ning, B.; Socola, F.; Safah, H.; Reynolds, T.; Ibrahim, M.; Safa, F.; Alfonso, T.; Luk, A.; Mushatt, D. M.; Hu, T.; Saba, N. S., 313 COVID-19 in Patients with hematological Malignancies: High False Negative Rate with High Mortality. In 62nd ASH Annual Meeting and Exposition, 2020. https://ash.confex.com/ash/2020/webprogram/Paper138611.html
489. Northeastern, Modeling of COVID-19 epidemic in the United States. https://covid19.gleamproject.org/#icubedproj.
490. Novavax, Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom. https://ir.novavax.com/news-releases/news-release-details/novavax-initiates-phase-3-efficacy-trial- covid-19-vaccine-united.
491. Novelli, L.; Raimondi, F.; Ghirardi, A.; Pellegrini, D.; Capodanno, D.; Sotgiu, G.; Guagliumi, G.; Senni, M.; Russo, F. M.; Lorini, F. L.; Rizzi, M.; Barbui, T.; Rambaldi, A.; Cosentini, R.; Grazioli, L. S.; Marchesi, G.; Sferrazza Papa, G. F.; Cesa, S.; Colledan, M.; Civiletti, R.; Conti, C.; Casati, M.; Ferri, F.; Camagni, S.; Sessa, M.; Masciulli, A.; Gavazzi, A.; Falanga, A.; Da Pozzo, L. F.; Buoro, S.; Remuzzi, G.; Ruggenenti, P.; Callegaro, A.; D'Antiga, L.; Pasulo, L.; Pezzoli, F.; Gianatti, A.; Parigi, P.; Farina, C.; Bellasi, A.; Solidoro, P.; Sironi, S.; Di Marco, F.; Fagiuoli, S., At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy. Panminerva Med 2020. 
492. Now, C. A., America's COVID warning system. https://covidactnow.org/?s=38532.
493. O’Hearn, K.; Gertsman, S.; Webster, R.; Tsampalieros, A.; Ng, R.; Gibson, J.; Sampson, M.; Sikora, L.; McNally, J. D., Efficacy and Safety of Disinfectants for Decontamination of N95 and SN95 Filtering Facepiece Respirators: A Systematic Review. Journal of Hospital Infection. https://doi.org/10.1016/j.jhin.2020.08.005
494. Observatory, U., COVID-19 Trends for U.S. Counties; ESRI: 2020. https://urbanobservatory.maps.arcgis.com/apps/MapSeries/index.html?appid=ad46e587a9134fcdb43ff 54c16f8c39b
495. Oetjens, M. T.; Luo, J. Z.; Chang, A.; Leader, J. B.; Hartzel, D. N.; Moore, B. S.; Strande, N. T.; Kirchner, H. L.; Ledbetter, D. H.; Justice, A. E.; Carey, D. J.; Mirshahi, T., Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients. PLoS One 2020, 15 (11), e0242182.
496. Offeddu, V.; Yung, C. F.; Low, M. S. F.; Tam, C. C., Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis. Clin Infect Dis 2017, 65 (11), 1934-1942. https://www.ncbi.nlm.nih.gov/pubmed/29140516
497. Ogega, C. O.; Skinner, N. E.; Blair, P. W.; Park, H.-S.; Littlefield, K.; Ganesan, A.; Ladiwala, P.; Antar, A. A.; Ray, S. C.; Betenbaugh, M. J.; Pekosz, A.; Klein, S.; Manabe, Y. C.; Cox, A. L.; Bailey, J. R., Durable SARS-CoV-2 B cell immunity after mild or severe disease. medRxiv 2020, 2020.10.28.20220996. https://www.medrxiv.org/content/medrxiv/early/2020/10/30/2020.10.28.20220996.full.pdf
498. Olson, D. R.; Huynh, M.; Fine, A.; Baumgartner, J.; Castro, A.; Chan, H. T.; Daskalakis, D.; Devinney, K.; Guerra, K.; Harper, S.; Kennedy, J.; Konty, K.; Li, W.; McGibbon, E.; Shaff, J.; Thompson, C.; Vora, N. M.; Van Wye, G., Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak — New York City, March 11–May 2, 2020. Morbidity and Mortality Weekly Report 2020, (ePub: 11 May 2020). https://www.cdc.gov/mmwr/volumes/69/wr/mm6919e5.htm?s_cid=mm6919e5_w
499. Omrani, A. S.; Pathan, S. A.; Thomas, S. A.; Harris, T. R. E.; Coyle, P. V.; Thomas, C. E.; Qureshi, I.; Bhutta, Z. A.; Mawlawi, N. A.; Kahlout, R. A.; Elmalik, A.; Azad, A. M.; Daghfal, J.; Mustafa, M.; Jeremijenko, A.; Soub, H. A.; Khattab, M. A.; Maslamani, M. A.; Thomas, S. H., Randomized double- blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19. EClinicalMedicine 2020, 29, 100645.
500. Onder, G.; Rezza, G.; Brusaferro, S., Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020. https://doi.org/10.1001/jama.2020.4683
501. Ong, S. W. X.; Tan, Y. K.; Chia, P. Y.; Lee, T. H.; Ng, O. T.; Wong, M. S. Y.; Marimuthu, K., Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. Jama 2020. https://jamanetwork.com/journals/jama/articlepdf/2762692/jama_ong_2020_ld_200016.pdf
502. Oran, D. P.; Topol, E. J., Prevalence of Asymptomatic SARS-CoV-2 Infection. Annals of Internal Medicine 2020, 0 (0), null. https://www.acpjournals.org/doi/abs/10.7326/M20-3012
503. Ortolan, A.; Lorenzin, M.; Felicetti, M.; Doria, A.; Ramonda, R., Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. International Journal of Infectious Diseases 2020. https://doi.org/10.1016/j.ijid.2020.07.076
504. Oster, A. M.; Caruso, E.; DeVies, J.; Hartnett, K. P.; Boehmer, T. K., Transmission Dynamics by Age Group in COVID-19 Hotspot Counties — United States, April–September 2020. Morbidity and Mortality Weekly Report 2020, ePub (9 October 2020). https://www.cdc.gov/mmwr/volumes/69/wr/mm6941e1.htm
505. Oude Munnink, B. B.; Sikkema, R. S.; Nieuwenhuijse, D. F.; Molenaar, R. J.; Munger, E.; Molenkamp, R.; van der Spek, A.; Tolsma, P.; Rietveld, A.; Brouwer, M.; Bouwmeester-Vincken, N.; Harders, F.; Hakze- van der Honing, R.; Wegdam-Blans, M. C. A.; Bouwstra, R. J.; GeurtsvanKessel, C.; van der Eijk, A. A.; Velkers, F. C.; Smit, L. A. M.; Stegeman, A.; van der Poel, W. H. M.; Koopmans, M. P. G., Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science 2020, eabe5901. http://science.sciencemag.org/content/early/2020/11/09/science.abe5901.abstract
506. Owusu, D.; Kim, L.; O’Halloran, A.; Whitaker, M.; Piasecki, A. M.; Reingold, A.; Alden, N. B.; Maslar, A.; Anderson, E. J.; Ryan, P. A.; Kim, S.; Como-Sabetti, K.; Hancock, E. B.; Muse, A.; Bennett, N. M.; Billing, L. M.; Sutton, M.; Talbot, K.; Ortega, J.; Brammer, L.; Fry, A. M.; Hall, A. J.; Garg, S.; Team, C.-N. S., Characteristics of Adults aged 18–49 Years without Underlying Conditions Hospitalized with Laboratory- Confirmed COVID-19 in the United States, COVID-NET — March–August 2020. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa1806
507. Pairo-Castineira, E.; Clohisey, S.; Klaric, L.; Bretherick, A.; Rawlik, K.; Parkinson, N.; Pasko, D.; Walker, S.; Richmond, A.; Head Fourman, M.; Law, A.; Furniss, J.; Gountouna, E.; Wrobel, N.; Russell, C. D.; Moutsianas, L.; Wang, B.; Meynert, A.; Yang, Z.; Zhai, R.; Zheng, C.; Griffith, F.; Oosthuyzen, W.; Shih, B.; Keating, S.; Zechner, M.; Haley, C.; Porteous, D. J.; Hayward, C.; Knight, J.; Summers, C.; Shankar-Hari, M.; Turtle, L.; Ho, A.; Hinds, C.; Horby, P.; Nichol, A.; Maslove, D.; Ling, L.; Klenerman, P.; McAuley, D.; Montgomery, H.; Walsh, T.; Shen, X.; Rowan, K.; Fawkes, A.; Murphy, L.; Ponting, C. P.; Tenesa, A.; Caulfield, M.; Scott, R.; Openshaw, P. J. M.; Semple, M. G.; Vitart, V.; Wilson, J. F.; Baillie, J. K., Genetic mechanisms of critical illness in Covid-19. medRxiv 2020, 2020.09.24.20200048. http://medrxiv.org/content/early/2020/09/25/2020.09.24.20200048.1.abstract
508. Pairo-Castineira, E.; Clohisey, S.; Klaric, L.; Bretherick, A. D.; Rawlik, K.; Pasko, D.; Walker, S.; Parkinson, N.; Fourman, M. H.; Russell, C. D.; Furniss, J.; Richmond, A.; Gountouna, E.; Wrobel, N.; Harrison, D.; Wang, B.; Wu, Y.; Meynert, A.; Griffiths, F.; Oosthuyzen, W.; Kousathanas, A.; Moutsianas, L.; Yang, Z.; Zhai, R.; Zheng, C.; Grimes, G.; Beale, R.; Millar, J.; Shih, B.; Keating, S.; Zechner, M.; Haley, C.; Porteous, D. J.; Hayward, C.; Yang, J.; Knight, J.; Summers, C.; Shankar-Hari, M.; Klenerman, P.; Turtle, L.; Ho, A.; Moore, S. C.; Hinds, C.; Horby, P.; Nichol, A.; Maslove, D.; Ling, L.; McAuley, D.; Montgomery, H.; Walsh, T.; Pereira, A.; Renieri, A.; Millar, J.; Nichol, A.; Walsh, T.; Openshaw, P. J. M.; Shankar-Hari, M.; Ponting, C.; Meikle, J.; Finernan, P.; McMaster, E.; Law, A.; Baillie, J. K.; Paterson, T.; Wackett, T.; Armstrong, R.; Clark, R.; Coutts, A.; Donnelly, L.; Gilchrist, T.; Hafezi, K.; Macgillivray, L.; Maclean, A.; McCafferty, S.; Morrice, K.; Weaver, J.; Boz, C.; Golightly, A.; Ward, M.; Mal, H.; Szoor-McElhinney, H.; Brown, A.; Hendry, R.; Stenhouse, A.; Cullum, L.; Law, D.; Law, S.; Law, R.; Swets, M.; Day, N.; Taneski, F.; Duncan, E.; Parkinson, N.; Collier, D.; Wood, S.; Zak, A.; Borra, C.; Matharu, M.; May, P.; Alldis, Z.; Mitchelmore, O.; Bowles, R.; Easthorpe, A.; Bibi, F.; Lancoma-Malcolm, I.; Gurasashvili, J.; Pheby, J.; Shiel, J.; Bolton, M.; Patel, M.; Taylor, M.; Zongo, O.; Ebano, P.; Harding, P.; Astin-Chamberlain, R.; Choudhury, Y.; Cox, A.; Kallon, D.; Burton, M.; Hall, R.; Blowes, S.; Prime, Z.; Biddle, J.; Prysyazhna, O.; Newman, T.; Tierney, C.; Kassam, J.; Shankar-Hari, M.; Ostermann, M.; Campos, S.; Bociek, A.; Lim, R.; Grau, N.; Jones, T. O.; Whitton, C.; Marotti, M.; Arbane, G.; Bonner, S.; Hugill, K.; Reid, J.; Welters, I.; Waugh, V.; Williams, K.; Shaw, D.; Roman, J. F.; Martinez, M. L.; Johnson, E.; Waite, A.; Johnson, B.; Hamilton, O.; Mulla, S.; McPhail, M.; Smith, J.; Baillie, J. K.; Barclay, L.; Hope, D.; McCulloch, C.; McQuillan, L.; Clark, S.; Singleton, J.; Priestley, K.; Rea, N.; Callaghan, M.; Campbell, R.; Andrew, G.; Marshall, L.; McKechnie, S.; Hutton, P.; Bashyal, A.; Davidson, N.; Summers, C.; Polgarova, P.; Stroud, K.; Pathan, N.; Elston, K.; Agrawal, S.; Battle, C.; Newey, L.; Rees, T.; Harford, R.; Brinkworth, E.; Williams, M.; Murphy, C.; White, I.; Croft, M.; Bandla, N.; Gellamucho, M.; Tomlinson, J.; Turner, H.; Davies, M.; Quinn, A.; Hussain, I.; Thompson, C.; Parker, H.; Bradley, R.; Griffiths, R.; Scriven, J.; Gill, J.; Puxty, A.; Cathcart, S.; Salutous, D.; Turner, L.; Duffy, K.; Puxty, K.; Joseph, A.; Herdman-Grant, R.; Simms, R.; Swain, A.; Naranjo, A.; Crowe, R.; Sollesta, K.; Loveridge, A.; Baptista, D.; Morino, E.; Davey, M.; Golden, D.; Jones, J.; Cuesta, J. M.; Haldeos, A.; Bakthavatsalam, D.; Vincent, R.; Elhassan, M.; Xavier, K.; Ganesan, A.; Abdelrazik, D. P. M.; Morgan, J.; Akeroyd, L.; Bano, S.; Warren, D.; Bromley, M.; Sellick, K.; Gurr, L.; Wilkinson, B.; Nagarajan, V.; Szedlak, P.; Cupitt, J.; Stoddard, E.; Benham, L.; Preston, S.; Slawson, N.; Bradshaw, Z.; brown, J.; Caswell, M.; Melling, S.; Bamford, P.; Faulkner, M.; Cawley, K.; Jeffrey, H.; London, E.; Sainsbury, H.; Nagra, I.; Nasir, F.; Dunmore, C.; Jones, R.; Abraheem, A.; Al- Moasseb, M.; Girach, R.; Brantwood, C.; Alexander, P.; Bradley-Potts, J.; Allen, S.; Felton, T.; Manna, S.; Farnell-Ward, S.; Leaver, S.; Queiroz, J.; Maccacari, E.; Dawson, D.; Delgado, C. C.; Saluzzio, R. P.; Ezeobu, O.; Ding, L.; Sicat, C.; Kanu, R.; The Gen, O. I.; Gen, O. C.; Gen, O. c.-i.; Central, m.; laboratory, t.; Data analysis, t.; Barts Health Nhs Trust, L. U. K.; Guys; St Thomas’ Hospital, L. U. K.; James Cook University Hospital, M. U. K.; The Royal Liverpool University Hospital, L. U. K.; King’s College Hospital, L. U. K.; Royal Infirmary of Edinburgh, E. U. K.; John Radcliffe Hospital, O. U. K.; Addenbrooke’s Hospital, C. U. K.; Morriston Hospital, S. U. K.; Ashford; St Peter’s Hospital, S. U. K.; Royal Stoke University Hospital, S. U. K.; Queen Elizabeth Hospital, B. U. K.; Glasgow Royal Infirmary, G. U. K.; Kingston Hospital, S. U. K.; The Tunbridge Wells, H.; Maidstone Hospital, K. U. K.; North Middlesex University Hospital Nhs Trust, L. U. K.; Bradford Royal Infirmary, B. U. K.; Blackpool Victoria Hospital, B. U. K.; Countess of Chester Hospital, C. U. K.; Wythenshawe Hospital, M. U. K.; St George’s Hospital, L. U. K., Genetic mechanisms of critical illness in Covid-19. Nature 2020. https://doi.org/10.1038/s41586-020-03065-y
509. Pan, D.; Sze, S.; Minhas, J. S.; Bangash, M. N.; Pareek, N.; Divall, P.; Williams, C. M. L.; Oggioni, M. R.; Squire, I. B.; Nellums, L. B.; Hanif, W.; Khunti, K.; Pareek, M., The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2020.100404
510. Pan, F.; Ye, T.; Sun, P.; Gui, S.; Liang, B.; Li, L.; Zheng, D.; Wang, J.; Hesketh, R. L.; Yang, L.; Zheng, C., Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia. Radiology 0 (0), 200370. https://pubs.rsna.org/doi/abs/10.1148/radiol.2020200370
511. Pan, H.; Peto, R.; Henao-Restrepo, A. M.; Preziosi, M. P.; Sathiyamoorthy, V.; Abdool Karim, Q.; Alejandria, M. M.; Hernández García, C.; Kieny, M. P.; Malekzadeh, R.; Murthy, S.; Reddy, K. S.; Roses Periago, M.; Abi Hanna, P.; Ader, F.; Al-Bader, A. M.; Alhasawi, A.; Allum, E.; Alotaibi, A.; Alvarez- Moreno, C. A.; Appadoo, S.; Asiri, A.; Aukrust, P.; Barratt-Due, A.; Bellani, S.; Branca, M.; Cappel-Porter, H. B. C.; Cerrato, N.; Chow, T. S.; Como, N.; Eustace, J.; García, P. J.; Godbole, S.; Gotuzzo, E.; Griskevicius, L.; Hamra, R.; Hassan, M.; Hassany, M.; Hutton, D.; Irmansyah, I.; Jancoriene, L.; Kirwan, J.; Kumar, S.; Lennon, P.; Lopardo, G.; Lydon, P.; Magrini, N.; Maguire, T.; Manevska, S.; Manuel, O.; McGinty, S.; Medina, M. T.; Mesa Rubio, M. L.; Miranda-Montoya, M. C.; Nel, J.; Nunes, E. P.; Perola, M.; Portolés, A.; Rasmin, M. R.; Raza, A.; Rees, H.; Reges, P. P. S.; Rogers, C. A.; Salami, K.; Salvadori, M. I.; Sinani, N.; Sterne, J. A. C.; Stevanovikj, M.; Tacconelli, E.; Tikkinen, K. A. O.; Trelle, S.; Zaid, H.; Røttingen, J. A.; Swaminathan, S., Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med 2020.
512. Papamanoli, A.; Yoo, J.; Grewal, P.; Predun, W.; Hotelling, J.; Jacob, R.; Mojahedi, A.; Skopicki, H. A.; Mansour, M.; Marcos, L. A.; Kalogeropoulos, A. P., High-Dose Methylprednisolone in Nonintubated Patients with Severe COVID-19 Pneumonia. Eur J Clin Invest 2020, e13458.
513. Paranjpe, I.; Fuster, V.; Lala, A.; Russak, A.; Glicksberg, B. S.; Levin, M. A.; Charney, A. W.; Narula, J.; Fayad, Z. A.; Bagiella, E.; Zhao, S.; Nadkarni, G. N., Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19. Journal of the American College of Cardiology 2020, 27327. http://www.onlinejacc.org/content/accj/early/2020/05/05/j.jacc.2020.05.001.full.pdf
514. Park, S. W.; Champredon, D.; Earn, D. J. D.; Li, M.; Weitz, J. S.; Grenfell, B. T.; Dushoff, J., Reconciling early-outbreak preliminary estimates of the basic reproductive number and its uncertainty: a new framework and applications to the novel coronavirus (2019-nCoV) outbreak. 2020, 1-13.
515. Park, S. Y.; Kim, Y.-M.; Yi, S.; Lee, S.; Na, B.-J.; Kim, C. B.; Kim, J.-i.; Kim, H. S.; Kim, Y. B.; Park, Y.; Huh, I. S.; Kim, H. K.; Yoon, H. J.; Jang, H.; Kim, K.; Chang, Y.; Kim, I.; Lee, H.; Gwack, J.; Kim, S. S.; Kim, M.; Kweon, S.; Choe, Y. J.; Park, O.; Park, Y. J.; Jeong, E. K., Coronavirus Disease Outbreak in Call Center, South Korea. Emerging Infectious Disease journal 2020, 26 (8), 1666. https://wwwnc.cdc.gov/eid/article/26/8/20-1274_article
516. Park, Y. J.; Choe, Y. J.; Park, O.; Park, S. Y.; Kim, Y.-M.; Kim, J.; Kweon, S.; Woo, Y.; Gwack, J.; Kim, S. S.; Lee, J.; Hyun, J.; Ryu, B.; Jang, Y. S.; Kim, H.; Shin, S. H.; Yi, S.; Lee, S.; Kim, H. K.; Lee, H.; Jin, Y.; Park, E.; Choi, S. W.; Kim, M.; Song, J.; Choi, S. W.; Kim, D.; Jeon, B.-H.; Yoo, H.; Jeong, E. K., Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020. Emerging Infectious Disease journal 2020, 26 (10). https://wwwnc.cdc.gov/eid/article/26/10/20-1315_article
517. Parker, C. W.; Singh, N.; Tighe, S.; Blachowicz, A.; Wood, J. M.; Seuylemezian, A.; Vaishampayan, P.; Urbaniak, C.; Hendrickson, R.; Laaguiby, P.; Clark, K.; Clement, B. G.; O’Hara, N. B.; Couto-Rodriguez, M.; Bezdan, D.; Mason, C. E.; Venkateswaran, K., End-to-End Protocol for the Detection of SARS-CoV-2 from Built Environments. mSystems 2020, 5 (5), e00771-20. https://msystems.asm.org/content/msys/5/5/e00771-20.full.pdf
518. Parri, N.; Lenge, M.; Buonsenso, D., Children with Covid-19 in Pediatric Emergency Departments in Italy. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMc2007617 
519. Parshley, L., Kids catch and spread coronavirus half as much as adults, Iceland study confirms. National Geographic December 10, 2020, 2020. https://www.nationalgeographic.com/science/2020/12/we-now-know-how-much-children-spread- coronavirus/#close
520. Pastor-Barriuso, R.; Pérez-Gómez, B.; Hernán, M. A.; Pérez-Olmeda, M.; Yotti, R.; Oteo-Iglesias, J.; Sanmartín, J. L.; León-Gómez, I.; Fernández-García, A.; Fernández-Navarro, P.; Cruz, I.; Martín, M.; Delgado-Sanz, C.; Fernández de Larrea, N.; León Paniagua, J.; Muñoz-Montalvo, J. F.; Blanco, F.; Larrauri, A.; Pollán, M., Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study. BMJ 2020, 371, m4509. https://www.bmj.com/content/bmj/371/bmj.m4509.full.pdf
521. Patolia, H.; Pan, J.; Harb, C.; Marr, L. C.; Baffoe-Bonnie, A., Filtration evaluation and clinical use of expired elastomeric P-100 filter cartridges during the COVID-19 pandemic. Infection Control & Hospital Epidemiology 2020, 1-6. https://www.cambridge.org/core/article/filtration-evaluation-and-clinical-use- of-expired-elastomeric-p100-filter-cartridges-during-the-covid19- pandemic/D5EFCC5EEF65FEA210E1070149CB9DEF
522. Patterson, E. I.; Elia, G.; Grassi, A.; Giordano, A.; Desario, C.; Medardo, M.; Smith, S. L.; Anderson, E. R.; Prince, T.; Patterson, G. T.; Lorusso, E.; Lucente, M. S.; Lanave, G.; Lauzi, S.; Bonfanti, U.; Stranieri, A.; Martella, V.; Solari Basano, F.; Barrs, V. R.; Radford, A. D.; Agrimi, U.; Hughes, G. L.; Paltrinieri, S.; Decaro, N., Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy. Nature Communications 2020, 11 (1), 6231. https://doi.org/10.1038/s41467-020-20097-0
523. Pau, A. K.; Aberg, J.; Baker, J.; Belperio, P. S.; Coopersmith, C. M.; Crew, P.; Glidden, D. V.; Grund, B.; Gulick, R. M.; Harrison, C.; Kim, A.; Lane, H. C.; Masur, H.; Sheikh, V.; Singh, K.; Yazdany, J.; Tebas, P., Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel. Annals of Internal Medicine 2020, 0 (0), null. https://www.acpjournals.org/doi/abs/10.7326/M20-6448
524. Payne, D. C., SARS-CoV-2 Infections and Serologic Responses from a Sample of US Navy Service Members—USS Theodore Roosevelt, April 2020. MMWR. Morbidity and Mortality Weekly Report 2020, 69.
525. Peccia, J.; Zulli, A.; Brackney, D. E.; Grubaugh, N. D.; Kaplan, E. H.; Casanovas-Massana, A.; Ko, A. I.; Malik, A. A.; Wang, D.; Wang, M.; Warren, J. L.; Weinberger, D. M.; Arnold, W.; Omer, S. B., Measurement of SARS-CoV-2 RNA in wastewater tracks community infection dynamics. Nature Biotechnology 2020. https://doi.org/10.1038/s41587-020-0684-z
526. Peckham, H.; de Gruijter, N. M.; Raine, C.; Radziszewska, A.; Ciurtin, C.; Wedderburn, L. R.; Rosser, E. C.; Webb, K.; Deakin, C. T., Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communications 2020, 11 (1), 6317. https://doi.org/10.1038/s41467- 020-19741-6
527. Peltier, R. E.; Wang, J.; Hollenbeck, B. L.; Lanza, J.; Furtado, R. M.; Cyr, J.; Ellison, R.; Kobayashi, K. J., Addressing Decontaminated Respirators: Some Methods Appear to Damage Mask Integrity and Protective Function. Infection Control & Hospital Epidemiology 2020, 1-9.
528. Perchetti, G. A.; Huang, M.-L.; Peddu, V.; Jerome, K. R.; Greninger, A. L., Stability of SARS-CoV-2 in PBS for Molecular Detection. Journal of Clinical Microbiology 2020.
529. Perkins, A.; Espana, G., NotreDame-FRED COVID-19 forecasts. https://github.com/confunguido/covid19_ND_forecasting/blob/master/README.md.
530. Perry, R. J.; Smith, C. J.; Roffe, C.; Simister, R. J.; Narayanamoorthi, S.; Marigold, R.; Willmot, M.; Dixit, A.; Hassan, A.; Quinn, T.; Ankolekar, S.; Zhang, L.; Banerjee, S.; Ahmed, U.; Padmanabhan, N.; Ferdinand, P.; McGrane, F.; Banaras, A.; Marks, I. H.; Werring, D. J., Characteristics and outcomes of COVID-19-associated stroke: a UK multicentre case-control study. Journal of Neurology, Neurosurgery &amp; Psychiatry 2020, jnnp-2020-324927. https://jnnp.bmj.com/content/jnnp/early/2020/11/03/jnnp- 2020-324927.full.pdf
531. Peto, L.; Rodger, G.; Carter, D. P.; Osman, K. L.; Yavuz, M.; Johnson, K.; Raza, M.; Parker, M. D.; Wyles, M. D.; Andersson, M.; Justice, A.; Vaughan, A.; Hoosdally, S.; Stoesser, N.; Matthews, P. C.; Eyre, D. W.; Peto, T. E.; Carroll, M. W.; de Silva, T. I.; Crook, D. W.; Evans, C. M.; Pullan, S. T., Diagnosis of SARS-CoV-2 infection with LamPORE, a high-throughput platform combining loop-mediated isothermal amplification and nanopore sequencing. medRxiv 2020, 2020.09.18.20195370. https://www.medrxiv.org/content/medrxiv/early/2020/09/25/2020.09.18.20195370.full.pdf
532. Petrakis, D.; Margină, D.; Tsarouhas, K.; Tekos, F.; Stan, M.; Nikitovic, D.; Kouretas, D.; Spandidos, D. A.; Tsatsakis, A., Obesity ‐ a risk factor for increased COVID‐19 prevalence, severity and lethality (Review). Mol Med Rep 2020, 22 (1), 9-19. https://doi.org/10.3892/mmr.2020.11127
533. Pfizer, PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19 ACHIEVED SUCCESS IN FIRST INTERIM ANALYSIS FROM PHASE 3 STUDY. https://www.pfizer.com/news/press- release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against.
534. Pfizer, PFIZER AND BIONTECH CONCLUDE PHASE 3 STUDY OF COVID-19 VACCINE CANDIDATE, MEETING ALL PRIMARY EFFICACY ENDPOINTS. https://www.pfizer.com/news/press-release/press- release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine.
535. Pfizer, PFIZER AND BIONTECH TO SUBMIT EMERGENCY USE AUTHORIZATION REQUEST TODAY TO THE U.S. FDA FOR COVID-19 VACCINE. https://www.pfizer.com/news/press-release/press-release- detail/pfizer-and-biontech-submit-emergency-use-authorization.
536. Pickering, B.; Smith, G.; Pinette, M.; Embury-Hyatt, C.; Moffat, E.; Marszal, P.; Lewis, C. E., Susceptibility of domestic swine to experimental infection with SARS-CoV-2. bioRxiv 2020, 2020.09.10.288548. http://biorxiv.org/content/early/2020/09/10/2020.09.10.288548.abstract
537. Pigoga, J. L.; Friedman, A.; Broccoli, M.; Hirner, S.; Naidoo, A. V.; Singh, S.; Werner, K.; Wallis, L. A., Clinical and historical features associated with severe COVID-19 infection: a systematic review. medRxiv 2020, 2020.04.23.20076653. https://www.medrxiv.org/content/medrxiv/early/2020/04/27/2020.04.23.20076653.full.pdf
538. Piroth, L.; Cottenet, J.; Mariet, A.-S.; Bonniaud, P.; Blot, M.; Tubert-Bitter, P.; Quantin, C., Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. The Lancet Respiratory Medicine 2020. https://doi.org/10.1016/S2213-2600(20)30527-0
539. Pitman-Hunt, C.; Leja, J.; Jiwani, Z. M.; Rondot, D.; Ang, J.; Kannikeswaran, N., SARS-CoV-2 Transmission in an Urban Community: The Role of Children and Household Contacts. Journal of the Pediatric Infectious Diseases Society 2020. https://doi.org/10.1093/jpids/piaa158
540. Plante, J. A.; Liu, Y.; Liu, J.; Xia, H.; Johnson, B. A.; Lokugamage, K. G.; Zhang, X.; Muruato, A. E.; Zou, J.; Fontes-Garfias, C. R.; Mirchandani, D.; Scharton, D.; Bilello, J. P.; Ku, Z.; An, Z.; Kalveram, B.; Freiberg, A. N.; Menachery, V. D.; Xie, X.; Plante, K. S.; Weaver, S. C.; Shi, P.-Y., Spike mutation D614G alters SARS- CoV-2 fitness and neutralization susceptibility. bioRxiv 2020, 2020.09.01.278689. http://biorxiv.org/content/early/2020/09/02/2020.09.01.278689.abstract
541. Plante, J. A.; Liu, Y.; Liu, J.; Xia, H.; Johnson, B. A.; Lokugamage, K. G.; Zhang, X.; Muruato, A. E.; Zou, J.; Fontes-Garfias, C. R.; Mirchandani, D.; Scharton, D.; Bilello, J. P.; Ku, Z.; An, Z.; Kalveram, B.; Freiberg, A. N.; Menachery, V. D.; Xie, X.; Plante, K. S.; Weaver, S. C.; Shi, P. Y., Spike mutation D614G alters SARS- CoV-2 fitness. Nature 2020.
542. Pollán, M.; Pérez-Gómez, B.; Pastor-Barriuso, R.; al., e., Prevalence of SARS-CoV-2 in Spain (ENE- COVID): a nationwide, population-based seroepidemiological study. The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)31483-5
543. Popa, A.; Genger, J.-W.; Nicholson, M. D.; Penz, T.; Schmid, D.; Aberle, S. W.; Agerer, B.; Lercher, A.; Endler, L.; Colaço, H.; Smyth, M.; Schuster, M.; Grau, M. L.; Martínez-Jiménez, F.; Pich, O.; Borena, W.; Pawelka, E.; Keszei, Z.; Senekowitsch, M.; Laine, J.; Aberle, J. H.; Redlberger-Fritz, M.; Karolyi, M.; Zoufaly, A.; Maritschnik, S.; Borkovec, M.; Hufnagl, P.; Nairz, M.; Weiss, G.; Wolfinger, M. T.; von Laer, D.; Superti-Furga, G.; Lopez-Bigas, N.; Puchhammer-Stöckl, E.; Allerberger, F.; Michor, F.; Bock, C.; Bergthaler, A., Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Science Translational Medicine 2020, eabe2555. https://stm.sciencemag.org/content/scitransmed/early/2020/11/20/scitranslmed.abe2555.full.pdf
544. Poston, D.; Weisblum, Y.; Wise, H.; Templeton, K.; Jenks, S.; Hatziioannou, T.; Bieniasz, P. D., Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection. medRxiv 2020, 2020.10.08.20209650. https://www.medrxiv.org/content/medrxiv/early/2020/10/11/2020.10.08.20209650.full.pdf
545. Potter, D.; Riffon, M.; Kakamada, S.; Miller, R. S.; Komatsoulis, G. A., Disproportionate impact of COVID-19 disease among racial and ethnic minorities in the U.S. cancer population as seen in CancerLinQ Discovery data. Journal of Clinical Oncology 2020, 38 (29_suppl), 84-84. https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.29_suppl.84
546. Prentiss, M.; Chu, A.; Berggren, K. K., Superspreading Events Without Superspreaders: Using High Attack Rate Events to Estimate N<sub>o</sub> for Airborne Transmission of COVID-19. medRxiv 2020, 2020.10.21.20216895. https://www.medrxiv.org/content/medrxiv/early/2020/10/23/2020.10.21.20216895.full.pdf
547. Press, A., Finland deploys coronavirus-sniffing dogs at main airport. https://www.msn.com/en- us/news/world/finland-deploys-coronavirus-sniffing-dogs-at-main-airport/ar-BB19li6Z?li=BBnbcA1 (accessed 23 SEP 2020).
548. Price-Haywood, E. G.; Burton, J.; Fort, D.; Seoane, L., Hospitalization and Mortality among Black Patients and White Patients with Covid-19. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMsa2011686
549. Qin, J.; You, C.; Lin, Q.; Hu, T.; Yu, S.; Zhou, X., Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study. Science Advances 2020, 07 Aug 2020. https://advances.sciencemag.org/content/early/2020/08/07/sciadv.abc1202
550. Qiu, H.; Wu, J.; Hong, L.; Luo, Y.; Song, Q.; Chen, D., Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(20)30198-5
551. Rai, B.; Shukla, A.; Dwivedi, L. K., Estimates of serial interval for COVID-19: A systematic review and meta-analysis. Clinical Epidemiology and Global Health 2020. http://www.sciencedirect.com/science/article/pii/S2213398420301895
552. Rajasingham, R.; Bangdiwala, A. S.; Nicol, M. R.; Skipper, C. P.; Pastick, K. A.; Axelrod, M. L.; Pullen, M. F.; Nascene, A. A.; Williams, D. A.; Engen, N. W.; Okafor, E. C.; Rini, B. I.; Mayer, I. A.; McDonald, E. G.; Lee, T. C.; Li, P.; MacKenzie, L. J.; Balko, J. M.; Dunlop, S. J.; Hullsiek, K. H.; Boulware, D. R.; Lofgren, S. M.; team, o. b. o. t. C. P., Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa1571
553. Ramasamy, M. N.; Minassian, A. M.; Ewer, K. J.; al., e., Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single- blind, randomised, controlled, phase 2/3 trial. The Lancet 2020. http://www.sciencedirect.com/science/article/pii/S0140673620324661
554. Rambaut, A., Phylodynamic analysis of nCoV-2019 genomes - 27-Jan-2020. http://virological.org/t/phylodynamic-analysis-of-ncov-2019-genomes-27-jan-2020/353.
555. Rambaut, A.; Nick Loman2; Oliver Pybus3; Wendy Barclay4; Jeff Barrett5; Alesandro Carabelli6; Tom Connor7; Tom Peacock4; David L Robertson8; Erik Volz4; (CoG-UK)9., C.-G. C. U., Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2- lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563.
556. Rapid Expert Consultation, Rapid Expert Consultation Update on SARS-CoV-2 Surface Stability and Incubation for the COVID-19 Pandemic (March 27, 2020). The National Academies Press: Washington, DC, 2020. https://www.nap.edu/read/25763/chapter/1
557. Rapkiewicz, A. V.; Mai, X.; Carsons, S. E.; Pittaluga, S.; Kleiner, D. E.; Berger, J. S.; Thomas, S.; Adler, N. M.; Charytan, D. M.; Gasmi, B.; Hochman, J. S.; Reynolds, H. R., Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine 2020, 100434. http://www.sciencedirect.com/science/article/pii/S2589537020301784
558. Rasheed, A. M.; Fatak, D. F.; Hashim, H. A.; Maulood, M. F.; Kabah, K. K.; Almusawi, Y. A.; Abdulamir, A. S., The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq. Infez Med 2020, 28 (3), 357-366.
559. Ratnesar-Shumate, S.; Williams, G.; Green, B.; Krause, M.; Holland, B.; Wood, S.; Bohannon, J.; Boydston, J.; Freeburger, D.; Hooper, I.; Beck, K.; Yeager, J.; Altamura, L. A.; Biryukov, J.; Yolitz, J.; Schuit, M.; Wahl, V.; Hevey, M.; Dabisch, P., Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces. The Journal of Infectious Diseases 2020. https://doi.org/10.1093/infdis/jiaa274
560. Ray, J. G.; Schull, M. J.; Vermeulen, M. J.; Park, A. L., Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study. Ann Intern Med 2020. https://www.acpjournals.org/doi/abs/10.7326/M20-4511
561. Ray, M., Bharat Biotech’s Covid-19 vaccine gets nod for Phase 3 trial. Here’s how it came through. https://www.hindustantimes.com/india-news/bharat-biotech-s-covid-19-vaccine-gets-nod-for-phase-3- trial-here-s-how-it-came-through/story-Hcxt2OVsWr7gPxw6dnvxKP.html.
562. Regeneron, REGN-COV2 INDEPENDENT DATA MONITORING COMMITTEE RECOMMENDS HOLDING ENROLLMENT IN HOSPITALIZED PATIENTS WITH HIGH OXYGEN REQUIREMENTS AND CONTINUING ENROLLMENT IN PATIENTS WITH LOW OR NO OXYGEN REQUIREMENTS. Regeneron: 2020. https://investor.regeneron.com/news-releases/news-release-details/regn-cov2-independent-data- monitoring-committee-recommends
563. Regeneron Pharmaceuticals, I., REGENERON'S REGN-COV2 ANTIBODY COCKTAIL REDUCED VIRAL LEVELS AND IMPROVED SYMPTOMS IN NON-HOSPITALIZED COVID-19 PATIENTS. 2020; p 3. https://newsroom.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody- cocktail-reduced-viral-levels-and
564. Regeneron Pharmaceuticals, I., REGENERON’S CASIRIVIMAB AND IMDEVIMAB ANTIBODY COCKTAIL FOR COVID-19 IS FIRST COMBINATION THERAPY TO RECEIVE FDA EMERGENCY USE AUTHORIZATION. 2020. https://investor.regeneron.com/news-releases/news-release-details/regenerons-regen-cov2-first- antibody-cocktail-covid-19-receive
565. Reich, N., Ensemble. https://reichlab.io/.
566. Remuzzi, A.; Remuzzi, G., COVID-19 and Italy: what next? The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)30627-9
567. Ren, L.; Yu, S.; Xu, W.; Overton, J. L.; Chiamvimonvat, N.; Thai, P. N., Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis. J Cardiol 2020.
568. Ren, X.; Li, Y.; Yang, X.; Li, Z.; Cui, J.; Zhu, A.; Zhao, H.; Yu, J.; Nie, T.; Ren, M.; Dong, S.; Cheng, Y.; Chen, Q.; Chang, Z.; Sun, J.; Wang, L.; Feng, L.; Gao, G. F.; Feng, Z.; Li, Z., Evidence for pre-symptomatic transmission of coronavirus disease 2019 (COVID-19) in China. Influenza and Other Respiratory Viruses 2020, n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/irv.12787
569. Reuters, Frozen food package polluted by living coronavirus could cause infection, China's CDC says. https://www.reuters.com/article/us-health-coronavirus-china-packaging-idUKKBN2720MD (accessed 01 Nov 2020).
570. Reuters, WHO looks at mink farm biosecurity globally after Danish coronavirus cases. Farge, E.; Kelland, K., Eds. 2020. https://in.reuters.com/article/health-coronavirus-who/who-looking-at- biosecurity-in-other-countries-after-danish-covid-19-mink-outbreak-idINKBN27M1F4?il=0
571. Rice, K.; Wynne, B.; Martin, V.; Ackland, G. J., Effect of school closures on mortality from coronavirus disease 2019: old and new predictions. BMJ 2020, 371, m3588. https://www.bmj.com/content/bmj/371/bmj.m3588.full.pdf
572. Richard, M.; Kok, A.; de Meulder, D.; Bestebroer, T. M.; Lamers, M. M.; Okba, N. M. A.; Fentener van Vlissingen, M.; Rockx, B.; Haagmans, B. L.; Koopmans, M. P. G.; Fouchier, R. A. M.; Herfst, S., SARS- CoV-2 is transmitted via contact and via the air between ferrets. Nature Communications 2020, 11 (1), 3496. https://doi.org/10.1038/s41467-020-17367-2
573. Richter, W.; Hofacre, K.; Willenberg, Z., Final Report for the Bioquell Hydrogen Peroxide Vapor (HPV) Decontamination for Reuse of N95 Respirators; Battelle Memorial Institute: 2016. http://wayback.archive- it.org/7993/20170113034232/http://www.fda.gov/downloads/EmergencyPreparedness/Counterterrori sm/MedicalCountermeasures/MCMRegulatoryScience/UCM516998.pdf
574. Rickman, H. M.; Rampling, T.; Shaw, K.; Martinez-Garcia, G.; Hail, L.; Coen, P.; Shahmanesh, M.; Shin, G. Y.; Nastouli, E.; Houlihan, C. F., Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa816
575. Riddell, S.; Goldie, S.; Hill, A.; Eagles, D.; Drew, T. W., The effect of temperature on persistence of SARS-CoV-2 on common surfaces. Virology Journal 2020, 17 (1), 145. https://doi.org/10.1186/s12985- 020-01418-7
576. Riou, J.; Althaus, C. L., Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Eurosurveillance 2020, 25 (4), 2000058. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.4.2000058
577. Riphagen, S.; Gomez, X.; Gonzalez-Martinez, C.; Wilkinson, N.; Theocharis, P., Hyperinflammatory shock in children during COVID-19 pandemic. The Lancet. https://doi.org/10.1016/S0140- 6736(20)31094-1
578. Roberts, M., Oxford/AstraZeneca Covid vaccine 'dose error' explained. https://www.bbc.com/news/health-55086927.
579. Robertson, L. J.; Moore, J. S.; Blighe, K.; Ng, K. Y.; Quinn, N.; Jennings, F.; Warnock, G.; Sharpe, P.; Clarke, M.; Maguire, K.; Rainey, S.; Price, R.; Burns, W.; Kowalczyk, A.; Awuah, A.; McNamee, S.; Wallace, G.; Sager, S.; Chao Shern, C.; Nesbit, M. A.; McLaughlin, J.; Moore, T., SARS-CoV-2 antibody testing in a UK population: detectable IgG for up to 20 weeks post infection. medRxiv 2020, 2020.09.29.20201509. https://www.medrxiv.org/content/medrxiv/early/2020/10/01/2020.09.29.20201509.full.pdf
580. Rockx, B.; Kuiken, T.; Herfst, S.; Bestebroer, T.; Lamers, M. M.; Oude Munnink, B. B.; de Meulder, D.; van Amerongen, G.; van den Brand, J.; Okba, N. M. A.; Schipper, D.; van Run, P.; Leijten, L.; Sikkema, R.; Verschoor, E.; Verstrepen, B.; Bogers, W.; Langermans, J.; Drosten, C.; Fentener van Vlissingen, M.; Fouchier, R.; de Swart, R.; Koopmans, M.; Haagmans, B. L., Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 2020, eabb7314. https://science.sciencemag.org/content/sci/early/2020/04/16/science.abb7314.full.pdf
581. Rodda, L. B.; Netland, J.; Shehata, L.; Pruner, K. B.; Morawski, P. M.; Thouvenel, C.; Takehara, K. K.; Eggenberger, J.; Hemann, E. A.; Waterman, H. R.; Fahning, M. L.; Chen, Y.; Rathe, J.; Stokes, C.; Wrenn, S.; Fiala, B.; Carter, L. P.; Hamerman, J. A.; King, N. P.; Gale, M.; Campbell, D. J.; Rawlings, D.; Pepper, M., Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. medRxiv 2020, 2020.08.11.20171843. https://www.medrxiv.org/content/medrxiv/early/2020/08/15/2020.08.11.20171843.full.pdf
582. Rokkas, T., Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis. Annals of Gastroenterology 2020, 33 (4), 355-365. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315709/
583. Roschewski, M.; Lionakis, M. S.; Sharman, J. P.; Roswarski, J.; Goy, A.; Monticelli, M. A.; Roshon, M.; Wrzesinski, S. H.; Desai, J. V.; Zarakas, M. A.; Collen, J.; Rose, K.; Hamdy, A.; Izumi, R.; Wright, G. W.; Chung, K. K.; Baselga, J.; Staudt, L. M.; Wilson, W. H., Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Science Immunology 2020, 5 (48), eabd0110. http://immunology.sciencemag.org/content/5/48/eabd0110.abstract
584. Rosenke, K.; Meade-White, K.; Letko, M.; Clancy, C.; Hansen, F.; Liu, Y.; Okumura, A.; Tang-Huau, T.- L.; Li, R.; Saturday, G.; Feldmann, F.; Scott, D.; Wang, Z.; Munster, V.; Jarvis, M. A.; Feldmann, H., Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerging Microbes & Infections 2020, 1-36. https://doi.org/10.1080/22221751.2020.1858177
585. Ross, C., CDC says people with history of severe allergic reactions can get Covid-19 vaccine. https://www.statnews.com/2020/12/13/cdc-says-people-with-history-of-severe-allergic-reactions-can- get-covid-19-vaccine/.
586. Rothe, C.; Schunk, M.; Sothmann, P.; Bretzel, G.; Froeschl, G.; Wallrauch, C.; Zimmer, T.; Thiel, V.; Janke, C.; Guggemos, W.; Seilmaier, M.; Drosten, C.; Vollmar, P.; Zwirglmaier, K.; Zange, S.; Wölfel, R.; Hoelscher, M., Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMc2001468 https://www.nejm.org/doi/10.1056/NEJMc2001468
587. Ruktanonchai, N. W.; Floyd, J. R.; Lai, S.; Ruktanonchai, C. W.; Sadilek, A.; Rente-Lourenco, P.; Ben, X.; Carioli, A.; Gwinn, J.; Steele, J. E.; Prosper, O.; Schneider, A.; Oplinger, A.; Eastham, P.; Tatem, A. J., Assessing the impact of coordinated COVID-19 exit strategies across Europe. Science 2020, eabc5096. https://science.sciencemag.org/content/sci/early/2020/07/16/science.abc5096.full.pdf
588. Rundle, A., Severe COVID-19 Risk Mapping. https://columbia.maps.arcgis.com/apps/webappviewer/index.html?id=ade6ba85450c4325a12a5b9c09 ba796c.
589. Russell, T. W.; Wu, J. T.; Clifford, S.; Edmunds, W. J.; Kucharski, A. J.; Jit, M., Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study. The Lancet Public Health 2020. https://doi.org/10.1016/S2468-2667(20)30263-2
590. RUSSO, R.; Levine, C.; Veilleux, C.; Peixoto, B.; McCormick-Ell, J.; Block, T.; Gresko, A.; Delmas, G.; Chitale, P.; Frees, A.; Ruiz, A.; Alland, D., Decontaminating N95 respirators during the Covid-19 pandemic: simple and practical approaches to increase decontamination capacity, speed, safety and ease of use. medRxiv 2020, 2020.08.17.20177022. https://www.medrxiv.org/content/medrxiv/early/2020/08/21/2020.08.17.20177022.full.pdf
591. Ryan, D. J.; Toomey, S.; Madden, S. F.; Casey, M.; Breathnach, O. S.; Morris, P. G.; Grogan, L.; Branagan, P.; Costello, R. W.; De Barra, E.; Hurley, K.; Gunaratnam, C.; McElvaney, N. G.; OBrien, M. E.; Sulaiman, I.; Morgan, R. K.; Hennessy, B. T., Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19). Thorax 2020, thoraxjnl-2020-215705. https://thorax.bmj.com/content/thoraxjnl/early/2020/10/23/thoraxjnl-2020-215705.full.pdf
592. Ryan, K. A.; Bewley, K. R.; Fotheringham, S. A.; Brown, P.; Hall, Y.; Marriott, A. C.; Tree, J. A.; Allen, L.; Aram, M. J.; Brunt, E.; Buttigieg, K. R.; Cavell, B. E.; Carter, D. P.; Cobb, R.; Coombes, N. S.; Godwin, K. J.; Gooch, K. E.; Gouriet, J.; Halkerston, R.; Harris, D. J.; Humphries, H. E.; Hunter, L.; Ho, C. M. K.; Kennard, C. L.; Leung, S.; Ngabo, D.; Osman, K. L.; Paterson, J.; Penn, E. J.; Pullan, S. T.; Rayner, E.; Slack, G. S.; Steeds, K.; Taylor, I.; Tipton, T.; Thomas, S.; Wand, N. I.; Watson, R. J.; Wiblin, N. R.; Charlton, S.; Hallis, B.; Hiscox, J. A.; Funnell, S.; Dennis, M. J.; Whittaker, C. J.; Catton, M. G.; Druce, J.; Salguero, F. J.; Carroll, M. W., Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge. bioRxiv 2020, 2020.05.29.123810. https://www.biorxiv.org/content/biorxiv/early/2020/05/29/2020.05.29.123810.full.pdf
593. Saeed, O.; Castagna, F.; Agalliu, I.; Xue, X.; Patel, S. R.; Rochlani, Y.; Kataria, R.; Vukelic, S.; Sims, D. B.; Alvarez, C.; Rivas-Lasarte, M.; Garcia, M. J.; Jorde, U. P., Statin Use and In-Hospital Mortality in Diabetics with COVID-19. J Am Heart Assoc 2020, e018475.
594. Safewell, SafeSpace. https://www.safewellsolutions.co.uk/products/safespace/ (accessed 10 Oct 2020).
595. Sakoulas, G.; Geriak, M.; Kullar, R.; Greenwood, K. L.; Habib, M.; Vyas, A.; Ghafourian, M.; Dintyala, V. N. K.; Haddad, F., Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019. Crit Care Explor 2020, 2 (11), e0280.
596. Salazar, E.; Christensen, P. A.; Graviss, E. A.; Nguyen, D. T.; Castillo, B.; Chen, J.; Lopez, B. V.; Eagar, T. N.; Yi, X.; Zhao, P.; Rogers, J.; Shehabeldin, A.; Joseph, D.; Masud, F.; Leveque, C.; Olsen, R. J.; Bernard, D. W.; Gollihar, J.; Musser, J. M., Significantly decreased mortality in a large cohort of COVID-19 patients transfused early with convalescent plasma containing high titer anti-SARS-CoV-2 spike protein IgG. The American Journal of Pathology 2020. http://www.sciencedirect.com/science/article/pii/S0002944020304892
597. Sanchez, G. V.; Biedron, C.; Fink, L. R.; al., e., Initial and Repeated Point Prevalence Surveys to Inform SARS-CoV-2 Infection Prevention in 26 Skilled Nursing Facilities — Detroit, Michigan, March–May 2020. Morbidity and Mortality Weekly Report 2020, ePub: 1 July 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6927e1.htm?s_cid=mm6927e1_w#suggestedcitation 
598. Sandhu, T.; Tieng, A.; Chilimuri, S.; Franchin, G., A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection. Can J Infect Dis Med Microbiol 2020, 2020, 8865954.
599. Santarpia, J. L.; Rivera, D. N.; Herrera, V.; Morwitzer, M. J.; Creager, H.; Santarpia, G. W.; Crown, K. K.; Brett-Major, D.; Schnaubelt, E.; Broadhurst, M. J.; Lawler, J. V.; Reid, S. P.; Lowe, J. J., Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center. medRxiv 2020, 2020.03.23.20039446. https://www.medrxiv.org/content/medrxiv/early/2020/03/26/2020.03.23.20039446.1.full.pdf
600. Schlottau, K.; Rissmann, M.; Graaf, A.; Schön, J.; Sehl, J.; Wylezich, C.; Höper, D.; Mettenleiter, T. C.; Balkema-Buschmann, A.; Harder, T.; Grund, C.; Hoffmann, D.; Breithaupt, A.; Beer, M., SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study. The Lancet Microbe 2020. https://doi.org/10.1016/S2666-5247(20)30089-6
601. Schnirring, L., New coronavirus infects health workers, spreads to Korea. http://www.cidrap.umn.edu/news-perspective/2020/01/new-coronavirus-infects-health-workers- spreads-korea.
602. Schuit, M.; Ratnesar-Shumate, S.; Yolitz, J.; Williams, G.; Weaver, W.; Green, B.; Miller, D.; Krause, M.; Beck, K.; Wood, S.; Holland, B.; Bohannon, J.; Freeburger, D.; Hooper, I.; Biryukov, J.; Altamura, L. A.; Wahl, V.; Hevey, M.; Dabisch, P., Airborne SARS-CoV-2 is Rapidly Inactivated by Simulated Sunlight. The Journal of Infectious Diseases 2020. https://doi.org/10.1093/infdis/jiaa334
603. Sciences, C. A. o. M., The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19. https://clinicaltrials.gov/ct2/show/NCT04659239.
604. Self, W. H.; Semler, M. W.; Leither, L. M.; Casey, J. D.; Angus, D. C.; Brower, R. G.; Chang, S. Y.; Collins, S. P.; Eppensteiner, J. C.; Filbin, M. R.; Files, D. C.; Gibbs, K. W.; Ginde, A. A.; Gong, M. N.; Harrell, F. E., Jr; Hayden, D. L.; Hough, C. L.; Johnson, N. J.; Khan, A.; Lindsell, C. J.; Matthay, M. A.; Moss, M.; Park, P. K.; Rice, T. W.; Robinson, B. R. H.; Schoenfeld, D. A.; Shapiro, N. I.; Steingrub, J. S.; Ulysse, C. A.; Weissman, A.; Yealy, D. M.; Thompson, B. T.; Brown, S. M.; National Heart, L.; Network, B. I. P. C. T., Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA 2020. https://doi.org/10.1001/jama.2020.22240
605. Self, W. H.; Tenforde, M. W.; Stubblefield, W. B.; Feldstein, L. R.; Steingrub, J. S.; Shapiro, N. I.; Ginde, A. A.; Prekker, M. E.; Brown, S. M.; Peltan, I. D.; Gong, M. N.; Aboodi, M. S.; Khan, A.; Exline, M. C.; Files, D. C.; Gibbs, K. W.; Lindsell, C. J.; Rice, T. W.; Jones, I. D.; Halasa, N.; Talbot, H. K.; Grijalva, C. G.; Casey, J. D.; Hager, D. N.; Qadir, N.; Henning, D. J.; Coughlin, M. M.; Schiffer, J.; Semenova, V.; Li, H.; Thornburg, N. J.; Patel, M. M., Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6947a2.htm?s_cid=mm6947a2_w.
606. Seow, J.; Graham, C.; Merrick, B.; Acors, S.; Steel, K. J. A.; Hemmings, O.; O'Bryne, A.; Kouphou, N.; Pickering, S.; Galao, R.; Betancor, G.; Wilson, H. D.; Signell, A. W.; Winstone, H.; Kerridge, C.; Temperton, N.; Snell, L.; Bisnauthsing, K.; Moore, A.; Green, A.; Martinez, L.; Stokes, B.; Honey, J.; Izquierdo-Barras, A.; Arbane, G.; Patel, A.; OConnell, L.; O Hara, G.; MacMahon, E.; Douthwaite, S.; Nebbia, G.; Batra, R.; Martinez-Nunez, R.; Edgeworth, J. D.; Neil, S. J. D.; Malim, M. H.; Doores, K., Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. medRxiv 2020, 2020.07.09.20148429. https://www.medrxiv.org/content/medrxiv/early/2020/07/11/2020.07.09.20148429.full.pdf
607. sermet, i.; temmam, s.; huon, c.; behillil, s.; gadjos, v.; bigot, t.; lurier, t.; chretien, d.; backovick, m.; Moisan-Delaunay, A.; donati, f.; albert, m.; foucaud, e.; Mesplees, B.; benoist, g.; fayes, a.; duval- arnould, m.; cretolle, c.; charbit, m.; aubart, m.; Auriau, J.; lorrot, m.; Kariyawasam, D.; fertita, l.; Orliaguet, G.; pigneur, b.; Bader-Meunier, B.; briand, c.; toubiana, j.; Guilleminot, T.; van der werf, s.; leruez-ville, m.; eloit, m., Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection and associated Multisystem Inflammatory Syndrome in children. medRxiv 2020, 2020.06.29.20142596. https://www.medrxiv.org/content/medrxiv/early/2020/06/30/2020.06.29.20142596.full.pdf
608. Services, I. o. M. a. L., REALM Project Releases Results from Latest Tests of Coronavirus on Leather, Summary of Research. https://www.imls.gov/news/realm-project-releases-results-latest-tests- coronavirus-leather-summary-research.
609. Shacham, E.; Scroggins, S.; Ellis, M.; Garza, A., Association of County-Wide Mask Ordinances with Reductions in Daily CoVID-19 Incident Case Growth in a Midwestern Region Over 12 Weeks. medRxiv 2020, 2020.10.28.20221705. https://www.medrxiv.org/content/medrxiv/early/2020/10/30/2020.10.28.20221705.full.pdf
610. Shan, B.; Broza, Y. Y.; Li, W.; Wang, Y.; Wu, S.; Liu, Z.; Wang, J.; Gui, S.; Wang, L.; Zhang, Z.; Liu, W.; Zhou, S.; Jin, W.; Zhang, Q.; Hu, D.; Lin, L.; Zhang, Q.; Li, W.; Wang, J.; Liu, H.; Pan, Y.; Haick, H., Multiplexed Nanomaterial-Based Sensor Array for Detection of COVID-19 in Exhaled Breath. ACS Nano 2020. https://doi.org/10.1021/acsnano.0c05657
611. Shekerdemian, L. S.; Mahmood, N. R.; Wolfe, K. K.; Riggs, B. J.; Ross, C. E.; McKiernan, C. A.; Heidemann, S. M.; Kleinman, L. C.; Sen, A. I.; Hall, M. W.; Priestley, M. A.; McGuire, J. K.; Boukas, K.; Sharron, M. P.; Burns, J. P.; Collaborative, f. t. I. C.-P., Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatrics 2020. https://doi.org/10.1001/jamapediatrics.2020.1948
612. Shen, M.; Zu, J.; Fairley, C. K.; Pagán, J. A.; An, L.; Du, Z.; Guo, Y.; Rong, L.; Xiao, Y.; Zhuang, G.; Li, Y.; Zhang, L., Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use. medRxiv 2020, 2020.10.28.20221234. https://www.medrxiv.org/content/medrxiv/early/2020/10/30/2020.10.28.20221234.full.pdf
613. Shepardson, D., U.S. CDC issues 'strong recommendation' for mask mandate on airplanes, trains. Reuters 2020. https://ca.reuters.com/article/instant-article/idUSL1N2HA24V
614. Sherina, N.; Piralla, A.; Du, L.; Wan, H.; Kumagai-Braesh, M.; Andrell, J.; Braesch-Andersen, S.; Cassaniti, I.; Percivalle, E.; Sarasini, A.; Bergami, F.; Di Martino, R.; Colaneri, M.; Vecchia, M.; Sambo, M.; Zuccaro, V.; Bruno, R.; Oggionni, T.; Meloni, F.; Abolhassani, H.; Bertoglio, F.; Schubert, M.; Byrne-Steele, M.; Han, J.; Hust, M.; Xue, Y.; Hammarstrom, L.; Baldanti, F.; Marcotte, H.; Pan-Hammarstrom, Q., Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection. bioRxiv 2020, 2020.11.06.371617. https://www.biorxiv.org/content/biorxiv/early/2020/11/06/2020.11.06.371617.full.pdf
615. Shi, J.; Wen, Z.; Zhong, G.; Yang, H.; Wang, C.; Huang, B.; Liu, R.; He, X.; Shuai, L.; Sun, Z.; Zhao, Y.; Liu, P.; Liang, L.; Cui, P.; Wang, J.; Zhang, X.; Guan, Y.; Tan, W.; Wu, G.; Chen, H.; Bu, Z., Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science 2020, eabb7015. https://science.sciencemag.org/content/sci/early/2020/04/07/science.abb7015.full.pdf
616. Shi, Q.; Hu, Y.; Peng, B.; Tang, X.-J.; Wang, W.; Su, K.; Luo, C.; Wu, B.; Zhang, F.; Zhang, Y.; Anderson, B.; Zhong, X.-N.; Qiu, J.-F.; Yang, C. Y.; Huang, A.-L., Effective control of SARS-CoV-2 transmission in Wanzhou, China. Nature Medicine 2020. https://doi.org/10.1038/s41591-020-01178-5
617. Shi, S.; Qin, M.; Shen, B.; Cai, Y.; Liu, T.; Yang, F.; Gong, W.; Liu, X.; Liang, J.; Zhao, Q.; Huang, H.; Yang, B.; Huang, C., Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiology 2020. https://doi.org/10.1001/jamacardio.2020.0950
618. Sia, S. F.; Yan, L. M.; Chin, A. W. H.; Fung, K.; Choy, K. T.; Wong, A. Y. L.; Kaewpreedee, P.; Perera, R.; Poon, L. L. M.; Nicholls, J. M.; Peiris, M.; Yen, H. L., Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 2020.
619. Silcott, D.; Kinahan, S.; Santarpia, J.; Silcott, B.; Silcott, R.; Silcott, P.; Silcott, B.; Distelhorst, S.; Herrera, V.; Rivera, D.; Crown, K.; Lucero, G.; Bryden, W.; McLoughlin, M.; Cetta, M.; Accardi, R., TRANSCOM/AMC Commercial Aircraft Cabin Aerosol Dispersion Tests; USATRANSCOM and AMC: 2020. https://www.ustranscom.mil/cmd/docs/TRANSCOM%20Report%20Final.pdf
620. Simmons, S.; Carrion, R.; Alfson, K.; Staples, H.; Jinadatha, C.; Jarvis, W.; Sampathkumar, P.; Chemaly, R. F.; Khawaja, F.; Povroznik, M.; Jackson, S.; Kaye, K. S.; Rodriguez, R. M.; Stibich, M., Deactivation of SARS-CoV-2 with Pulsed Xenon Ultraviolet: implications for environmental COVID-19 control. Infection Control & Hospital Epidemiology 2020, 1-19. https://www.cambridge.org/core/article/deactivation-of-sarscov2-with-pulsed-xenon-ultraviolet- implications-for-environmental-covid19-control/AD5CF52419E27E86E0114059FBA78D4C
621. Simonovich, V. A.; Burgos Pratx, L. D.; Scibona, P.; Beruto, M. V.; Vallone, M. G.; Vázquez, C.; Savoy, N.; Giunta, D. H.; Pérez, L. G.; Sánchez, M. D. L.; Gamarnik, A. V.; Ojeda, D. S.; Santoro, D. M.; Camino, P. J.; Antelo, S.; Rainero, K.; Vidiella, G. P.; Miyazaki, E. A.; Cornistein, W.; Trabadelo, O. A.; Ross, F. M.; Spotti, M.; Funtowicz, G.; Scordo, W. E.; Losso, M. H.; Ferniot, I.; Pardo, P. E.; Rodriguez, E.; Rucci, P.; Pasquali, J.; Fuentes, N. A.; Esperatti, M.; Speroni, G. A.; Nannini, E. C.; Matteaccio, A.; Michelangelo, H. G.; Follmann, D.; Lane, H. C.; Belloso, W. H., A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia. N Engl J Med 2020.
622. Singh, K.; Mittal, S.; Gollapudi, S.; Butzmann, A.; Kumar, J.; Ohgami, R. S., A meta-analysis of SARS- CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity. International Journal of Laboratory Hematology n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/ijlh.13354
623. Sinovac, Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV). https://clinicaltrials.gov/ct2/show/NCT04456595?term=vaccine&cond=covid-19&draw=2&rank=1.
624. Sit, T. H. C.; Brackman, C. J.; Ip, S. M.; Tam, K. W. S.; Law, P. Y. T.; To, E. M. W.; Yu, V. Y. T.; Sims, L. D.; Tsang, D. N. C.; Chu, D. K. W.; Perera, R.; Poon, L. L. M.; Peiris, M., Infection of dogs with SARS-CoV-2. Nature 2020.
625. Skalina, K. A.; Goldstein, D. Y.; Sulail, J.; Hahm, E.; Narlieva, M.; Szymczak, W.; Fox, A. S., Extended Storage of SARS-CoV2 Nasopharyngeal Swabs Does Not Negatively Impact Results of Molecular-Based Testing. medRxiv 2020, 2020.05.16.20104158. https://www.medrxiv.org/content/medrxiv/early/2020/05/20/2020.05.16.20104158.full.pdf
626. Smarr, B. L.; Aschbacher, K.; Fisher, S. M.; Chowdhary, A.; Dilchert, S.; Puldon, K.; Rao, A.; Hecht, F. M.; Mason, A. E., Feasibility of continuous fever monitoring using wearable devices. Scientific Reports 2020, 10 (1), 21640. https://doi.org/10.1038/s41598-020-78355-6
627. Sobel Leonard, A.; Weissman, D. B.; Greenbaum, B.; Ghedin, E.; Koelle, K., Transmission Bottleneck Size Estimation from Pathogen Deep-Sequencing Data, with an Application to Human Influenza A Virus. Journal of Virology 2017, 91 (14), e00171-17. https://jvi.asm.org/content/jvi/91/14/e00171-17.full.pdf 
628. Song, J.-Y.; Yun, J.-G.; Noh, J.-Y.; Cheong, H.-J.; Kim, W.-J., Covid-19 in South Korea — Challenges of Subclinical Manifestations. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMc2001801
629. Soni, M., Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection. International Journal of Laboratory Hematology 2020, n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/ijlh.13425
630. Ssentongo, A. E.; Ssentongo, P.; Heilbrunn, E. S.; Lekoubou, A.; Du, P.; Liao, D.; Oh, J. S.; Chinchilli, V. M., Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis. Open Heart 2020, 7 (2), e001353. http://openheart.bmj.com/content/7/2/e001353.abstract
631. Stadnytskyi, V.; Bax, C. E.; Bax, A.; Anfinrud, P., The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission. Proceedings of the National Academy of Sciences 2020, 202006874. https://www.pnas.org/content/pnas/early/2020/05/12/2006874117.full.pdf
632. Staff, G. B., Originally Built for Bioterrorism Agents, This Decontamination System Now Clears SARS- CoV-2 from Military Aircraft. Global Biodefense 2020. https://globalbiodefense.com/2020/11/05/military-aircraft-sars-cov-2-sanitization-with-hot-air-system/ 
633. Sterne, J. A. C.; Murthy, S.; Diaz, J. V.; Slutsky, A. S.; Villar, J.; Angus, D. C.; Annane, D.; Azevedo, L. C. P.; Berwanger, O.; Cavalcanti, A. B.; Dequin, P. F.; Du, B.; Emberson, J.; Fisher, D.; Giraudeau, B.; Gordon, A. C.; Granholm, A.; Green, C.; Haynes, R.; Heming, N.; Higgins, J. P. T.; Horby, P.; Jüni, P.; Landray, M. J.; Le Gouge, A.; Leclerc, M.; Lim, W. S.; Machado, F. R.; McArthur, C.; Meziani, F.; Møller, M. H.; Perner, A.; Petersen, M. W.; Savovic, J.; Tomazini, B.; Veiga, V. C.; Webb, S.; Marshall, J. C., Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. Jama 2020. https://jamanetwork.com/journals/jama/fullarticle/2770279
634. Strohbehn, G. W.; Heiss, B. L.; Rouhani, S. J.; Trujillo, J. A.; Yu, J.; Kacew, A. J.; Higgs, E. F.; Bloodworth, J. C.; Cabanov, A.; Wright, R. C.; Koziol, A. K.; Weiss, A.; Danahey, K.; Karrison, T. G.; Edens, C. C.; Ventura, I. B.; Pettit, N. N.; Patel, B. K.; Pisano, J.; Strek, M. E.; Gajewski, T. F.; Ratain, M. J.; Reid, P. D., COVIDOSE: A phase 2 clinical trial of low-dose tocilizumab in the treatment of non-critical COVID-19 pneumonia. Clin Pharmacol Ther 2020.
635. Stubblefield, W. B.; Talbot, H. K.; Feldstein, L.; Tenforde, M. W.; Rasheed, M. A. U.; Mills, L.; Lester, S. N.; Freeman, B.; Thornburg, N. J.; Jones, I. D.; Ward, M. J.; Lindsell, C. J.; Baughman, A.; Halasa, N.; Grijalva, C. G.; Rice, T. W.; Patel, M. M.; Self, W. H.; Investigators, I. V. E. i. t. C. I., Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for COVID-19 Patients — Nashville, Tennessee. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa936 
636. Su, H.; Yang, M.; Wan, C.; Yi, L.-X.; Tang, F.; Zhu, H.-Y.; Yi, F.; Yang, H.-C.; Fogo, A. B.; Nie, X.; Zhang, C., Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney International. https://doi.org/10.1016/j.kint.2020.04.003
637. Suarez, D. L.; Pantin-Jackwood, M. J.; Swayne, D. E.; Lee, S. A.; DeBlois, S. M.; Spackman, E., Lack of susceptibility of poultry to SARS-CoV-2 and MERS-CoV. bioRxiv 2020, 2020.06.16.154658. http://biorxiv.org/content/early/2020/06/16/2020.06.16.154658.abstract
638. Sugano, N.; Ando, W.; Fukushima, W., Cluster of SARS-CoV-2 infections linked to music clubs in Osaka, Japan: asymptomatically infected persons can transmit the virus as soon as 2 days after infection. The Journal of Infectious Diseases 2020. https://doi.org/10.1093/infdis/jiaa542
639. Sukhyun, R.; Seikh Taslim, A.; Cheolsun, J.; Baekjin, K.; Benjamin, J. C., Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020. Emerging Infectious Disease journal 2020, 26 (10). https://wwwnc.cdc.gov/eid/article/26/10/20- 1886_article
640. Sun, J.; Zhu, A.; Li, H.; Zheng, K.; Zhuang, Z.; Chen, Z.; Shi, Y.; Zhang, Z.; Chen, S. B.; Liu, X.; Dai, J.; Li, X.; Huang, S.; Huang, X.; Luo, L.; Wen, L.; Zhuo, J.; Li, Y.; Wang, Y.; Zhang, L.; Zhang, Y.; Li, F.; Feng, L.; Chen, X.; Zhong, N.; Yang, Z.; Huang, J.; Zhao, J.; Li, Y. M., Isolation of Infectious SARS-CoV-2 from Urine of a COVID-19 Patient. Emerg Microbes Infect 2020, 1-8.
641. Sun, K.; Wang, W.; Gao, L.; Wang, Y.; Luo, K.; Ren, L.; Zhan, Z.; Chen, X.; Zhao, S.; Huang, Y.; Sun, Q.; Liu, Z.; Litvinova, M.; Vespignani, A.; Ajelli, M.; Viboud, C.; Yu, H., Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science 2020, eabe2424. https://science.sciencemag.org/content/sci/early/2020/11/23/science.abe2424.full.pdf
642. Sun, S.; Cai, X.; Wang, H.; He, G.; Lin, Y.; Lu, B.; Chen, C.; Pan, Y.; Hu, X., Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clinica Chimica Acta 2020, 507, 174-180. http://www.sciencedirect.com/science/article/pii/S0009898120301790
643. Suthar, M. S.; Zimmerman, M. G.; Kauffman, R. C.; Mantus, G.; Linderman, S. L.; Hudson, W. H.; Vanderheiden, A.; Nyhoff, L.; Davis, C. W.; Adekunle, S.; Affer, M.; Sherman, M.; Reynolds, S.; Verkerke, H. P.; Alter, D. N.; Guarner, J.; Bryksin, J.; Horwath, M.; Arthur, C. M.; Saakadze, N.; Smith, G. H.; Edupuganti, S.; Scherer, E. M.; Hellmeister, K.; Cheng, A.; Morales, J. A.; Neish, A. S.; Stowell, S. R.; Frank, F.; Ortlund, E.; Anderson, E.; Menachery, V. D.; Rouphael, N.; Mehta, A.; Stephens, D. S.; Ahmed, R.; Roback, J. D.; Wrammert, J., Rapid generation of neutralizing antibody responses in COVID-19 patients. Cell Reports Medicine 2020. https://doi.org/10.1016/j.xcrm.2020.100040
644. Tabata, S.; Imai, K.; Kawano, S.; Ikeda, M.; Kodama, T.; Miyoshi, K.; Obinata, H.; Mimura, S.; Kodera, T.; Kitagaki, M.; Sato, M.; Suzuki, S.; Ito, T.; Uwabe, Y.; Tamura, K., Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the <em>Diamond Princess</em> cruise ship: a retrospective analysis. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(20)30482-5
645. Takahashi, T.; Ellingson, M. K.; Wong, P.; Israelow, B.; Lucas, C.; Klein, J.; Silva, J.; Mao, T.; Oh, J. E.; Tokuyama, M.; Lu, P.; Venkataraman, A.; Park, A.; Liu, F.; Meir, A.; Sun, J.; Wang, E. Y.; Casanovas- Massana, A.; Wyllie, A. L.; Vogels, C. B. F.; Earnest, R.; Lapidus, S.; Ott, I. M.; Moore, A. J.; Anastasio, K.; Askenase, M. H.; Batsu, M.; Beatty, H.; Bermejo, S.; Bickerton, S.; Brower, K.; Bucklin, M. L.; Cahill, S.; Campbell, M.; Cao, Y.; Courchaine, E.; Datta, R.; DeIuliis, G.; Geng, B.; Glick, L.; Handoko, R.; Kalinich, C.; Khoury-Hanold, W.; Kim, D.; Knaggs, L.; Kuang, M.; Kudo, E.; Lim, J.; Linehan, M.; Lu-Culligan, A.; Malik, A. A.; Martin, A.; Matos, I.; McDonald, D.; Minasyan, M.; Mohanty, S.; Muenker, M. C.; Naushad, N.; Nelson, A.; Nouws, J.; Nunez-Smith, M.; Obaid, A.; Ott, I.; Park, H.-J.; Peng, X.; Petrone, M.; Prophet, S.; Rahming, H.; Rice, T.; Rose, K.-A.; Sewanan, L.; Sharma, L.; Shepard, D.; Silva, E.; Simonov, M.; Smolgovsky, M.; Song, E.; Sonnert, N.; Strong, Y.; Todeasa, C.; Valdez, J.; Velazquez, S.; Vijayakumar, P.; Wang, H.; Watkins, A.; White, E. B.; Yang, Y.; Shaw, A.; Fournier, J. B.; Odio, C. D.; Farhadian, S.; Dela Cruz, C.; Grubaugh, N. D.; Schulz, W. L.; Ring, A. M.; Ko, A. I.; Omer, S. B.; Iwasaki, A.; Yale, I. r. t., Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 2020. https://doi.org/10.1038/s41586-020-2700-3
646. Tan, C. W.; Ho, L. P.; Kalimuddin, S.; Cherng, B. P. Z.; Teh, Y. E.; Thien, S. Y.; Wong, H. M.; Tern, P. J. W.; Chandran, M.; Chay, J. W. M.; Nagarajan, C.; Sultana, R.; Low, J. G. H.; Ng, H. J., Cohort study to evaluate effect of vitamin D, magnesium, and vitamin B12 in combination on severe outcome progression in older patients with coronavirus (COVID-19). Nutrition 2020, 79-80, 111017. http://www.sciencedirect.com/science/article/pii/S0899900720303002
647. Tan, F.; Wang, K.; Liu, J.; Liu, D.; Luo, J.; Zhou, R., Viral Transmission and Clinical Features in Asymptomatic Carriers of SARS-CoV-2 in Wuhan, China. Frontiers in Medicine 2020, 7 (547). https://www.frontiersin.org/article/10.3389/fmed.2020.00547
648. Team, D. W., 'Covaxin': Bharat Biotech to begin Phase-III trials of COVID-19 vaccine in UP from October. https://www.dnaindia.com/india/report-covaxin-bharat-biotech-covid-19-vaccine-phase-3- trials-uttar-pradesh-october-2845194.
649. Tenforde, M. W.; Kim, S. S.; Lindsell, C. J.; al., e., Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020. Morbidity and Mortality Weekly Report 2020, ePub: 24 July 2020. 
650. The Novel Coronavirus Pneumonia Emergency Response Epidemiology, T., The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Weekly 2020, 2, 1-10. http://weekly.chinacdc.cn//article/id/e53946e2-c6c4-41e9-9a9b- fea8db1a8f51
651. Thomas, P.; Alexander, P. E.; Ahmed, U.; Elderhorst, E.; El-Khechen, H.; Mammen, M. J.; Debono, V. B.; Aponte Torres, Z.; Aryal, K.; Brocard, E.; Sagastuy, B.; Alhazzani, W., Vertical transmission risk of SARS-CoV-2 infection in the third trimester: a systematic scoping review. The Journal of Maternal-Fetal & Neonatal Medicine 2020, 1-8. https://doi.org/10.1080/14767058.2020.1786055
652. Thomson, E. C.; Rosen, L. E.; Shepherd, J. G.; Spreafico, R.; da Silva Filipe, A.; Wojcechowskyj, J. A.; Davis, C.; Piccoli, L.; Pascall, D. J.; Dillen, J.; Lytras, S.; Czudnochowski, N.; Shah, R.; Meury, M.; Jesudason, N.; De Marco, A.; Li, K.; Bassi, J.; Toole, A.; Pinto, D.; Colquhoun, R. M.; Culap, K.; Jackson, B.; Zatta, F.; Rambaut, A.; Jaconi, S.; Sreenu, V. B.; Nix, J.; Jarrett, R. F.; Beltramello, M.; Nomikou, K.; Pizzuto, M.; Tong, L.; Cameroni, E.; Johnson, N.; Wickenhagen, A.; Ceschi, A.; Mair, D.; Ferrari, P.; Smollett, K.; Sallusto, F.; Carmichael, S.; Garzoni, C.; Nichols, J.; Galli, M.; Hughes, J.; Riva, A.; Ho, A.; Semple, M. G.; Openshaw, P. J. M.; Baillie, K.; Rihn, S. J.; Lycett, S. J.; Virgin, H. W.; Telenti, A.; Corti, D.; Robertson, D. L.; Snell, G., The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity. bioRxiv 2020, 2020.11.04.355842. http://biorxiv.org/content/early/2020/11/05/2020.11.04.355842.abstract
653. TILLETT, R.; SEVINSKY, J.; HARTLEY, P.; KERWIN, H.; CRAWFORD, N.; GORZALSKI, A.; LAVERDURE, C.; VERMA, S.; ROSSETTO, C.; FARRELL, M.; JACKSON, D.; Pandori, M.; VAN HOOSER, S., Genomic Evidence for a Case of Reinfection with SARS-CoV-2. The Lancet 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3681489
654. To, K. K.-W.; Tsang, O. T.-Y.; Leung, W.-S.; Tam, A. R.; Wu, T.-C.; Lung, D. C.; Yip, C. C.-Y.; Cai, J.-P.; Chan, J. M.-C.; Chik, T. S.-H., Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. The Lancet Infectious Diseases 2020.
655. Tomazini, B. M.; Maia, I. S.; Cavalcanti, A. B.; Berwanger, O.; Rosa, R. G.; Veiga, V. C.; Avezum, A.; Lopes, R. D.; Bueno, F. R.; Silva, M.; Baldassare, F. P.; Costa, E. L. V.; Moura, R. A. B.; Honorato, M. O.; Costa, A. N.; Damiani, L. P.; Lisboa, T.; Kawano-Dourado, L.; Zampieri, F. G.; Olivato, G. B.; Righy, C.; Amendola, C. P.; Roepke, R. M. L.; Freitas, D. H. M.; Forte, D. N.; Freitas, F. G. R.; Fernandes, C. C. F.; Melro, L. M. G.; Junior, G. F. S.; Morais, D. C.; Zung, S.; Machado, F. R.; Azevedo, L. C. P., Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. Jama 2020. https://jamanetwork.com/journals/jama/fullarticle/2770277
656. Torres, J. P.; Piñera, C.; De La Maza, V.; Lagomarcino, A. J.; Simian, D.; Torres, B.; Urquidi, C.; Valenzuela, M. T.; O’Ryan, M., Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Prevalence in Blood in a Large School Community Subject to a Coronavirus Disease 2019 Outbreak: A Cross-sectional Study. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa955
657. Tortajada, C.; Colomer, E.; Andreu-Ballester, J. C.; Esparcia, A.; Oltra, C.; Flores, J., Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and Intensive Care Unit admission in patients with COVID-19 according to patients' oxygen requirements. J Med Virol 2020.
658. Tosif, S.; Neeland, M. R.; Sutton, P.; Licciardi, P. V.; Sarkar, S.; Selva, K. J.; Do, L. A. H.; Donato, C.; Quan Toh, Z.; Higgins, R.; Van de Sandt, C.; Lemke, M. M.; Lee, C. Y.; Shoffner, S. K.; Flanagan, K. L.; Arnold, K. B.; Mordant, F. L.; Mulholland, K.; Bines, J.; Dohle, K.; Pellicci, D. G.; Curtis, N.; McNab, S.; Steer, A.; Saffery, R.; Subbarao, K.; Chung, A. W.; Kedzierska, K.; Burgner, D. P.; Crawford, N. W., Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19. Nature Communications 2020, 11 (1), 5703. https://doi.org/10.1038/s41467-020-19545-8
659. Toubiana, J.; Levy, C.; Allali, S.; Jung, C.; Leruez-Ville, M.; Varon, E.; Bajolle, F.; Ouldali, N.; Chareyre, J.; Béchet, S.; Elbez, A.; Casanova, J.-L.; Chalumeau, M.; Cohen, R.; Cohen, J. F., Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: a retrospective matched case–control study, Paris, France, April to May 2020. Eurosurveillance 2020, 25 (48), 2001813. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.48.2001813
660. Treibel, T. A.; Manisty, C.; Burton, M.; McKnight, Á.; Lambourne, J.; Augusto, J. B.; Couto-Parada, X.; Cutino-Moguel, T.; Noursadeghi, M.; Moon, J. C., COVID-19: PCR screening of asymptomatic health-care workers at London hospital. The Lancet. https://doi.org/10.1016/S0140-6736(20)31100-4
661. Tsay, C.; Lejarza, F.; Stadtherr, M. A.; Baldea, M., Modeling, state estimation, and optimal control for the US COVID-19 outbreak. Scientific Reports 2020, 10 (1), 10711. https://doi.org/10.1038/s41598- 020-67459-8
662. Tso, F. Y.; Lidenge, S. J.; Peña, P. B.; Clegg, A. A.; Ngowi, J. R.; Mwaiselage, J.; Ngalamika, O.; Julius, P.; West, J. T.; Wood, C., High prevalence of pre-existing serological cross-reactivity against SARS-CoV-2 in sub-Sahara Africa. International Journal of Infectious Diseases 2020. https://doi.org/10.1016/j.ijid.2020.10.104
663. Twin FM, NHS Trials "Unique" New Decontamination Tech to Reduce COVID Transmission Indoors. https://www.twinfm.com/article/nhs-trials-unique-new-decontamination-tech-to-reduce-covid- transmission-indoors (accessed 19 Oct 2020).
664. U.S. Food and Drug Administration (FDA), Enforcement Policy for Bioburden Reduction Systems Using Dry Heat to Support Single-User Resuse of Certain Filtering Facepiece Respirators During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. Guidance for Industry, Healthcare Organizations, Healthcare Personnel, and Food and Drug Administration Staff. https://www.fda.gov/media/143985/download (accessed 30 No 2020).
665. UCLA, COVID-19 Cases in the United States. https://covid19.uclaml.org/model.html.
666. Udwadia, Z. F.; Singh, P.; Barkate, H.; Patil, S.; Rangwala, S.; Pendse, A.; Kadam, J.; Wu, W.; Caracta, C. F.; Tandon, M., Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial. Int J Infect Dis 2020.
667. Ueki, H.; Furusawa, Y.; Iwatsuki-Horimoto, K.; Imai, M.; Kabata, H.; Nishimura, H.; Kawaoka, Y., Effectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2. mSphere 2020, 5 (5), e00637-20. https://msphere.asm.org/content/msph/5/5/e00637-20.full.pdf
668. Ulrich, L.; Wernike, K.; Hoffmann, D.; Mettenleiter, T. C.; Beer, M., Experimental infection of cattle with SARS-CoV-2. bioRxiv 2020, 2020.08.25.254474. http://biorxiv.org/content/early/2020/08/25/2020.08.25.254474.abstract
669. Urigo, C.; Soin, S.; Sahu, A., Spontaneous pneumomediastinum as a complication of a COVID-19 related pneumonia: case report and review of literature. Radiology Case Reports 2020, 15 (12), 2577- 2581. http://www.sciencedirect.com/science/article/pii/S1930043320305148
670. van de Veerdonk, F. L.; Kouijzer, I. J. E.; de Nooijer, A. H.; van der Hoeven, H. G.; Maas, C.; Netea, M. G.; Brüggemann, R. J. M., Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19. JAMA Network Open 2020, 3 (8), e2017708-e2017708. https://doi.org/10.1001/jamanetworkopen.2020.17708
671. van der Sande, M.; Teunis, P.; Sabel, R., Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population. Plos One 2008, 3 (7). <Go to ISI>://WOS:000264065800020
672. van Doorn, A. S.; Meijer, B.; Frampton, C. M. A.; Barclay, M. L.; de Boer, N. K. H., Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission. Alimentary Pharmacology & Therapeutics n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.16036 
673. van Doremalen, N.; Bushmaker, T.; Morris, D. H.; Holbrook, M. G.; Gamble, A.; Williamson, B. N.; Tamin, A.; Harcourt, J. L.; Thornburg, N. J.; Gerber, S. I.; Lloyd-Smith, J. O.; de Wit, E.; Munster, V. J., Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine 2020. https://doi.org/10.1056/NEJMc2004973
674. van Dorp, L.; Acman, M.; Richard, D.; Shaw, L. P.; Ford, C. E.; Ormond, L.; Owen, C. J.; Pang, J.; Tan, C. C. S.; Boshier, F. A. T.; Ortiz, A. T.; Balloux, F., Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infection, Genetics and Evolution 2020, 104351. http://www.sciencedirect.com/science/article/pii/S1567134820301829
675. van Dorp, L.; Richard, D.; Tan, C. C. S.; Shaw, L. P.; Acman, M.; Balloux, F., No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nature Communications 2020, 11 (1), 5986. https://doi.org/10.1038/s41467-020-19818-2
676. Varga, Z.; Flammer, A. J.; Steiger, P.; Haberecker, M.; Andermatt, R.; Zinkernagel, A. S.; Mehra, M. R.; Schuepbach, R. A.; Ruschitzka, F.; Moch, H., Endothelial cell infection and endotheliitis in COVID-19. The Lancet 2020, 395 (10234), 1417-1418. https://doi.org/10.1016/S0140-6736(20)30937-5
677. Verma, S.; Dhanak, M.; Frankenfield, J., Visualizing droplet dispersal for face shields and masks with exhalation valves. arXiv preprint arXiv:2008.00125 2020.
678. Vilke, G. M.; Brennan, J. J.; Cronin, A. O.; Castillo, E. M., Clinical features of covid-19 patients: is temperature screening useful? The Journal of Emergency Medicine 2020. http://www.sciencedirect.com/science/article/pii/S073646792030977X
679. Viola, I. M.; Peterson, B.; Pisetta, G.; Pavar, G.; Akhtar, H.; Menolascina, F.; Mangano, E.; Dunn, K.; Gabl, R.; Nila, A.; Molinari, E.; Cummins, C.; Thompson, G.; Lo, M.; Denison, F.; Digard, P.; Malik, O.; Dunn, M. J. G.; Mehendale, F., Face Coverings, Aerosol Dispersion and Mitigation of Virus Transmission Risk. arXiv.org: 2020.
680. Vivanti, A. J.; Vauloup-Fellous, C.; Prevot, S.; Zupan, V.; Suffee, C.; Do Cao, J.; Benachi, A.; De Luca, D., Transplacental transmission of SARS-CoV-2 infection. Nature Communications 2020, 11 (1), 3572. https://doi.org/10.1038/s41467-020-17436-6
681. Volz, E. M.; Hill, V.; McCrone, J. T.; Price, A.; Jorgensen, D.; Toole, A.; Southgate, J. A.; Johnson, R.; Jackson, B.; Nascimento, F. F.; Rey, S. M.; Nicholls, S. M.; Colquhoun, R. M.; da Silva Filipe, A.; Shepherd, J. G.; Pascall, D. J.; Shah, R.; Jesudason, N.; Li, K.; Jarrett, R.; Pacchiarini, N.; Bull, M.; Geidelberg, L.; Siveroni, I.; Goodfellow, I. G.; Loman, N. J.; Pybus, O.; Robertson, D. L.; Thomson, E. C.; Rambaut, A.; Connor, T. R., Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity. medRxiv 2020, 2020.07.31.20166082. http://medrxiv.org/content/early/2020/09/01/2020.07.31.20166082.abstract
682. Voss, J. D.; Skarzynski, M.; McAuley, E. M.; Maier, E. J.; Gibbons, T.; Fries, A. C.; Chapleau, R. R., Variants in SARS-CoV-2 Associated with Mild or Severe Outcome. medRxiv 2020, 2020.12.01.20242149. http://medrxiv.org/content/early/2020/12/03/2020.12.01.20242149.abstract
683. Wajnberg, A.; Amanat, F.; Firpo, A.; Altman, D. R.; Bailey, M. J.; Mansour, M.; McMahon, M.; Meade, P.; Mendu, D. R.; Muellers, K.; Stadlbauer, D.; Stone, K.; Strohmeier, S.; Simon, V.; Aberg, J.; Reich, D. L.; Krammer, F.; Cordon-Cardo, C., Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science 2020, eabd7728. https://science.sciencemag.org/content/sci/early/2020/10/27/science.abd7728.full.pdf
684. Walsh, K. A.; Jordan, K.; Clyne, B.; Rohde, D.; Drummond, L.; Byrne, P.; Ahern, S.; Carty, P. G.; O'Brien, K. K.; O'Murchu, E.; O'Neill, M.; Smith, S. M.; Ryan, M.; Harrington, P., SARS-CoV-2 Detection, Viral Load and Infectivity over the Course of an Infection: SARS-CoV-2 Detection, Viral Load and Infectivity. The Journal of infection 2020, S0163-4453(20)30449-7. https://pubmed.ncbi.nlm.nih.gov/32615199 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323671/
685. Walsh, K. A.; Spillane, S.; Comber, L.; Cardwell, K.; Harrington, P.; Connell, J.; Teljeur, C.; Broderick, N.; de Gascun, C. F.; Smith, S. M.; Ryan, M.; O'Neill, M., The duration of infectiousness of individuals infected with SARS-CoV-2. Journal of Infection. https://doi.org/10.1016/j.jinf.2020.10.009
686. Wambier, C. G.; Vaño-Galván, S.; McCoy, J.; Gomez-Zubiaur, A.; Herrera, S.; Hermosa-Gelbard, Á.; Moreno-Arrones, O. M.; Jiménez-Gómez, N.; González-Cantero, A.; Pascual, P. F.; Segurado-Miravalles, G.; Shapiro, J.; Pérez-García, B.; Goren, A., Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients &#x2013; the &#x201c;Gabrin sign&#x201d. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2020.05.079
687. Wang, D.; Hu, B.; Hu, C.; Zhu, F.; Liu, X.; Zhang, J.; Wang, B.; Xiang, H.; Cheng, Z.; Xiong, Y.; Zhao, Y.; Li, Y.; Wang, X.; Peng, Z., Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA 2020. https://doi.org/10.1001/jama.2020.1585 https://jamanetwork.com/journals/jama/articlepdf/2761044/jama_wang_2020_oi_200019.pdf
688. Wang, D.; Li, R.; Wang, J.; Jiang, Q.; Gao, C.; Yang, J.; Ge, L.; Hu, Q., Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. BMC Infectious Diseases 2020, 20 (1), 519. https://doi.org/10.1186/s12879-020- 05242-w
689. Wang, D.; You, Y.; Zhou, X.; Zong, Z.; Huang, H.; Zhang, H.; Yong, X.; Cheng, Y.; Yang, L.; Guo, Q.; Long, Y.; Liu, Y.; Huang, J.; Du, L., Selection of homemade mask materials for preventing transmission of COVID-19: a laboratory study. medRxiv 2020.
690. Wang, K.; Zhao, S.; Li, H.; Song, Y.; Wang, L.; Wang, M. H.; Peng, Z.; Li, H.; He, D., Real-time estimation of the reproduction number of the novel coronavirus disease (COVID-19) in China in 2020 based on incidence data. Annals of Translational Medicine 2020, 8 (11), 689. http://atm.amegroups.com/article/view/43447
691. Wang, L.; Didelot, X.; Yang, J.; Wong, G.; Shi, Y.; Liu, W.; Gao, G. F.; Bi, Y., Inference of person-to- person transmission of COVID-19 reveals hidden super-spreading events during the early outbreak phase. Nature Communications 2020, 11 (1), 5006. https://doi.org/10.1038/s41467-020-18836-4
692. Wang, Q.; Berger, N. A.; Xu, R., Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection. JAMA Oncology 2020. https://doi.org/10.1001/jamaoncol.2020.6178
693. Wang, R.; Qian, C.; Pang, Y.; Li, M.; Yang, Y.; Ma, H.; Zhao, M.; Qian, F.; Yu, H.; Liu, Z.; Ni, T.; Zheng, Y.; Wang, Y., opvCRISPR: One-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection. Biosensors and Bioelectronics 2021, 172, 112766. http://www.sciencedirect.com/science/article/pii/S0956566320307533
694. Wang, S.; Ma, P.; Zhang, S.; Song, S.; Wang, Z.; Ma, Y.; Xu, J.; Wu, F.; Duan, L.; Yin, Z.; Luo, H.; Xiong, N.; Xu, M.; Zeng, T.; Jin, Y., Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia 2020. https://doi.org/10.1007/s00125-020-05209-1
695. Wang, W.; Xu, Y.; Gao, R.; Lu, R.; Han, K.; Wu, G.; Tan, W., Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA 2020. https://doi.org/10.1001/jama.2020.3786
696. Wang, X.; Du, Z.; Huang, G.; Pasco, R.; Fox, S.; Galvani, A.; Pignone, M.; Johnston, S. C.; Meyers, L. A., Effects of Cocooning on Coronavirus Disease Rates after Relaxing Social Distancing. Emerging Infectious Disease journal 2020, 26 (12), 3066. https://wwwnc.cdc.gov/eid/article/26/12/20- 1930_article
697. Wang, X.; Ferro, E. G.; Zhou, G.; Hashimoto, D.; Bhatt, D. L., Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers. JAMA 2020. https://doi.org/10.1001/jama.2020.12897
698. Wang, X.; Pan, Y.; Zhang, D.; Chen, L.; Jia, L.; Li, X.; Yang, P.; Wang, Q.; Macintyre, C. R., Basic epidemiological parameter values from data of real-world in mega-cities: the characteristics of COVID-19 in Beijing, China. BMC Infectious Diseases 2020, 20 (1), 526. https://doi.org/10.1186/s12879-020-05251- 9
699. Wang, Y.; Chen, B.; Li, Y.; Zhang, L.; Wang, Y.; Yang, S.; Xiao, X.; Qin, Q., The Use of Renin- Angiotensin-Aldosterone System (RAAS) Inhibitors is Associated with a Lower Risk of Mortality in Hypertensive COVID-19 Patients: A Systematic Review and Meta-analysis. J Med Virol 2020.
700. Wang, Y.; Tian, H.; Zhang, L.; Zhang, M.; Guo, D.; Wu, W.; Zhang, X.; Kan, G. L.; Jia, L.; Huo, D.; Liu, B.; Wang, X.; Sun, Y.; Wang, Q.; Yang, P.; MacIntyre, C. R., Reduction of secondary transmission of SARS- CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing,China. BMJ Global Health 2020, 5 (5), e002794. https://gh.bmj.com/content/bmjgh/5/5/e002794.full.pdf
701. Wang, Y.; Zhang, D.; Du, G.; Du, R.; Zhao, J.; Jin, Y.; Fu, S.; Gao, L.; Cheng, Z.; Lu, Q.; Hu, Y.; Luo, G.; Wang, K.; Lu, Y.; Li, H.; Wang, S.; Ruan, S.; Yang, C.; Mei, C.; Wang, Y.; Ding, D.; Wu, F.; Tang, X.; Ye, X.; Ye, Y.; Liu, B.; Yang, J.; Yin, W.; Wang, A.; Fan, G.; Zhou, F.; Liu, Z.; Gu, X.; Xu, J.; Shang, L.; Zhang, Y.; Cao, L.; Guo, T.; Wan, Y.; Qin, H.; Jiang, Y.; Jaki, T.; Hayden, F. G.; Horby, P. W.; Cao, B.; Wang, C., Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet 2020, 395 (10236), 1569-1578. http://www.sciencedirect.com/science/article/pii/S0140673620310229
702. Ward, H.; Cooke, G.; Atchison, C.; Whitaker, M.; Elliott, J.; Moshe, M.; Brown, J. C.; Flower, B.; Daunt, A.; Ainslie, K.; Ashby, D.; Donnelly, C.; Riley, S.; Darzi, A.; Barclay, W.; Elliott, P., Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults Preprint 2020. https://www.imperial.ac.uk/media/imperial-college/institute-of-global-health-innovation/MEDRXIV- 2020-219725v1-Elliott.pdf
703. Wathore, R.; Gupta, A.; Bherwani, H.; Labhasetwar, N., Understanding air and water borne transmission and survival of coronavirus: Insights and way forward for SARS-CoV-2. Science of The Total Environment 2020, 749, 141486. http://www.sciencedirect.com/science/article/pii/S0048969720350154
704. WCS, A Tiger at Bronx Zoo Tests Positive for COVID-19; The Tiger and the Zoo’s Other Cats Are Doing Well at This Time. https://newsroom.wcs.org/News- Releases/articleType/ArticleView/articleId/14010/A-Tiger-at-Bronx-Zoo-Tests-Positive-for-COVID-19- The-Tiger-and-the-Zoos-Other-Cats-Are-Doing-Well-at-This-Time.aspx (accessed April 6, 2020).
705. Wei, W. E.; Li, Z.; Chiew, C. J.; Yong, S. E.; Toh, M. P.; Lee, V. J., Presymptomatic transmission of SARS-CoV-2 - Singapore, January 23 - March 16, 2020. Morbidity and Mortality Weekly Report 2020, ePub (1 April 2020). https://www.cdc.gov/mmwr/volumes/69/wr/mm6914e1.htm
706. Wei, Y.; Wei, L.; Liu, Y.; Huang, L.; Shen, S.; Zhang, R.; Chen, J.; Zhao, Y.; Shen, H.; Chen, F., A systematic review and meta-analysis reveals long and dispersive incubation period of COVID-19. medRxiv 2020, 2020.06.20.20134387. https://www.medrxiv.org/content/medrxiv/early/2020/06/22/2020.06.20.20134387.full.pdf
707. Weill, J. A.; Stigler, M.; Deschenes, O.; Springborn, M. R., Social distancing responses to COVID-19 emergency declarations strongly differentiated by income. Proceedings of the National Academy of Sciences 2020, 202009412. https://www.pnas.org/content/pnas/early/2020/07/28/2009412117.full.pdf 
708. Weisberg, S. P.; Connors, T. J.; Zhu, Y.; Baldwin, M. R.; Lin, W.-H.; Wontakal, S.; Szabo, P. A.; Wells, S. B.; Dogra, P.; Gray, J.; Idzikowski, E.; Stelitano, D.; Bovier, F. T.; Davis-Porada, J.; Matsumoto, R.; Poon, M. M. L.; Chait, M.; Mathieu, C.; Horvat, B.; Decimo, D.; Hudson, K. E.; Zotti, F. D.; Bitan, Z. C.; La Carpia, F.; Ferrara, S. A.; Mace, E.; Milner, J.; Moscona, A.; Hod, E.; Porotto, M.; Farber, D. L., Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nature Immunology 2020. https://doi.org/10.1038/s41590-020-00826-9
709. Weissman, D.; Alameh, M. G.; de Silva, T.; Collini, P.; Hornsby, H.; Brown, R.; LaBranche, C. C.; Edwards, R. J.; Sutherland, L.; Santra, S.; Mansouri, K.; Gobeil, S.; McDanal, C.; Pardi, N.; Hengartner, N.; Lin, P. J. C.; Tam, Y.; Shaw, P. A.; Lewis, M. G.; Boesler, C.; Şahin, U.; Acharya, P.; Haynes, B. F.; Korber, B.; Montefiori, D. C., D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization. Cell Host Microbe 2020.
710. Weissman, D. N.; de Perio, M. A.; Radonovich, L. J., Jr, COVID-19 and Risks Posed to Personnel During Endotracheal Intubation. JAMA 2020. https://doi.org/10.1001/jama.2020.6627
711. Wellinghausen, N.; Plonné, D.; Voss, M.; Ivanova, R.; Frodl, R.; Deininger, S., SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons. Journal of Clinical Virology 2020, 130, 104542. http://www.sciencedirect.com/science/article/pii/S1386653220302845 
712. Westblade, L. F.; Brar, G.; Pinheiro, L. C.; Paidoussis, D.; Rajan, M.; Martin, P.; Goyal, P.; Sepulveda, J. L.; Zhang, L.; George, G.; Liu, D.; Whittier, S.; Plate, M.; Small, C. B.; Rand, J. H.; Cushing, M. M.; Walsh, T. J.; Cooke, J.; Safford, M. M.; Loda, M.; Satlin, M. J., SARS-CoV-2 Viral Load Predicts Mortality in Patients with and Without Cancer Who Are Hospitalized with COVID-19. Cancer Cell 2020. http://www.sciencedirect.com/science/article/pii/S1535610820304815
713. Whitman, J. D.; Hiatt, J.; Mowrey, C. T.; al., e., Test performance evaluation of SARS-CoV-2 serological assays. Unpublished Preprint 2020. https://www.dropbox.com/s/cd1628cau09288a/SARS- CoV-2_Serology_Manuscript.pdf?dl=0
714. Whittaker, E.; Bamford, A.; Kenny, J.; Kaforou, M.; Jones, C. E.; Shah, P.; Ramnarayan, P.; Fraisse, A.; Miller, O.; Davies, P.; Kucera, F.; Brierley, J.; McDougall, M.; Carter, M.; Tremoulet, A.; Shimizu, C.; Herberg, J.; Burns, J. C.; Lyall, H.; Levin, M.; Group, f. t. P.-T. S.; EUCLIDS; Consortia, P., Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA 2020, 324 (3), 259-269. https://doi.org/10.1001/jama.2020.10369 
715. Whitworth, C.; Mu, Y.; Houston, H.; Martinez-Smith, M.; Noble-Wang, J.; Coulliette-Salmond, A.; Rose, L., Persistence of Bacteriophage Phi 6 on Porous and Nonporous Surfaces and the Potential for Its Use as an Ebola Virus or Coronavirus Surrogate. Applied and Environmental Microbiology 2020, 86 (17), e01482-20. https://aem.asm.org/content/aem/86/17/e01482-20.full.pdf
716. Whitworth, J., U.S. FDA ‘aware’ of China testing food for coronavirus. https://www.foodsafetynews.com/2020/06/u-s-fda-aware-of-china-testing-food-for-coronavirus/ (accessed 06/22/2020).
717. WHO, Advice on the use of masks on the context of COVID-19. Interim Guidance. 5 June 2020.; World Health Organization: 2020. https://www.who.int/emergencies/diseases/novel-coronavirus- 2019/advice-for-public/when-and-how-to-use-masks
718. WHO, "Immunity passports" in the context of COVID-19; World Health Organization: 2020. https://www.who.int/news-room/commentaries/detail/immunity-passports-in-the-context-of-covid-19 
719. WHO, Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected; 2020. https://www.who.int/publications-detail/infection-prevention-and-control-during- health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125
720. WHO, International Nonproprietary Names for Pharmaceutical Substances (INN). https://www.who.int/medicines/publications/druginformation/issues/WHO_DI_34-3_PL124- SpecialEdition.pdf.
721. WHO, Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases.
722. WHO, Mask use in the context of COVID-19; World Health Organization: 1 December 2020, 2020. https://apps.who.int/iris/rest/bitstreams/1319378/retrieve
723. WHO, Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. World Health Organization: 2020. https://www.who.int/news- room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with- covid-19
724. WHO, Transmission of SARS-CoV-2: implications for infection prevention precautions; World Health Organization: 2020. https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2- implications-for-infection-prevention-precautions
725. Widge, A. T.; Rouphael, N. G.; Jackson, L. A.; Anderson, E. J.; Roberts, P. C.; Makhene, M.; Chappell, J. D.; Denison, M. R.; Stevens, L. J.; Pruijssers, A. J.; McDermott, A. B.; Flach, B.; Lin, B. C.; Doria-Rose, N. A.; O’Dell, S.; Schmidt, S. D.; Neuzil, K. M.; Bennett, H.; Leav, B.; Makowski, M.; Albert, J.; Cross, K.; Edara, V.-V.; Floyd, K.; Suthar, M. S.; Buchanan, W.; Luke, C. J.; Ledgerwood, J. E.; Mascola, J. R.; Graham, B. S.; Beigel, J. H., Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMc2032195
726. Wiersinga, W. J.; Rhodes, A.; Cheng, A. C.; Peacock, S. J.; Prescott, H. C., Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA 2020. https://doi.org/10.1001/jama.2020.12839
727. Williams, S.; Sheard, N.; Stuart, B.; Phan, H. T. T.; Borca, F.; Wilkinson, T. M. A.; Burke, H.; Freeman, A.; Investigators, R. C., Comparisons of early and late presentation to hospital in COVID-19 patients. Respirology 2020, n/a (n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/resp.13985
728. Wölfel, R.; Corman, V. M.; Guggemos, W.; Seilmaier, M.; Zange, S.; Müller, M. A.; Niemeyer, D.; Jones, T. C.; Vollmar, P.; Rothe, C.; Hoelscher, M.; Bleicker, T.; Brünink, S.; Schneider, J.; Ehmann, R.; Zwirglmaier, K.; Drosten, C.; Wendtner, C., Virological assessment of hospitalized patients with COVID- 2019. Nature 2020. https://doi.org/10.1038/s41586-020-2196-x
729. Wong, F.; Collins, J. J., Evidence that coronavirus superspreading is fat-tailed. Proceedings of the National Academy of Sciences 2020, 202018490. https://www.pnas.org/content/pnas/early/2020/10/30/2018490117.full.pdf
730. Wong, M. C.; Javornik Cregeen, S. J.; Ajami, N. J.; Petrosino, J. F., Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019. bioRxiv 2020, 2020.02.07.939207. https://www.biorxiv.org/content/biorxiv/early/2020/02/13/2020.02.07.939207.full.pdf
731. Wong, Y. C.; Lau, S. Y.; Wang To, K. K.; Mok, B. W. Y.; Li, X.; Wang, P.; Deng, S.; Woo, K. F.; Du, Z.; Li, C.; Zhou, J.; Woo Chan, J. F.; Yuen, K. Y.; Chen, H.; Chen, Z., Natural transmission of bat-like SARS-CoV- 2PRRA variants in COVID-19 patients. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa953
732. Woodworth, K. R.; Olsen, E. O. M.; Neelam, V.; Lewis, E. L.; Galang, R. R.; Oduyebo, T.; Aveni, K.; Yazdy, M. M.; Harvey, E.; Longcore, N. D.; Barton, J.; Fussman, C.; Siebman, S.; Lush, M.; Patrick, P. H.; Halai, U.-A.; Valencia-Prado, M.; Orkis, L.; Sowunmi, S.; Schlosser, L.; Khuwaja, S.; Read, J. S.; Hall, A. J.; Meaney-Delman, D.; Ellington, S. R.; Gilboa, S. M.; Tong, V. T., Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy. SET-NET, 16 Jurisdictions, March 29–October 14, 2020. https://www.cdc.gov/mmwr/volumes/69/wr/mm6944e2.htm?s_cid=mm6944e2_w.
733. Woolf, S. H.; Chapman, D. A.; Sabo, R. T.; Weinberger, D. M.; Hill, L., Excess Deaths From COVID-19 and Other Causes, March-April 2020. JAMA 2020. https://doi.org/10.1001/jama.2020.11787
734. Woolsey, C. B.; Borisevich, V.; Prasad, A. N.; Agans, K. N.; Deer, D. J.; Dobias, N. S.; Heymann, J. C.; Foster, S. L.; Levine, C. B.; Medina, L.; Melody, K.; Geisbert, J. B.; Fenton, K. A.; Geisbert, T. W.; Cross, R. W., Establishment of an African green monkey model for COVID-19. bioRxiv 2020, 2020.05.17.100289. http://biorxiv.org/content/early/2020/05/17/2020.05.17.100289.abstract
735. Worthham, J. M.; Lee, J. T.; Althomsons, S.; al., e., Characteristics of Persons Who Died with COVID- 19 — United States, February 12–May 18, 2020. Morbidity and Mortality Weekly Report 2020, ePub: July 10, 2020 (69). https://www.cdc.gov/mmwr/volumes/69/wr/mm6928e1.htm
736. Wrapp, D.; Wang, N.; Corbett, K. S.; Goldsmith, J. A.; Hsieh, C.-L.; Abiona, O.; Graham, B. S.; McLellan, J. S., Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. bioRxiv 2020, 2020.02.11.944462. https://www.biorxiv.org/content/biorxiv/early/2020/02/15/2020.02.11.944462.full.pdf
737. Wright, E. S.; Lakdawala, S. S.; Cooper, V. S., SARS-CoV-2 genome evolution exposes early human adaptations. bioRxiv 2020, 2020.05.26.117069. https://www.biorxiv.org/content/biorxiv/early/2020/05/26/2020.05.26.117069.full.pdf
738. Wu, C.; Hou, D.; Du, C.; Cai, Y.; Zheng, J.; Xu, J.; Chen, X.; Chen, C.; Hu, X.; Zhang, Y.; Song, J.; Wang, L.; Chao, Y. C.; Feng, Y.; Xiong, W.; Chen, D.; Zhong, M.; Hu, J.; Jiang, J.; Bai, C.; Zhou, X.; Xu, J.; Song, Y.; Gong, F., Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis. Crit Care 2020, 24 (1), 643.
739. Wu, G.; Yang, P.; Xie, Y.; Woodruff, H. C.; Rao, X.; Guiot, J.; Frix, A.-N.; Louis, R.; Moutschen, M.; Li, J.; Li, J.; Yan, C.; Du, D.; Zhao, S.; Ding, Y.; Liu, B.; Sun, W.; Albarello, F.; D'Abramo, A.; Schininà, V.; Nicastri, E.; Occhipinti, M.; Barisione, G.; Barisione, E.; Halilaj, I.; Lovinfosse, P.; Wang, X.; Wu, J.; Lambin, P., Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID- 19 Patients at Hospital Admission: an International Multicenter Study. European Respiratory Journal 2020, 2001104. https://erj.ersjournals.com/content/erj/early/2020/06/25/13993003.01104- 2020.full.pdf
740. Wu, J. T.; Leung, K.; Leung, G. M., Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet 2020. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30260-9/fulltext
741. Wu, L.-P.; Wang, N.-C.; Chang, Y.-H.; Tian, X.-Y.; Na, D.-Y.; Zhang, L.-Y.; Zheng, L.; Lan, T.; Wang, L.- F.; Liang, G.-D., Duration of antibody responses after severe acute respiratory syndrome. Emerging infectious diseases 2007, 13 (10), 1562. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851497/pdf/07-0576_finalD.pdf
742. Xiao, K.; Zhai, J.; Feng, Y.; Zhou, N.; Zhang, X.; Zou, J. J.; Li, N.; Guo, Y.; Li, X.; Shen, X.; Zhang, Z.; Shu, F.; Huang, W.; Li, Y.; Zhang, Z.; Chen, R. A.; Wu, Y. J.; Peng, S. M.; Huang, M.; Xie, W. J.; Cai, Q. H.; Hou, F. H.; Chen, W.; Xiao, L.; Shen, Y., Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Nature 2020.
743. Xie, Y.; Bowe, B.; Maddukuri, G.; Al-Aly, Z., Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study. BMJ 2020, 371, m4677. https://www.bmj.com/content/bmj/371/bmj.m4677.full.pdf
744. Xinhua, China detects large quantity of novel coronavirus at Wuhan seafood market http://www.xinhuanet.com/english/2020-01/27/c_138735677.htm.
745. Xu, X. K.; Liu, X. F.; Wu, Y.; Ali, S. T.; Du, Z.; Bosetti, P.; Lau, E. H. Y.; Cowling, B. J.; Wang, L., Reconstruction of Transmission Pairs for novel Coronavirus Disease 2019 (COVID-19) in mainland China: Estimation of Super-spreading Events, Serial Interval, and Hazard of Infection. Clin Infect Dis 2020.
746. Yan, C. H.; Faraji, F.; Prajapati, D. P.; Boone, C. E.; DeConde, A. S., In Association of chemosensory dysfunction and Covid-19 in patients presenting with influenza-like symptoms. International Forum of Allergy & Rhinology, Wiley Online Library: 2020.
747. Yan, F.; Huang, F.; Xu, J.; Yang, P.; Qin, Y.; Lv, J.; Zhang, S.; Ye, L.; Gong, M.; Liu, Z.; Wei, J.; Xie, T.; Xu, K. F.; Gao, G. F.; Wang, F. S.; Cai, L.; Jiang, C., Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients. Cell Discov 2020, 6 (1), 77.
748. Yan, L.; Shu, K.; Guan, J.; Shanchang, H., Unusual Features of the SARS-CoV-2 Genome Suggesting Sophisticated Laboratory Modification Rather Than Natural Evolution and Delineation of Its Probable Synthetic Route. Zenodo 2020. https://zenodo.org/record/4028830#.X3JdatpKiUn
749. Yang, C.; Jiang, M.; Wang, X.; Tang, X.; Fang, S.; Li, H.; Zuo, L.; Jiang, Y.; Zhong, Y.; Chen, Q.; Zheng, C.; Wang, L.; Wu, S.; Wu, W.; Liu, H.; Yuan, J.; Liao, X.; Zhang, Z.; Shi, X.; Geng, Y.; Zhang, H.; Zheng, H.; Wan, M.; Lu, L.; Ren, X.; Cui, Y.; Zou, X.; Feng, T.; Xia, J.; Yang, R.; Liu, Y.; Mei, S.; Li, B.; Yang, Z.; Hu, Q., Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study. Emerging Microbes & Infections 2020, 9 (1), 2368-2378. https://doi.org/10.1080/22221751.2020.1837018
750. Yang, L.; Dai, J.; Zhao, J.; Wang, Y.; Deng, P.; Wang, J., Estimation of incubation period and serial interval of COVID-19: analysis of 178 cases and 131 transmission chains in Hubei province, China. Epidemiology and Infection 2020, 148, e117. https://www.cambridge.org/core/article/estimation-of- incubation-period-and-serial-interval-of-covid19-analysis-of-178-cases-and-131-transmission-chains-in- hubei-province-china/C1B194C01268F005AAFBE8D50CB5F945
751. Yang, P.; Qi, J.; Zhang, S.; Bi, G.; Wang, X.; Yang, Y.; Sheng, B.; Mao, X., Feasibility of Controlling COVID-19 Outbreaks in the UK by Rolling Interventions. medRxiv 2020, 2020.04.05.20054429. https://www.medrxiv.org/content/medrxiv/early/2020/04/07/2020.04.05.20054429.full.pdf
752. Yap, T. F.; Liu, Z.; Shveda, R. A.; Preston, D. J., A predictive model of the temperature-dependent inactivation of coronaviruses. Applied Physics Letters 2020, 117 (6), 060601. https://aip.scitation.org/doi/abs/10.1063/5.0020782
753. Yehya, N.; Venkataramani, A.; Harhay, M. O., Statewide Interventions and Covid-19 Mortality in the United States: An Observational Study. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa923
754. Yekta, R.; Vahid-Dastjerdi, L.; Norouzbeigi, S.; Mortazavian, A. M., Food Products as Potential Carriers of SARS-CoV-2. Food Control 2020, 107754. http://www.sciencedirect.com/science/article/pii/S0956713520306708
755. Yonker, L. M.; Neilan, A. M.; Bartsch, Y.; Patel, A. B.; Regan, J.; Arya, P.; Gootkind, E.; Park, G.; Hardcastle, M.; St. John, A.; Appleman, L.; Chiu, M. L.; Fialkowski, A.; De la Flor, D.; Lima, R.; Bordt, E. A.; Yockey, L. J.; D’Avino, P.; Fischinger, S.; Shui, J. E.; Lerou, P. H.; Bonventre, J. V.; Yu, X. G.; Ryan, E. T.; Bassett, I. V.; Irimia, D.; Edlow, A. G.; Alter, G.; Li, J. Z.; Fasano, A., Pediatric SARS-CoV-2: Clinical Presentation, Infectivity, and Immune Responses. The Journal of Pediatrics 2020. https://doi.org/10.1016/j.jpeds.2020.08.037
756. Yu, B.; Li, C.; Sun, Y.; Wang, D. W., Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes. Cell Metab 2020.
757. Yu, W.-B.; Tang, G.-D.; Zhang, L.; Corlett, R. T., Decoding evolution and transmissions of novel pneumonia coronavirus using the whole genomic data. ChinaXiv 2020. http://www.chinaxiv.org/abs/202002.00033
758. Yuki, F.; Eiichiro, S.; Naho, T.; Reiko, M.; Ikkoh, Y.; Yura, K. K.; Mayuko, S.; Konosuke, M.; Takeaki, I.; Yugo, S.; Shohei, N.; Kazuaki, J.; Tadatsugu, I.; Tomimasa, S.; Motoi, S.; Hiroshi, N.; Hitoshi, O., Clusters of Coronavirus Disease in Communities, Japan, January–April 2020. Emerging Infectious Disease journal 2020, 26 (9). https://wwwnc.cdc.gov/eid/article/26/9/20-2272_article
759. Zangmeister, C. D.; Radney, J. G.; Vicenzi, E. P.; Weaver, J. L., Filtration Efficiencies of Nanoscale Aerosol by Cloth Mask Materials Used to Slow the Spread of SARS CoV-2. ACS Nano 2020. https://doi.org/10.1021/acsnano.0c05025
760. Zeng, H.-L.; Lu, Q.-B.; Yang, Q.; Wang, X.; Yue, D.-Y.; Zhang, L.-K.; Li, H.; Liu, W.; Li, H.-J., Longitudinal Profile of Laboratory Parameters and Their Application in the Prediction for Fatal Outcome Among Patients Infected With SARS-CoV-2: A Retrospective Cohort Study. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa574
761. Zhang, J.; Wu, J.; Sun, X.; Xue, H.; Shao, J.; Cai, W.; Jing, Y.; Yue, M.; Dong, C., Associations of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis. Epidemiology and Infection 2020, 1-19. https://www.cambridge.org/core/article/associations-of-hypertension-with-the- severity-and-fatality-of-sarscov2-infection-a-metaanalysis/4116FAD7D866737099F976E7E7FAEB15
762. Zhang, L.; Jackson, C. B.; Mou, H.; Ojha, A.; Rangarajan, E. S.; Izard, T.; Farzan, M.; Choe, H., The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv 2020, 2020.06.12.148726. http://biorxiv.org/content/early/2020/06/12/2020.06.12.148726.abstract 
763. Zhang, Q.; Zhang, H.; Huang, K.; Yang, Y.; Hui, X.; Gao, J.; He, X.; Li, C.; Gong, W.; Zhang, Y.; Peng, C.; Gao, X.; Chen, H.; Zou, Z.; Shi, Z.; Jin, M., SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation. bioRxiv 2020, 2020.04.01.021196. http://biorxiv.org/content/early/2020/04/03/2020.04.01.021196.abstract
764. Zhang, T.; Wu, Q.; Zhang, Z., Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak. Current Biology 2020, 30 (7), 1346-1351.e2. http://www.sciencedirect.com/science/article/pii/S0960982220303602
765. Zhang, Y.; Muscatello, D.; Tian, Y.; Chen, Y.; Li, S.; Duan, W.; Ma, C.; Sun, Y.; Wu, S.; Ge, L.; Yang, P.; Jia, L.; Wang, Q.; MacIntyre, C. R., Role of presymptomatic transmission of COVID-19: evidence from Beijing, China. Journal of Epidemiology and Community Health 2020, jech-2020-214635. https://jech.bmj.com/content/jech/early/2020/08/26/jech-2020-214635.full.pdf
766. Zhao; Musa; Lin; Ran; Yang; Wang; Lou; Yang; Gao; He; Wang., Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Modelling Analysis of the Early Outbreak. Journal of Clinical Medicine 2020, 9 (2), 388.
767. Zhao, G.; Jiang, Y.; Qiu, H.; Gao, T.; Zeng, Y.; Guo, Y.; Yu, H.; Li, J.; Kou, Z.; Du, L.; Tan, W.; Jiang, S.; Sun, S.; Zhou, Y., Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus. PLoS One 2015, 10 (12), e0145561. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689477/pdf/pone.0145561.pdf
768. Zhao, J.; Yuan, Q.; Wang, H.; Liu, W.; Liao, X.; Su, Y.; Wang, X.; Yuan, J.; Li, T.; Li, J.; Qian, S.; Hong, C.; Wang, F.; Liu, Y.; Wang, Z.; He, Q.; He, B.; Zhang, T.; Ge, S.; Liu, L.; Zhang, J.; Xia, N.; Zhang, Z., Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019. SSRN 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3546052#
769. Zhao, L.; Qi, Y.; Luzzatto-Fegiz, P.; Cui, Y.; Zhu, Y., COVID-19: Effects of Environmental Conditions on the Propagation of Respiratory Droplets. Nano Letters 2020, 20 (10), 7744-7750. https://doi.org/10.1021/acs.nanolett.0c03331
770. Zhen-Dong, T.; An, T.; Ke-Feng, L.; Peng, L.; Hong-Ling, W.; Jing-Ping, Y.; Yong-Li, Z.; Jian-Bo, Y., Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerging Infectious Disease journal 2020, 26 (5). https://wwwnc.cdc.gov/eid/article/26/5/20-0198_article
771. Zheng, H.; Li, H.; Guo, L.; Liang, Y.; Li, J.; Wang, X.; Hu, Y.; Wang, L.; Liao, Y.; Yang, F.; Li, Y.; Fan, S.; Li, D.; Cui, P.; Wang, Q.; Shi, H.; Chen, Y.; Yang, Z.; Yang, J.; Shen, D.; Cun, W.; Zhou, X.; Dong, X.; Wang, Y.; Chen, Y.; Dai, Q.; Jin, W.; He, Z.; Li, Q.; Liu, L., Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression. PLOS Pathogens 2020, 16 (11), e1008949. https://doi.org/10.1371/journal.ppat.1008949
772. Zhifei, A., Vaccine to undergo 3rd phase of trials. http://en.nhc.gov.cn/2020-11/20/c_82209.htm. 
773. Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; Guan, L.; Wei, Y.; Li, H.; Wu, X.; Xu, J.; Tu, S.; Zhang, Y.; Chen, H.; Cao, B., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. https://doi.org/10.1016/S0140-6736(20)30566-3
774. Zhou, H.; Chen, X.; Hu, T.; Li, J.; Song, H.; Liu, Y.; Wang, P.; Liu, D.; Yang, J.; Holmes, E. C.; Hughes, A. C.; Bi, Y.; Shi, W., A novel bat coronavirus reveals natural insertions at the S1/S2 cleavage site of the Spike protein and a possible recombinant origin of HCoV-19. bioRxiv 2020, 2020.03.02.974139. https://www.biorxiv.org/content/biorxiv/early/2020/03/11/2020.03.02.974139.full.pdf
775. Zhou, L.; Yao, M.; Zhang, X.; Hu, B.; Li, X.; Chen, H.; Zhang, L.; Liu, Y.; Du, M.; Sun, B.; Jiang, Y.; Zhou, K.; Hong, J.; Yu, N.; Ding, Z.; Xu, Y.; Hu, M.; Morawska, L.; Grinshpun, S. A.; Biswas, P.; Flagan, R. C.; Zhu, B.; Liu, W.; Zhang, Y., Breath-, air- and surface-borne SARS-CoV-2 in hospitals. Journal of Aerosol Science 2020, 105693. http://www.sciencedirect.com/science/article/pii/S0021850220301786
776. Zhou, P.; Yang, X.-L.; Wang, X.-G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.-R.; Zhu, Y.; Li, B.; Huang, C.-L.; Chen, H.-D.; Chen, J.; Luo, Y.; Guo, H.; Jiang, R.-D.; Liu, M.-Q.; Chen, Y.; Shen, X.-R.; Wang, X.; Zheng, X.- S.; Zhao, K.; Chen, Q.-J.; Deng, F.; Liu, L.-L.; Yan, B.; Zhan, F.-X.; Wang, Y.-Y.; Xiao, G.; Shi, Z.-L., Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv 2020, 2020.01.22.914952. https://www.biorxiv.org/content/biorxiv/early/2020/01/23/2020.01.22.914952.1.full.pdf
777. Zhu, F.-C.; Guan, X.-H.; Li, Y.-H.; Huang, J.-Y.; Jiang, T.; Hou, L.-H.; Li, J.-X.; Yang, B.-F.; Wang, L.; Wang, W.-J.; Wu, S.-P.; Wang, Z.; Wu, X.-H.; Xu, J.-J.; Zhang, Z.; Jia, S.-Y.; Wang, B.-S.; Hu, Y.; Liu, J.-J.; Zhang, J.; Qian, X.-A.; Li, Q.; Pan, H.-X.; Jiang, H.-D.; Deng, P.; Gou, J.-B.; Wang, X.-W.; Wang, X.-H.; Chen, W., Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet 2020. https://doi.org/10.1016/S0140-6736(20)31605-6
778. Zhu, S.; Zong, Z., Why did so few healthcare workers in China get COVID-19 infection. QJM: An International Journal of Medicine 2020.
779. Zhu, Y.; Bloxham, C. J.; Hulme, K. D.; Sinclair, J. E.; Tong, Z. W. M.; Steele, L. E.; Noye, E. C.; Lu, J.; Xia, Y.; Chew, K. Y.; Pickering, J.; Gilks, C.; Bowen, A. C.; Short, K. R., A meta-analysis on the role of children in SARS-CoV-2 in household transmission clusters. Clinical Infectious Diseases 2020. https://doi.org/10.1093/cid/ciaa1825
780. Zietz, M.; Zucker, J.; Tatonetti, N. P., Associations between blood type and COVID-19 infection, intubation, and death. Nature Communications 2020, 11 (1), 5761. https://doi.org/10.1038/s41467-020- 19623-x
781. Zou, L.; Ruan, F.; Huang, M.; Liang, L.; Huang, H.; Hong, Z.; Yu, J.; Kang, M.; Song, Y.; Xia, J.; Guo, Q.; Song, T.; He, J.; Yen, H.-L.; Peiris, M.; Wu, J., SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. New England Journal of Medicine 2020. https://www.nejm.org/doi/full/10.1056/NEJMc2001737
782. Zuo, J.; Dowell, A.; Pearce, H.; Verma, K.; Long, H.; Begum, J.; Aiano, F.; Amin-Chowdhury, Z.; Hallis, B.; Stapley, L.; Borrow, R.; Linley, E.; Ahmad, S.; Parker, B.; Horsley, A.; Amirthalingam, G.; Brown, K.; Ramsay, M. E.; Ladhani, S.; Moss, P., Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection. bioRxiv 2020, 2020.11.01.362319. https://www.biorxiv.org/content/biorxiv/early/2020/11/02/2020.11.01.362319.full.pdf
783. Dobolyi, K., Surfactant protein-D and pulmonary host defense. Fake Jounral. http://www.cnn.com